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Biological systems are commonly modeled as reaction networks, which describe the system at
the resolution of biochemical species. Cellular systems, however, are governed by events at a
finer scale: local interactions among macromolecular domains. The multi-domain structure
of macromolecules, combined with the local nature of interactions, can lead to a combina-
torial explosion that pushes reaction network methods to their limits. As an alternative,
rule-based models (RBMs) describe the domain-based structure and local interactions found
in biological systems. Molecular complexes are represented by graphs: functional domains as
vertices, macromolecules as groupings of vertices, and molecular bonding as edges. Reaction
rules, which describe classes of reactions, govern local modifications to molecular graphs,
such as binding, post-translational modification, and degradation. RBMs can be trans-
formed to equivalent reaction networks and simulated by differential or stochastic methods,
or simulated directly with a network-free approach that avoids the problem of combinatorial
complexity.
Although RBMs and network-free methods resolve many problems in systems modeling,
challenges remain. I address three challenges here: (i) managing model complexity due to
cooperative interactions, (ii) representing biochemical systems in the compartmental setting
of cells and organisms, and (iii) reducing the memory burden of large-scale network-free sim-
ulations. First, I present a general theory of energy-based modeling within the BioNetGen
framework. Free energy is computed under a pattern-based formalism, and contextual vari-
iii
ations within reaction classes are enumerated automatically. Next, I extend the BioNetGen
language to permit description of compartmentalized biochemical systems, with treatment of
volumes, surfaces and transport. Finally, a hybrid particle/population method is developed
to reduce memory requirements of network-free simulations. All methods are implemented
and available as part of BioNetGen.
The remainder of this work presents an application to sepsis and inflammation. A
multi-organ model of peritoneal infection and systemic inflammation is constructed and
calibrated to experiment. Extra-corporeal blood purification, a potential treatment for sep-
sis, is explored in silico. Model simulations demonstrate that removal of blood cytokines and
chemokines is a sufficient mechanism for improved survival in sepsis. However, differences
between model predictions and the latest experimental data suggest directions for further
exploration.
Keywords: rule-based modeling, biochemical kinetics, cell signaling, sepsis, inflammation,
hemoadsorption.
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1.0 RULE-BASED MODELING OF BIOCHEMICAL SYSTEMS
This chapter introduces reaction network and rule-based formalisms for modeling the kinet-
ics of biochemical systems. First, I review reaction network formalism for kinetic modeling,
the workhouse of systems modeling. The standard methods for generating trajectories from
network models are presented, including continuous and discrete stochastic methods. Par-
ticular attention will be paid to the limitations of network-based methods in the context of
cell signaling applications. Next, I will present Rule-based modeling as a solution to some of
the limitations of network methods. The connection between rule-based models and reaction
network, via network generation, will be presented. Network-free simulation methods, which
extend simulation capability to massive and infinite networks, will be described. Finally,
limitations of rule-based modeling will be discussed, which provides the starting point for
methodological developments in subsequent chapters.
1.1 SYSTEMS BIOLOGY
If the task of the “omics”, e.g. genomics and proteomics, is cataloging the parts of the cell
and establishing the basic relationships among the parts; then the task of systems biology is
understanding how parts come together to form systems that sense the environment, make
decisions, and regulate the cellular activity [1]. There are two contrasting but complementary
approaches to the task. The first is a data-driven approach, a natural extension of the
“omics”. The data driven paradigm emphasizes high-throughput experiments that collect
data on a whole cell scale, such as microarray expression studies. Statistical analysis and
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machine learning methods are then applied to the data set with the intent of finding patterns
and relationships in the data.
The big-data approach stands in contrast to the mechanistic modeling approach. Mecha-
nistic modeling, a bottom-up approach, has roots in the principles of physics and chemistry.
Mechanistic models begin with only a few parts and the interactions among them and con-
struct formal models based on a biochemical and biophysical understanding of the interac-
tions. The models are analyzed with both qualitative and quantitative methods to determine
the properties of the system. As the small system is understood in isolation, the scope of the
model is expanded to include more of the surrounding context. As the scope of mechanistic
modeling increases, the necessity of reconciling mechanistic models with big-data becomes
apparent. Thus, the two contrasting approaches are complementary in the end. Indeed, a
number of studies that combine high-throughput data with mechanistic models have been
published [2–4]
The holy grail of mechanistic modeling is a complete model of the cell based on biophysical
and biochemistry principles. Much progress has been made towards a complete model of
the cell. A complete genomic and biochemical model of the simple bacterium Mycoplasma
genitalium, published in 2012 [5], demonstrates progress towards this goal. But much work
remains, especially in regards to eukaryotic cells, which are an order of magnitude more
complex than bacteria.
Understanding the behavior of biochemical systems is a difficult task that often confounds
our natural intuition. Simple biochemical circuits are capable of producing a wide variety of
behaviors, such as linear response, step response, oscillations, on-off switching, and so forth
[6]. Predicting the behavior of a system requires knowledge of the mathematical relationships
between the components. Furthermore, two systems with the same mathematical form but
different parameters can behave very differently. For example, a negative feedback amplifier
can become an oscillator with only a change in parameter values. Therefore, it is important
to analyze dynamical systems with quantitative methods rather than relying on intuition.
Nonetheless, there do exist rigorous qualitative analysis methods for dynamical systems.
Uri Alon et al. [7–9] identified a number of regulatory motifs that are capable of specific
kinds of behavior. Although the presence of a motif is not always a sufficient condition for a
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certain behavior, it is often necessary condition. Thus, qualitative methods are a useful tool
when anchored to theoretical underpinnings.
Biochemical systems are non-linear and, as there is no grand theory of non-linear dy-
namics, it is often necessary to rely on numerical simulations of biochemical systems. Com-
putational methods are especially important for large systems with multiple feedback loops
and a variety of network motifs that confound intuition.
1.2 REACTION NETWORK MODELING
The reaction network (RN) is a common formalism for kinetic modeling of biochemical
systems [10]. A reaction network is composed of a set of biochemical species, and a set of
reactions that describe transformations of species from one kind to another, and a propensity
(i.e. rate) function for each reaction. RNs can be interpreted as continuous or discrete
stochastic process. The former can be represented as systems of ODEs and the later as
continuous-time, discrete-state Markov chains. RNs are a workhorse of systems modeling,
with successful applications in cell cycle regulation [11–14], extrinsic apoptosis [15,16], EGF
receptor signaling [17, 18], the MAP kinase cascade [19], inflammation [20–23] and many
more.
RN is best illustrated by example. Consider a simple model of ligand-induced recep-
tor phosphorylation. Let {L, R, LR, LRp} be a set of species representing free ligand, free
receptor, ligand-receptor complex, and phosphorylated ligand-receptor complex. The set of
reactions describes the biochemical interactions among the species: ligand-receptor binding,
and receptor phosphorylation.
L + R
k1+,k1− LR
LR
k2→ LRp
LRp
k3→ LR
The species on the left-hand side of a reaction are called reactants and those on the
right-hand side are products. The arrow,→, represents the direction of the reaction (usually
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left to right). A bi-directional arrow,, indicates that the reaction can be reversed, i.e. the
products will transform into the reactants. The parameters k1+, k2−, etc. are mass-action
rate constants (more on this below).
In the present example there are four reactions (one reversible, and two irreversible). The
first reaction transforms a free ligand L and a free receptor R into a ligand-receptor complex
LR. The reaction is bimolecular since their are two reactants. The reverse reaction does the
opposite: a ligand-receptor complex dissociates into free ligand and free receptor. The third
reaction transforms a ligand-receptor complex into a phosphorylated receptor complex LRp.
This reaction is unimolecular since it has just one reactant. The final reaction is the reverse
of the third. If the mechanism of the forward and reverse reaction is distinct, by convention
the reactions are written separately rather than as single reversible reaction. In this case,
phosphorylation and dephosphorylation are usually accomplished by different enzymes, so
the reactions are written separately.
Note that the names of the species are entirely arbitrary in a RN, so long as distinct
species have distinct names. In the example, the names were chosen to imply the biochemical
role of the species, e.g. the ligand is represented by L. However, the species could be labeled
in a nondescript fashion, such as X1, X2, and so forth. An important implication of this
fact is that the names do not necessarily contain any information about the composition of
the biochemical species. For example, we may infer that LR is a ligand-receptor dimer, but
a species like X2 is a black box. Consistent naming conventions are important for human-
readability. But even the best conventions, unless formalized, are prone to misinterpretation.
1.2.1 Mass-action kinetics
Mass-action kinetics, sometimes mistakenly called the Law of Mass Action, states that the
rate of a reaction is proportional to the product of reactant concentrations (see, e.g. [24]).
Mass-action kinetics can be derived from collision theory under the assumptions of well-
mixed conditions and elementary reaction mechanism, i.e. the reaction occurs in one step.
For this reason, mass-action kinetics are also called elementary kinetics. In the example
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above, mass-action kinetics assigns the following reaction rates:
rate1 = k1+[L][R]
rate2 = k1−[LR]
rate3 = k2[LR]
rate4 = k3[LRp].
Mass-action kinetics are often applied in the continuum limit of large particle concentra-
tions, where rates can be interpreted as a continuous flux of mass through the reaction. But
mass-action principles also apply to discrete systems, where the rate is interpreted as the
probability the reaction will “fire” per unit time. In a seminal 1976 paper, D.T. Gillespie [25]
derived mass-action kinetics for discrete stochastic systems. Gillespie showed that, under
certain assumptions, the probability for a specific set of particles to react via reaction r in
the infinitesimal time interval δt is given by kδt, where k is the per instance rate constant.
The total probability for any set of particles to react is given by the rate constant multiplied
by a combinatorial factor corresponding to the number of distinct reactant sets.
Consider the simple reaction A + B -> C with rate constant k. Let the population
vector ~x = (xA, xB) have number units. Each pair of particles A and B has a probability kδt
of reacting in time δt. Assuming the population vector has number units, there are xAxB
ways to select a pair of reactants. Thus the probability of any pair reacting in the interval
δt is kxAxBδt, corresponding to a total rate kxAxB.
The combinatorial factor is somewhat more complicated when two or more reactants
belong to identical species. Nonetheless, it is still a simple matter of combinatorics. Consider
the reaction A + A -> B. The number of ways to choose a pair of A particles is:(
xA
2
)
=
xA(xA − 1)
2
.
Thus the total reaction rate is:
k
xA(xA − 1)
2
. (1.1)
In limit of large concentrations, the total rate approaches kx2A/2, which is the continuum
mass action rate with constant k/2. There should be no confusion about the origin of the
factor of 2; this is a simple consequence of combinatorics.
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1.2.2 Non-elementary kinetics
Non-elementary reaction rates are common in biological systems models. Non-elementary
rates are appropriate where the reaction models a multi-step mechanism that is either un-
known or unnecessary to model in detail. Michaelis-Menten kinetics, perhaps the best known
non-elementary kinetic rate, describes a two-step enzymatic reaction:
S + E
k+,k−
 ES kcat→ P + E. (1.2)
The first step is reversible binding of a substrate, S, to enzyme, E. The second step is the
irreversible conversion of substrate to product, P. The Michaelis-Menten mechanism assumes
that the intermediate complex, ES, is in quasi-equilibrium with S and E. Eliminating ES, the
coarse-grain reaction is:
S + E
kcat,kM→ P + E. (1.3)
with reaction rate
kcat[E]tot[S]
kM + [S]
, (1.4)
where [E]tot is the sum of free and bound enzyme, and
kM =
kcat + k−
k+
(1.5)
is the Michaelis constant.
1.2.3 Formal description of reaction networks
Formally, a reaction network is defined by the tuple:
RN |= ( NS ∈ N, NR ∈ N, ~x ∈ NNs , {~rj, ~pj, fj: NNs → R≥0}Nrj=1, ) ,
where NS is the number of species, NR is the number of reactions, ~x is the species population
vector, and ~rj, ~pj, an fj are the reactant vector, the product vector, and the propensity
function for reaction j. The reactant vector encodes the reactants, with ri,j being the number
of species i consumed per reaction j. The product vector is similarly defined. The propensity
function maps the population vector to the propensity of reaction.
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A reaction event transforms the species population vector by consuming the reactants
and yielding the products. To make this precise, define the stoichiometry vector for reaction
j to be ~sj = ~pj − ~rj. Element si,j of the stoichiometry vector is the net change in the
population of species i due to reaction j:
~x
rj7→ ~x+ ~sj.
The propensity function fj(~x) is the rate of reaction j. The function is usually based on
mass-action kinetics, but in general is any function of the population species vector. The
general form of the mass-action propensity function is given by
fj(~x) = k
NS∏
i=1
rj,i∏
n=1
xi − (n− 1)
n
‖~x‖→∞−→ k
NS∏
i=1
x
rj
i
rj!
, (1.6)
with units per time.
Reaction networks are equivalent to stochastic Petri nets, a formal language for modeling
distributed computing systems [26]. Species correspond to places, reactions to transitions,
stoichiometry matrix to arcs, and species populations to tokens. Thus, formal analysis
techniques for Petri nets are equally applicable to reaction networks.
1.2.4 Simulation as a discrete stochastic system
1.2.4.1 Gillespie’s Stochastic Simulation Algorithm (SSA) The Gillespie direct
method is an algorithm for sampling kinetic trajectories from a discrete chemical reaction
system [25, 27, 28]. In the limit of a well-mixed system, it is an exact sampling method.
Since the method is simple and also important to the field, I will outline the algorithm here.
At each step, a reaction is selected to “fire”. The time until the next reaction is sampled
from the exponential distribution with rate given by the sum of reaction propensities, and
the specific reaction is selected by sampling from the propensity-weighted distribution over
all reactions. The reaction is fired by adding the stoichiometry vector to the population
vector and updating the time. Finally, reaction propensities are updated to reflect the new
population vector. Pseudocode for Gillespie’s direct method is listed in Algorithm 1.
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Algorithm 1: Gillespie’s direct method (SSA)
input..: (~sj, fj)
NR
j=1, list of reactions (stoichiometry vector, propensity fcn)
: ~x = (xi)
NS
i=1, initial species population; t, start time; tend, end time
output: ~x, final species population
foreach j ← 1 . . . NR do
a[j]← fj(~x) compute reaction propensity
atot ←
∑NR
j=1 a[j] compute total propensity
while t < tend do fire next reaction
u1, u2 ← Uniform(0, 1)
∆t← − log(u1)/atot time until next reaction
if t+ ∆t ≥ tend then last
j ← min{k : ∑kl=1 a[l] > atotu2} select reaction
t← t+ ∆t update time
~x← ~x+ ~sj update species vector
foreach j ← 1 . . . NR do
a[j]← fj(~x) update propensity
atot ←
∑NR
j=1 a[j]
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The computational cost of each reaction event with respect to the number of reactions,
NR, depends on the cost of selecting the next event and updating propensities. The original
direct method selected the next reaction by direct search, an O(NR) cost. The cost of
updating propensities depends on the density of the reaction dependencies. At worst, every
reaction must be updated, leading to O(NR) cost. But if the number of dependencies per
reaction can be bound below some number k, thenO(1) cost can be achieved by implementing
a dependency graph. In either case, the overall cost is O(NR) per reaction event.
Several variants of the direct method have been developed in an effort to reduce the com-
putational cost. Gibson and Bruck [29] developed the “next reaction method”, which relies
on a heap structure for selecting the next reaction and a dependency graph for propensity
updates. The Gibson-Bruck method reduces the asymptotic cost to O(logNR) per event,
assuming that the number of dependencies per reaction is bounded. Slepoy et al. developed
a constant time algorithm by organizing reactions in logarithmic classes of reaction propen-
sities [30]. The method relies on the assumptions that propensities are bounded above and
below by positive values, and the number of dependencies per reaction is bounded.
In practice, Cao et al. found that the direct method, with reactions presorted by propen-
sity, performed better than the the next reaction method or logarithmic classes on typical
reaction networks [31]. Despite the higher asymptotic cost of the direct method, the constant
factor was dominant for “typical” reaction networks considered.
1.2.4.2 Accelerated simulation methods The time cost of an exact stochastic sim-
ulation depends on various factors in addition to the number of reactions. Perhaps most
important is the propensity of the reactions. As the average reaction propensity increases,
the number of events that fire during a fixed time interval also increases. Accelerated meth-
ods have been developed in an attempt to reduce the cost of such simulations. The τ -leaping
method assumes the number of times a reaction fires in a fixed interval τ is Poisson dis-
tributed [32–34]. This approximation holds so long the expected relative change in propen-
sity during the fixed interval is small. The simulation parameter 0 <  1 sets the tolerance
of the approximation. As  goes to zero, τ -leaping converges to the exact distribution.
τ -leaping is problematic when a rare reaction event leads to a large change () in the
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propensity of other reactions. If this is the case, the τ -leaping assumption breaks down.
Several methods have been developed to attack this situation. Slow-scale SSA divides the
reactions into fast and slow groups [35]. The fast reactions are sampled with τ -leaping
and the slow reactions by exact sampling. The “Partitioned Leaping Algorithm” (PLA)
separates reactions into four regimes: exact stochastic, Poisson distributed, Langevin (SDE),
and continuous (ODE) [36,37]. The partition is computed automatically and adjusts on the
fly if the propensity of a reaction changes during the course of the simulation.
1.2.5 Simulation as a continuous system
In the limit of large concentrations, a reaction network can be interpreted as a system of
ordinary differential equations (ODEs). Consider species i with population xi. The rate of
change of xi is given by the summing over the contributions of all reactions
dxi
dt
=
Nr∑
j=1
si,jfj(~x).
Defining the stoichiometry matrix, S = (si,j), and the vector of reaction propensities, ~f =
(fj)
NR
j=1, this can be written more compactly as a system of ODEs
d~x
dt
= S ~f(~x). (1.7)
This system of (typically) non-linear ODEs can be numerically integrated to generate tra-
jectories. A number of libraries exist for fast, accurate, and robust integration of ODEs,
including SUNDIALS CVODE [38]. ODEs are also amenable to dynamical analysis and
other qualitative, but rigorous, analytic techniques. The XPP software package is a tool
for numerical analysis of ODEs, including facilities for plotting trajectories, nullclines, and
vector fields, as well as bifurcation analysis [39].
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1.3 COMBINATORIAL COMPLEXITY
Proteins involved in signaling, especially in eukaryotic cells, have a modular domain struc-
ture [40–42]. A domain is a component of a protein, often corresponding to a tertiary
substructure, that has a specific function or property. A domain might serve as a site for
protein-protein interaction, covalent modification (e.g. phosphorylation or ubiquitination),
or both. Alternatively, a domain might have catalytic activity, such as a kinase or phos-
photase activity, or anchor a protein in the cell membrane. Signaling proteins are often
composed of multiple domains with different functions. For example, a transmembrane re-
ceptor might consist of an extracellular ligand-binding domain, a transmembrane domain, a
cytosolic kinase domain, and several sites of covalent modification. Domains are modular in
the sense that the function of each domain is retained in the absence of the other domains.
For example, a kinase domain severed from its parent protein will typically retain its cat-
alytic activity. Nonetheless, allostery, i.e. cooperative interactions among protein domains,
often plays an important role in the protein function.
The domain structure of proteins and the local nature of interactions leads to a combi-
natorial explosion in the number of configurations that a signaling complexes can achieve
[43, 44]. To illustrate combinatorial complexity, consider a protein with N phosphorylation
sites. Assuming the sites are independently phosphorylated, the protein has 2N different
configurations. Each configuration corresponds to a species in a reaction network model.
Each species can participate in N different reactions, each corresponding to switching one
of the N sites between the phosphorylated and unphosphorylated state. In total there are
N ·2N reactions in the network. So a relatively simple protein model induces a large number
of species and reactions due to combinatorial complexity.
The above example is contrived, but nonetheless represents a common feature of signaling
networks. Combinatorial complexity arises in a variety of signaling pathways, including
FcRI signaling [45,46], epidermal growth factor receptor activation [47], p53 [48], G-coupled
protein receptors [49], JAK-family kinases [50], MAP kinase scaffolds [51] and more.
Consider the epidermal growth factor (EGF) receptor. Blinov et al. [52] constructed a
model of EGF receptor activation including 5 proteins, representing a total of 10 domains, 6
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protein-protein interactions, and 3 sites of phosphorylation. Despite the simple parts list, the
reaction network contained 356 distinct species participating in more than 3000 reactions.
Where do all these species come from? It is a simple consequence of combinatorics.
The 5 proteins are ligand (EGF), receptor (EGFR), and three cytosolic proteins (Shc,
Grb2, and Sos). EGF has a single domain for binding EGFR. The receptor has four domains:
an extracellular EGF-binding domain, a receptor dimerization domain, and two sites of
tyrosine phosphorylation. Tyrosine phosphorylation activates binding interfaces for Grb2
and Shc, respectively. Grb2 has two binding domains, one for phosphorylated EGFR and
other for Sos. Shc has an EGFR binding domain and a site of tyrosine phosphorylation and
Grb2 binding. Sos has a single domain for Grb2 binding.
Consider the configurations of individual receptor sites, excluding the dimerization do-
main. The ligand binding site can unbound or bound to EGF (2 states). The Grb2 binding
site can be unmodified, phosphorylated, bound to Grb2, or bound to a Grb2-Sos complex
(4 states). The Shc site can be unmodified, phosphorylated, bound to Shc, phosphorylated
Shc, a Shc-Grb2 complex, or a Shc-Grb2-Sos complex (6 states). The total number of a
configurations for a single receptor is 2 · 4 · 6 = 48. If we consider the dimerized receptor
pairs, after accounting for symmetry, the number of configurations is 48 · (48 + 1)/2 = 1176.
There are also 8 species that do not involve the receptor. In total there are 1232 possible
species! But the model only has 356 due to simplifying assumptions, e.g. only ligand-bound
receptors will dimerize.
In this relatively simple model, a few interactions among multidomain proteins leads
to an explosion in the number of species and reactions in the network. While it is still
theoretically possible to write a network model with any finite number of reactions, it is
difficult in practice to implement a model with more than a few hundred reactions without
relying on automated methods. Furthermore, large network models increase computational
burdens. In the best case, the space complexity of a reaction network is linear in the number
of reactions. But since the number of reactions in a combinatorial system tend to grow
exponentially in the number of protein domains1, the space complexity is exponential in the
number of domains in the model. Thus, a small increase in the biological scope can leads to
1For an example, see the comparison of reaction network size for variants of the FcRI signaling model [53].
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exponential growth in the network. The time cost of combinatorial systems also tends grows
with the number of reactions, since the assumptions required by constant- and logarithmic-
time algorithms do not typically hold for combinatorial systems. Specifically, the number of
reaction dependencies per reaction grows with the number of reactions.
The combinatorial problem is further exacerbated in systems with branching polymer-
ization. In such systems, the number of possible species is only limited by the number of
particles in the system. But the number of species grows exponentially in the number of
particles. Thus, even a few hundred particles can lead to a network size that exceeds Avo-
gadro’s number. Ligand-induced FcRI aggregation models prominently feature branching
polymerization that confounds network-based approaches [45, 53].
Combinatorial complexity pushes reaction network methods to the brink and then over
the edge. For such problems, alternative methods are required. Fortunately, the solution
already exists: rule-based languages and network-free simulation.
1.4 RULE-BASED MODELING
Rule-based modeling (RBM) is motivated by the modular domain structure of macro-
molecules and the problem of combinatorial complexity [54]. In RBM, macromolecules are
represented by structured objects that reflect the domain structure of their biological coun-
terparts. Each domain is represented by a node in a graph, called a site or component. Each
site has a type property and an optional state property. Type is a label that describes the
domain represented by the site, e.g. SH2. State is a label that represents a discrete mod-
ification to the site, such as post-translational modification, conformation, etc. Domains
that belong to the same macromolecule are grouped together to form a supernode, called
a molecule or an agent. Each molecule has a type property corresponding to the type of
macromolecule, e.g. EGFR. Noncovalent bonds between macromolecules are represented by
edges between the sites that mediate the protein-protein interaction.
Transformation of macromolecular complexes is governed by reaction rules. A reaction
rule consists of a set of reactant patterns, a set of product patterns, and a rate law. The
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reactant patterns describe molecular motifs that are potential sites of reaction. When a
reaction occurs, the reactant sites are transformed to the configuration described by the
product patterns. The rate law assigns the propensity for each set of reaction sites to
undergo reaction.
Reaction rules are analogous to organic reactions. Consider the esterification of an alcohol
and a carboxylic acid:
R-OH + R′-COOH → R′-COO-R + H20. (1.8)
This reaction scheme produces an ester and a water molecule by reacting an alcohol group
with a carboxylic acid group. This scheme describes a vast number of reactions. R and
R’ represent the unknown portions of the reacting molecules, which are not relevant to the
reaction mechanism. It is sufficient that the first reactant species has an alcohol group and
the second has a carboxylic group. In RBM, reactant patterns play the role of functional
groups. Like an organic reaction scheme, any molecular complex that contains the reactant
pattern motif can participate in the reaction. Thus, a reaction rule efficiently describes a
large class of reactions.
By representing molecular complexes by graphs, and classes of reactions by rules, RBM
goes a long way towards solving the combinatorial problem. Since the graph object retains
information about the composition and structure, the reactions that a species undergoes
can be computed by matching reactant motifs in the molecular structure. Furthermore, the
products of each reaction can be computed by operating on the reactant graphs, e.g. adding
an edge, changing a state, deleting nodes. Therefore, starting from an initial set of species
and reaction rules, it is possible to construct any reachable species by repeated application
of the reaction rules.
1.4.1 Network generation
Network generation is the process transforming a rule-based model into an equivalent reaction
network. Network generation is simple at its core. The reaction rules are applied to the initial
set of species in every possible combination. Products are constructed by transforming the
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reactant graph. Unique products are added to the species set and the process is iterated until
no new species are generated. Network generation usually proceeds under the assumption
that unlimited copies of each initial species are available. Thus, the network is not limited
by the availability of reagents.
It is not always possible to generate a network, since a RBM may encode an infinite
number of species and reactions. For example, a polymerization rule will generate a polymer
species for each possible length, resulting in a countably infinite species set. Conversely,
every finite reaction network can be obtained by network generation applied to some RBM 2.
Therefore, RBM are a superset of finite reaction network models.
Network generation is outlined in Algorithm 2. If more depth is desired, see Appendix B
for further details.
1.4.2 Network-free Simulation
Rule-based models permit compact representation of reaction network models; and, when
the reaction network is not too large, network generation provides access to all the simulation
methods available for reaction networks. But for larger reaction networks (> 103 species,
> 104 reactions), the computational cost of simulating networks becomes prohibitive [53].
In such cases, an alternative approach is required.
Network-free (NF) simulation is an approach that avoids network generation [55]. NF
methods are similar to agent-based approaches in that each molecule in the system is repre-
sented as an individual particle. This stands in contrast to network-based methods, where
molecular entities belonging to the same species are lumped together and represented as a
population variable. NF methods are fundamentally stochastic. Under the RBM formalism,
molecular complexes are represented as graphs; thus, it is possible to identify reactant sites
“on-the-fly” during a simulation. Upon selection of reactant sites, graph transformations are
applied in situ to construct the products.
2A finite reaction network is a RBM where each rule describes exactly one reaction and each molecule
contains zero components. Thus, every reaction network corresponds to a trivial RBM. But it is usually
possible to find a corresponding RBM with fewer rules than reactions.
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Algorithm 2: Network generation algorithm
input..: (~Rr, Tr, kr)NRr=1, a list of rules (reactant patterns, transformation, rate)
: seed species, set of initial species
output: species, set of all species; reactions, set of all reactions
queue ← seed species //a queue of species to process
species ← seed species; reactions ← {}
foreach r ← 1 . . . NR do //initialize rules
foreach p← 1 . . . |~Rr| do
sites[r][p]← {} //sites[r][p] tracks reactant p sites for rule r
while queue is not empty do //generate network
s← next(queue)
foreach r ← 1 . . . NR do //loop over rules
foreach p← 1 . . . |~Rr| do //loop over reactant patterns
Zp ← {all reactant p sites in species s}
foreach (z1, . . . , z|~Rr|) ∈
(
sites[r][1]× . . .× Zp × . . .× sites[r][|~Rr|]
)
do
transform sites z1 . . . z|~Rr| under Tr, obtaining products y1 . . . y|~Pr|
foreach y′ ← y1 . . . y|~Pr| do
if y′ /∈ species then add y′ to species and queue
map each reactant site z1 . . . z|~Rr| to its parent species x1 . . . x|~Rr|
construct reaction: rxn = [x1 + . . .+ x|~Rr|
k→ y1 + . . .+ y|~Pr|]
if rxn /∈ reactions then add rxn to reactions
add sites in Zp to sites[r][p]
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Pseudocode for network-free simulation is listed in Algorithm 3. Network-free simulation
gains efficiency by grouping reactions by rules. At each step of a simulation, the next reaction
rule is selected. Then a reactant set is chosen from among the possible sets for the selected
rule. This strategy is efficient since each potential reactant set has equal probability of
reacting. Therefore, the total propensity of a rule is computed by multiplying the number of
sites for each reactant pattern, and specific reactants are drawn from the uniform distribution
over reactant sites for each reactant pattern. Thus, computing rule propensities and selecting
reactants have constant cost in the number of sites. Therefore, the cost of selecting the next
reaction is linear in the number of reaction rules (worst case) and constant in the number of
reactant sites.
Upon selecting the reactants, the molecules are transformed in place. Transformation
can create or destroy reactant sites, so the list of sites must be updated after each event. If
site lists were calculated from scratch at each step, the algorithm would be quite inefficient.
Fortunately, it is only necessary to update molecules that belong to the same complex as one
of the reactant sites 3. Thus, the time cost of updating site lists is a function of the number
of reactant patterns in the rule, R; the number of molecules on the complexes matching the
reactant patterns; and the total number of reactant patterns in the system, Npatt. If we
assume the number of molecules per complex is bounded by C, then the number of updates
is no more than RCNpatt. With suitable data structures, the cost of adding or removing
items from the site list is constant in the size of the list [56]. Thus, the cost of an update
is no greater than CR
∑Npatt
n=1 Φ(n), where Φ(n) is the cost of checking if a molecule is a
site for reactant pattern n. Since reactant motifs are usually simple, we will assume Φ(n)
is bounded. Likewise, since the number of reactant patterns is usually one or two, we will
assume R is bounded. Under theses assumptions, the total update cost is O(CNpatt), which
is constant in both the number of particles and number of reactions in the network. If we
can also assume C is bounded (a reasonable assumption in non-polymerizing models), then
the cost is O(Nrules). Since the number of rules is typically much less than the number of
reactions, the NF update step scales efficiently in the class of models where the assumptions
3For a large class of models it is sufficient to update molecules within a fixed graph distance of the reactant
site [56].
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Algorithm 3: Network-free simulation algorithm
input..: (~Rr, ~Pr, Tr, kr)NRr=1, list of rules (reactant/product patterns, transform, rate);
: Mols, initial set of molecules; t, start time; tend, end time
output: Mols, final set of molecules
foreach r ← 1 . . . NR do //initialize rules
foreach p← 1 . . . |~Rj| do //initialize reactant site lists
sites[r][p]← (all reactant p sites in Mols)
a[r]← kr
∏|~Rr|
p=1 |sites[r][p]| //rule propensity
atot ←
∑NR
r=1 a[r] //total propensity
while t < tend do //fire next event
u1, u2 ← Uniform(0, 1)
∆t← − log(u1)/atot
if (t+ ∆t ≥ tend) then last
r ← min{j : ∑jk=1 a[k] > atotu2} //select rule
foreach p← 1 . . . |~Rr| do //select reactant sites
sp ← Uniform(sites[r][p])
if any pair of sites in s1, . . . , s|~Rr| belong to the same complex then
t← t+ ∆t; next
Umols ← {all molecules connected to sites s1, . . . , sp} //molecules to update
remove all sites in molecules of Umols from sites
apply transformation Tr to sites s1, . . . , snR
remove molecules deleted by Tr from Umols
add molecules synthesized by Tr to Umols
foreach r ← 1 . . . NR do
foreach p← 1 . . . |~Rr| do //update site lists
add all reactant p sites found in Umols to sites[r][p]
a[r]← kr ·
∏|~Rr|
p=1 |sites[r][p]|
atot ←
∑NR
r=1 a[r]
t← t+ ∆t
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hold. However, C may grow very large for models with a gel-phase (e.g. trivalent-ligand
bivalent-receptor aggregation [45,53]).
Several implementations of network-free simulators are available, including KaSim [57],
NFsim [53], and DYNSTOCH [58]. NFsim is notable in its support for functional rate
laws that depend on system properties (“global functions”) and local properties of reactants
(“local functions”).
1.4.3 BioNetGen: a rule-based modeling platform
BioNetGen (BNG) is a collection of open-source software tools for specifying, simulating,
and analyzing rule-based models of complex biochemical systems [59–62]. BNG software
reads models written in the BNG language (BNGL), a formal, text-based grammar for
specification of rule-based models. BNG software parses BNGL models and represents them
internally as graph objects. BNG includes tools for network generation and network-based
simulation, including ODE and SSA methods. Alternatively, BNGL models can be exported
for simulation by NFsim, a network-free simulator compatible with BNGL, or VCell, a
biochemical modeling platform with support for detailed spatial representation and PDE
simulation [63–65]
Since material in subsequent chapters extends BNGL, it is important that the reader
develop a familiarity with the syntax before proceeding. This chapter will present the basics
of BNGL syntax and its interpretation as graph objects. This material should provide the
necessary intuition, but further reading may be required for a deeper understanding. To
that end, BNGL syntax is presented in extended Backus-Naur form in Appendix A and the
graph-based formalism underlying BNG is included in Appendix B. For further reading, see
the BioNetGen book chapters [60, 61] or journal publications [59,66].
Although BNGL was chosen as a foundation for this work, it should be straightforward
to generalize methods to other RBM languages. The κ-calculus [67, 68] and the Stochastic
Simulation Compiler (SSC) [69] are closely related to BNGL. The partial network expansion
method (Chapter 4) and energy-modeling approach (Chapter 2) could be readily imple-
mented for these RBM languages.
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1.4.4 Macromolecules as structured objects
The fundamental object in BNGL is the molecule. Molecules are structured objects that con-
tain components. Components have state values (possibly null) and serve as sites for bond
formation. Typically, molecules correspond to biological macromolecules such as proteins,
while components represent protein functional domains. Component states may describe
post-translational modifications, such as phosphorylation, or other properties of the macro-
molecule, such as conformational state.
Molecules are defined through molecule types templates that specify the set of compo-
nents, and the possible state values of those components, that comprise a molecule. For
example, in Blinov et al. [52] the molecule type definition for the epidermal growth factor
receptor (EGFR) is
Egfr(l,r,Y1068∼Y∼pY,Y1148∼Y∼pY) .
This specifies that Egfr molecules have four components: l, r, Y1068, and Y1148. The first
two represent a ligand binding domain and a receptor dimerization domain, respectively.
The other two represent tyrosine residues 1068 and 1148, which are sites of phosphory-
lation [70, 71]. Both Y1068 and Y1148 can exist in two possible states, Y (tyrosine) and
pY (phosphorylated tyrosine). Names of molecule types, components, and states may be as-
signed any arbitrary string of alphanumeric characters [60,61], but conventionally are chosen
to correspond to biological entities.
Molecules can be thought of as instances of molecule types, the difference being that in
molecules a state for each molecular component must be explicitly specified. For example,
Egfr(l,r,Y1068∼pY,Y1148∼Y)
specifies an unligated Egfr monomer with a phosphorylated tyrosine at residue 1068 and an
unphosphorylated tyrosine at residue 1148.
1.4.5 Molecular complexes as graphs
BNGL represents molecular complexes within a hierarchical graph formalism: components
are represented by nodes, molecules are groupings of nodes, and bonds are edges between
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components [66, 72]. Molecules that are connected by bonds between their components are
said to belong to the same complex. Bound components are designated by a shared !LABEL
token following each component in the bond. For example,
Egf(r!0).Egfr(l!0,r!1,Y1068∼pY,Y1148∼Y).Egfr(l,r!1,Y1068∼pY,Y1148∼Y)
specifies a complex comprised of an Egfr dimer and a bound Egf ligand. The Egf ligand is
bound to the first Egfr molecule through a bond, labeled ‘0’, between its r component and
the l component of the Egfr molecule. The two Egfr molecules are bound to each other
through a second bond, labeled ‘1’, between their r components. The ‘.’ symbol specifies
that two molecules are part of the same complex. Molecules that are bound to each other
are necessarily in the same complex but molecules in the same complex need not be bound
directly to each other (e.g., the Egf ligand and the second Egfr molecule).
Two complexes that have the same molecular composition, with the same configuration of
bonds and states, are said to be instances of the same species . More formally, two complexes
are of the same species if their graphs are identical up to a labeled isomorphism [66].
1.4.6 Molecular motifs as subgraphs
Patterns describe structural motifs that may be found within complexes. In BNGL, patterns
are written just like complexes except that components, states, bonds, and molecules that
are not part of the motif are omitted. A pattern is said to match a complex (or species) if
the motif is found within the complex. Note that it is possible for a pattern to match at
multiple places within the same complex. In terms of graphs, a pattern is a subgraph and
a match is a subgraph isomorphism from the pattern into the complex graph [59, 66]. As
an example, the pattern Egfr(l,r) matches each instance of Egfr with unbound l and r
components, including
Egfr(l,r,Y1068∼Y,Y1148∼pY),
Egfr(l,r,Y1068∼pY,Y1148∼pY), and
Egfr(l,r,Y1068∼pY!0,Y1148∼pY).Grb2(SH2!0,SH3),
21
where the matches have been underlined. Since the components Y1068 and Y1148 are omitted
from the pattern they can be in any of their allowed states and either bound or unbound.
A pattern may also require that a component be bound without specifying its binding
partner by substituting the bond label with the ‘+’ wildcard (e.g., Egfr(l!+,r)). Similarly,
the bonding state can be specified as irrelevant (either bound or unbound) by using the ‘?’
wildcard (e.g., Egfr(l!?,r)). Finally, if a component is listed but no state is indicated then
the pattern will match the component regardless of state.
Patterns have two primary purposes in BNGL [60,61]: (i) they specify parts of a complex
that are involved in a reaction; (ii) they define the observable outputs (or simply observables)
of a model. The second function is critical for facilitating comparisons between simulation
predictions and experimental observations.
1.4.7 Biochemical reaction rules as graph transformations
Reaction rules (or simply rules) describe classes of reactions that transform the states of
complexes in a system. A rule consists of a set of reactant patterns, a set of product
patterns, a directionality arrow (unidirectional ‘->’ or bidirectional ‘<->’), and a rate law.
The reactant patterns match reaction sites (motifs) within complexes in the system. The
product patterns indicate how the reactant patterns are modified when the rule fires. The
rate law determines the firing rate per set of reactant matches. In terms of graphs, a rule is a
graph transformation with a dynamic rate that determines how frequently the transformation
is applied to each matching subgraph [66].
There are six basic transformations that can be encoded in a BNGL rule: (i) bond
addition, (ii) bond deletion, (iii) state change, (iv) molecule synthesis, (v) molecule deletion,
and (vi) complex deletion. 4 The transformations are implied by the differences between the
reactant and product patterns in a rule. For example, the rule
Egf(r) + Egfr(l,r) -> Egf(r!0).Egfr(l!0,r) k
4Complex synthesis is not considered to be an elemental transformation but rather a composite action
comprised of molecule syntheses and bond additions.
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matches Egf molecules with unbound r components and Egfr molecules with unbound l
and r components. The rate law is of the mass-action type (by default [60, 61]) with a rate
constant k. When the rule fires a bond is formed between the r component of Egf and the
l component of Egfr. We refer the reader to Refs. [60, 61] for further details regarding the
specifics of the BNGL syntax.
1.4.8 Anatomy of a BNGL model file
BioNetGen models are specified within text files having the .bngl extension. Model ele-
ments are specified in blocks delimited by begin and end tags. The entire model specifica-
tion is enclosed within a begin model / end model block and the model specification itself
is contained within six additional blocks: parameters, molecule types, seed species,
observables, functions, and reaction rules. Though not strictly required, it is sug-
gested that these blocks appear in this order. Molecule types, reaction rules, and observ-
ables have been discussed above. Values of rate parameters, initial populations of species,
etc., are listed in the parameters block and can be referenced in any subsequent block.
All initially-populated species and their population levels are specified in the seed species
block. These act as the starting point for network generation in BioNetGen and define the
initial system state for any subsequent simulations. Arbitrary functions of observables can be
defined in the functions block and used in place of rate constants in the reaction rules
block. Two types of functions can be defined: global and local [53,73]. Local functions take
as an argument a reference to a complex or molecule and evaluate observables over that
complex/molecule only. In contrast, global functions evaluate observables over the entire
domain.
Any actions to be performed on the model must be listed after the model specification
(i.e., the end model directive). Common actions include generating a network by iterative
application of the rule set to the set of initial seed species, simulating a network (either deter-
ministically or stochastically), performing a “network-free” simulation, changing or resetting
the values of species populations or rate parameters, reading in a previously-generated net-
work, and exporting the model and/or network in various file formats (e.g., SBML [74],
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M-file [75]). If multiple actions are listed in sequence then each is performed using the fi-
nal system state from the previous action as the initial state for the current action (unless
the system is explicitly reset to the initial conditions). For example, one might run an ini-
tial equilibration simulation in the absence of ligand, then add a dose of ligand and run
a second simulation to investigate the dose-response behavior of the system. We refer the
reader to Refs. [60–62] for further details regarding model specification and action syntax in
BioNetGen.
1.4.9 A Survey of Rule-based Languages and software
A number of rule-based languages, in addition to BNG, are described in the literature. In
this section, I will briefly survey some of these languages.
The κ-calculus is formal RBM language similar to BNGL. In contrast to BNGL, κ does
not natively support identical component types (i.e. sites) within a molecule (i.e. agent).
Furthermore, κ does not formally make the distinction between inter- and intra-molecular
reactions. The simplicity of κ lends itself to formal analysis. In practice, these limitations
are side-stepped by meta-κ, an extension of the language κ language that “compiles” to pure
κ. A network-free simulator, KaSim, is available for simulating κ. Exact model reduction
methods are also available κ models [76].
The Stochastic Simulation Compiler (SSC) is a rule-based language and software plat-
form. SSC generates a reaction network and compiles a custom SSA simulator to achieve
maximum performance [69]. The SSC language is similar to BNGL and κ, but the approach
to reaction rules is somewhat different. In BNGL and κ, graph transformations are inferred
from the differences between reactant patterns and product patterns. This requires a con-
vention for mapping molecules on the reactant side to their counterparts on the product side.
In contrast, SSC rules are specified by a set of reactant patterns and a set of transformations.
Thus, the transformation is explicit, rather than implied. SSC also supports a coarse-grained
representation of compartments and space via sub-volume discretization.
Simmune is a platform for multi-scale simulation of cellular systems [77,78]. At the small
scale, simmune implements rule-based methods for biochemical interactions. Biochemical
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signals are coupled to a coarse-grained, dynamic representation of cellular morphology. Cell
morphology is modeled as a cellular Potts models. Although RBM features in Simmune are
conceptually similar to BNGL and κ, models are specified using a graphical user interface
rather than a text-based language.
BioCham [79] is language for biochemical modeling with string-based formalism. Proteins
are represented by string tokens and complexes are formed by string concatenation. Despite
the formal differences, BioCham is a rule-based language in that reaction rules describe
classes of reactions. Reaction rules are implemented by substring matching and transforma-
tion of the parent string. The BioCham platform implements a number of analytic tools,
including bifurcation analysis and formal verification of temporal logic.
Relatively new to the scene, ML-rules is a multi-level rule-based language [80]. Objects
in ML-rules can be nested arbitrarily to construct systems with multiple levels, such as ex-
tracellular space, cells, and organelles. Object nesting is dynamic and governed by rules that
permit movement between levels, creation of new levels, and fusion of objects on the same
level. ML-rules extends RBM to biological processes such as receptor-mediated endocytosis
and the cell division.
1.5 THE LIMITS OF RULE-BASED MODELING
RBM languages provide a solution to the problem of combinatorial complexity at the level
of model description, while network-free methods resolve the simulation problem. But the
scale of modeling enabled by RBM also introduces new challenges. A few of those challenges,
which provide motivation for the remainder of this work, are presented in this section.
1.5.1 Biochemistry is compartmentalized, RBM 1.0 is not
Biochemistry takes place in the compartmentalized structure of cells. All cells have mem-
branes that separate the outside world from the inside. Eukaryotic cells are further parti-
tioned into cytosol, nucleus, and other organelles. The compartmental structure also exists
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at the level of the organism, which is composed of organs and tissues separated by endothe-
lial and epithelial barriers. Signaling pathways cross multiple levels of cellular structure.
Consider EGF receptor signaling, described earlier. The EGF molecule is present in the
extracellular space, but is detected by a transmembrane receptor. The receptor recruits and
activate proteins in the cytosol. The EGF signal cascades through the MAP kinase path-
way, activating transcription factors that are transported into the nucleus and regulator gene
expression.
Membranes play a key role in cellular biochemistry. In addition to dividing the cell
into compartments, membranes also mediate communication between the compartments via
transmembrane proteins. Membranes also serve as a surface for localizing macromolecules,
which can lead to enhanced reaction rates due to proximity. Despite the importance of
membranes and compartmentalization, the first generation of RBM languages have lim-
ited facilities for representing membranes, or localizing molecules and reactions to specific
compartments 5. This motivates the development of compartmental BNGL (cBNGL), an
extension of BNGL for compartmental modeling (Chapter 3).
1.5.2 The curse of cooperativity
Reaction rules describe a class of biochemical reactions with a common transformation and
rate law. Allostery—energetic cooperativity between distant sites on macromolecules—is a
ubiquitous feature of biological systems [81]. In the presence of cooperativity, reactions that
share a transformation but differ in context will have different rate constants. Thus, it is
not possible to lump such reactions into a single rule. This is the curve of cooperativity: it
is everywhere and it complicates everything.
Consider receptor dimerization reactions in three different contexts.
R + R <-> RR kp1 ,km1
LR + R <-> LRR kp2 ,km2
LR + LR <-> LRRL kp3 ,km3
The reactions describe receptor-receptor binding, but differ in ligand context. If the ligand
binding site is allosterically coupled to the receptor dimerization site, then the rate constants
5Since work on cBNGL was initiated in 2008, a number of additional rule-based languages with compart-
mental features have appeared in the literature, including SSC [69] and ML-rules [80].
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for each reaction will be different. Thus, the reactions cannot be described by a single reaction
rule with a common rate constant6. The situation is further complicated by constraints
among the rates constants introduced by thermodynamics cycles in the reaction network.
For the construction of simple models, cooperativity can be handled manually. But the
problem is exceedingly difficult for large, combinatorially complex models. Energy-based
modeling, a recent development in RBM [49], provides a partial solution by modeling cooper-
ativity directly and constructing contextual rule variations in a principled manner. Building
on this foundation, Chapter 2 presents a general framework and software implementation
for energy-based modeling in BNG.
1.5.3 Network-free simulation of large systems is expensive
Network-free (NF) methods enable simulation of models with combinatorially large reaction
networks. But since NF is intrinsically discrete stochastic, each molecule in the system
must be represented individually. Thus, systems with a large number of particles require
proportionally large memory resources. Although seldom a limiting factor for single pathway
models, memory requirements will become prohibitive as the field moves away from single
pathway models toward multi-pathway and whole cell models. Multi-cellular models will
require resources on yet another order of magnitude.
A number of strategies, including multi-scale modeling and model reduction techniques,
can reduce the cost of simulation. However, the potential for reduction in computational
cost of NF simulations has not been fully exploited. This motivates the development of
the Hybrid Particle/Population method in Chapter 4. This method substantially reduces
memory requirements of NF simulations by lumping species with high copy number.
1.5.4 Other limitations not addressed in this dissertation
Although RBM is a powerful and flexible framework, it is not applicable to all types of sys-
tems. RBM represents the connectivity of molecules via edges in a graph. Thus, RBM can be
6 It is possible to describe all three reactions with a single rule if the rate is given by a local func-
tion, an advanced concept introduced by Sneddon et al. [53]. However, local functions will not resolve the
interdependencies among the rates induced by thermodynamic cycles.
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viewed as “topological” modeling since the connectivity of molecules, but not the geometric
relationships, are described. Encoding distance and angles in current RBM frameworks is
impractical, at best. Thus, RBM is inadequate for modeling systems where geometry plays
an important role. For example, although RBM can represent the connectivity of amino acids
in a protein, representing angles and distances required for a molecular dynamic simulation
is not practical. Similarly, it is difficult to represent steric hindrance or rigidity that prevents
certain types of intramolecular bonds. Although future research may integrate RBM with
geometric models, this limitation is not addressed in the present work.
RBM also assumes that the state of a macromolecule can be adequately represented by
a discrete site structure. Thus, The modeling process begins with a choice of the discrete
structure for each macromolecule in the system. This information can be inferred from crys-
tallized structure or other experimental studies; however, at present there is no systemic
method for selecting the site structure. Furthermore, the modeling process may be con-
founded if the sites in the biological entity are not accurately described by a collection of
discrete sites. Although it may be possible to approximate the behavior of a protein with a
finer-grained discrete representation, this approach is both tedious and subject to combina-
torial explosion of influences among the sites. Again, this limitation is left for future work
in the field.
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2.0 MODELING ENERGY: A PATTERN-BASED APPROACH
2.1 MOTIVATION FOR ENERGY-BASED MODELING
A reaction rule in a rule-based model (RBM) encodes a class of reactions that share a common
transformation, such as bond formation or post-translational modification, and a common
rate law. The reactions differ only in the larger context of the reacting complexes, but this
does not influence the rate of reaction. If many reactions can be represented by a single
reaction rule, then the reaction network is highly compressible. The amount of compression
depends on the degree of kinetic homogeneity that the modeler (or the data) is willing to
accept.
The fundamental assumption of RBM is summarized in the maxim: “don’t write, don’t
care”. In other words, if a molecule component does not appear in the reaction rule, then its
state does not influence the rate of reaction. Reaction context is the set of components named
in the rule, but not modified. Reducing the reaction context in a rule typically increases the
number of reactions described by the rule, while reducing the number of kinetic parameters in
the model. Thus, there is a close relationship between reaction context and model complexity.
If a class of reactions with a common rate law can explain the data as well as independent
rate laws, then the common rate law is preferred. Therefore, eliminating reaction context
(as much as the data will allow) is an attempt to follow the principle of Occam’s Razor. In
the language of RBM, if two models explain the data, the one with least reaction context is
preferred.
Unfortunately, reaction context plays a very important role in biophysical models. Al-
lostery, i.e. cooperativity between distant sites on macromolecules, is a common feature
in biological systems. Allostery is mediated by a variety of mechanisms, such as ligand
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binging [82], covalent modification of protein residues [83–85], and conformational state
changes [86, 87]. Allostery is known or postulated to play in role in various biophysical
systems, including hemoglobin/oxygen binding [82], ligand-induced EGF receptor dimeriza-
tion [88], and G-protein coupled receptors [89–91].
Allosteric mechanisms, which are fundamentally related to reaction context, require the
reaction network to be partitioned into finer classes. Consequently, the modeler is forced to
write a large number of related reaction rules with different context and kinetic rates. I will
refer to the complexity induced by reaction context with the term contextual complexity. It
is important to distinguish this from the distinct concept of combinatorial complexity. Com-
binatorial complexity is the explosion of the reaction network size due to combinations of
multi-domain protein interactions, e.g. polymerization, scaffold assemblies, etc. In contrast,
contextual complexity is the explosion in the number of reaction rules required to represent
a reaction network due to reaction context. RBM effectively compresses combinatorially
complex networks so long as contextual complexity is minimal. As contextual complexity in-
creases, the benefits of RBM diminish. Under this reality, is RBM useful modeling paradigm
for systems with cooperative mechanisms?
In this chapter, I will address the problem of contextual complexity by coupling rule-
based modeling with an energy-based formalism. Energy-based approaches were first merged
with RBM by Ollivier et al. [49]. In that work, the authors developed a formalism for
modeling allostery mediated by conformational change. The energy-based approach to RBM,
or EBM for brevity, was later generalized to arbitrary pattern graphs by Vincent Danos et
al. [92, 93]. Under generalized EBM, energy is assigned to patterns, i.e. molecular motifs.
These energy patterns form the basis of a free energy accounting system. Free energy of
species formation, and subsequently the free energy change of a reaction, is computed by
counting free energy motifs in the species and summing the free energy contributions. Given
a set of free energy inequalities, Danos showed that it is a straightforward task to verify that
a kinetic model satisfies those constraints. However, the existence of free energy assignments
that are compatible with a given kinetic model is, in general, undecidable. Nonetheless,
Danos suggested that kinetic models that are compatible with free energy assignments could
be obtained by construction. The Allosteric Network Compiler (ANC) [49] demonstrates the
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construction approach in the limited context of allostery via conformational change.
In this chapter, I develop a general approach to constructing kinetic models that are
compatible with free energy assignments by construction. Under my approach, reaction
rules are decomposed into two components: atomic transformations (i.e. bond formation,
post-translational site modification, etc.) and a set of energy patterns. Energy patterns
refer to motifs in molecular complexes (bonds, states, pairs of bonds, etc.) and form the
building blocks of a free energy accounting system for molecular complexes. Cooperativity
among components, i.e. reaction context, is encoded in the set of energy patterns. Reactions
are generated by applying the atomic transformations to the initial species set (the usual
approach) and then kinetics are derived from the change in free energy of the reaction, as
computed from the energy patterns. This approach has several advantages over traditional
RBM. Most notably, (i) EBM typically requires fewer rules, (ii) rules have less context, and
(iii) the resulting reaction network is guaranteed to satisfy detailed balance. Thus, the EBM
approach is a promising solution to the problem of contextual complexity.
This chapter begins with an simple example of contextual complexity in a familiar
hemoglobin model. Then I will briefly present the theory of free energy and detailed bal-
ance in the context of chemical reaction systems. I then proceed to develop the formal
underpinnings of energy-based modeling, and demonstrate how the approach manages con-
textual complexity and guarantees detailed balance. A motivating example that illustrates
the method will be developed in parallel with EBM. Then I present several advances in
the energy-based approach, beyond the work of Danos and Ollivier; specifically, a general-
ization of energy-based kinetics that permits pure catalysis, and a method for integrating
non-equilibrium processes such as ATP driven reactions. Finally, I present software for EBM
within the BioNetGen platform, which is the major contribution in this chapter.
2.1.1 Contextual complexity: hemoglobin example
Consider a simple model of hemoglobin/oxygen binding. We will treat the hemoglobin
tetramer as a single object with four identical binding sites for oxygen and two conformations,
tense (T) and relaxed (R). We will assume that oxygen can bind to hemoglobin in either tense
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or relaxed conformations, although binding is more favorable in the tense state. Finally, we
assume that hemoglobin exists in an equilibrium of mixed tense and relaxed conformations,
even in the absence of oxygen. This is the Monod-Wyman-Changeaux model of hemoglobin
[82,83].
In the BioNetGen language (BNGL), the molecule types are:
begin molecule types
# Hemoglobin tetramer
Hgb(c∼R∼T,o2,o2,o2,o2)
# Free oxygen
O2(hgb)
end molecule types
where the c component represents the conformational state and the o2 components represent
the oxygen-binding heme group in the Hemoglobin subunits.
The system can be described by seven reaction rules: two for oxygen binding and five
for conformation changes.
begin reaction rules
# binding
Hgb(c∼R,o2) + O2(hgb) <-> Hgb(c∼R,o2!1).O2(hgb !1) kp1 , km1
Hgb(c∼T,o2) + O2(hgb) <-> Hgb(c∼T,o2!1).O2(hgb !1) kp2 , km2
# conformation change
Hgb(c∼R,o2,o2,o2,o2) <-> Hgb(c∼T,o2,o2,o2,o2) kp3 , km3
Hgb(c∼R,o2!+,o2,o2 ,o2) <-> Hgb(c∼T,o2!+,o2,o2,o2) kp4 , km4
Hgb(c∼R,o2!+,o2!+,o2 ,o2) <-> Hgb(c∼T,o2!+,o2!+,o2,o2) kp5 , km5
Hgb(c∼R,o2!+,o2!+,o2!+,o2) <-> Hgb(c∼T,o2!+,o2!+,o2!+,o2) kp6 , km6
Hgb(c∼R,o2!+,o2!+,o2!+,o2!+) <-> Hgb(c∼T,o2!+,o2!+,o2!+,o2!+) kp7 , km7
end reaction rules
The first thing we notice is the five different rules that correspond to the conformational
change from relaxed to tense. Each rule represents the same transformation in different
context. This is an example of contextual complexity. Not only is it tedious to enumerate the
rules, but each contextual variant introduces additional parameters. Although it is tempted
to simply assign the same kinetic rates to each equation, this will effectively decouple oxygen
binding from conformational state, which defeats the purpose of the model. Parameterization
is further complicated by hidden constraints in the set of parameters due to “loops” in the
reaction network. These constraints, required by the principle of detailed balance will be
described in the next section.
To simplify the discussion, I will introduce a shorthand representation for the species in
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the model system. Each hemoglobin species will be represented by a letter describing the
conformational state (R or T) and a number (0, 1, 2, 3, 4) representing the number of bound
oxygen. For example, a hemoglobin tetramer in the tense conformation with two bound
oxygen will be denoted T2. Finally, free oxygen is represented by the letter O2.
The reaction network implied by this rule model contains 11 species and 13 reversible re-
actions. The species are: O2, R0, R1, R2, R3, R4, T0, T1, T2, T3, T4. The reactions
are as follows,
begin reactions
R0 + O2 <-> R1 4*kp1 , km1
R1 + O2 <-> R2 3*kp1 , 2*km1
R2 + O2 <-> R3 2*kp1 , 3*km1
R3 + O2 <-> R4 1*kp1 , 4*km1
T0 + O2 <-> T1 4*kp2 , km2
T1 + O2 <-> T2 3*kp2 , 2*km2
T2 + O2 <-> T3 2*kp2 , 3*km2
T3 + O2 <-> T4 1*kp2 , 4*km2
R0 <-> T0 kp3 , km3
R1 <-> T1 kp4 , km4
R2 <-> T2 kp5 , km5
R3 <-> T3 kp6 , km6
R4 <-> T4 kp7 , km7
end reactions
where the rate constant multipliers are due to the number of free oxygen sites on the
hemoglobin (forward reaction) or the number of occupied heme sites (reverse reaction).
Figure 2.1 shows the possible states of hemoglobin tetramers and the allowed transitions
between states. There are a number of loops in the state transition diagram. As we will see
in the next section, these loops introduce parameter constraints.
2.2 FREE ENERGY PRINCIPLES FOR BIOCHEMICAL SYSTEMS
This section introduces the basics of free energy for biochemical kinetics. The first sec-
tions introduce the concepts of energy, entropy, and free energy for systems in equilibrium.
The discussion is informal with an emphasis on developing an intuition for free energy as
probability. Next, Gibbs’ free energy is presented along with its relationship to reaction
equilibrium in biochemical systems. This leads to the principle of detailed balance, which
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Figure 2.1: State transition diagram for hemoglobin model. Each circle represents a
possible state for a Hemoglobin tetramer. Possible state transitions are indicated by arrows
labeled by the respective equilibrium constants. Although state transitions are bidirectional,
the direction of the arrow indicates the frame of reference for the equilibrium constants.
R0 R1 R2 R3 R4
T0 T1 T2 T3 T4
KR01 KR12 KR23 KR34
KT01 KT12 KT23 KT34
        KRT0         KRT1      KRT2         KRT3          KRT4
places constraints on the parameterization of kinetic models.
This brief introduction to energy, entropy and free energy draws inspiration from Sta-
tistical Physics of Biomolecules by Daniel M. Zuckerman [94], chapter 3 in particular. The
reader is encouraged to read this text if further background on statistical mechanics is re-
quired. For further depth on statistical physics in the context of biochemical systems, the
reader is directed to Chemical Biophysics by Daniel A. Beard and Hong Qian [95].
2.2.1 Energy
Energy is a quantity associated with a specific state of a biochemical system. The energy of a
state is proportional to the logarithm of the probability that the system, at equilibrium, will
be in that state. (The system is at equilibrium if the probability distribution is stationary.)
If x is a state, then:
p(x) ∝ exp −E(x)
kBT
(2.1)
where E(x) is the energy of the state, kB is the Boltzmann constant, T is the absolute
temperature, and p(x) is the probability of the state. If a system can take on N discrete
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states labeled (s1, s2, . . . , sN), then the partition function for the system is defined to be:
Z =
N∑
n=1
exp
−E(sn)
kBT
. (2.2)
The normalized probability of a state can be obtained from the energy and the partition
function as follows:
p(s) =
1
Z
exp
−E(s)
kBT
. (2.3)
The partition function plays an important role in statistical mechanics, but for purposes here
it is sufficient to view Z as a normalization factor.
Consider a system with N particles, where each can take one of two states (xi ∈ {0, 1}).
Assuming the probability for particle i is independent of particle j, for all i 6= j, the probabil-
ity of system state ~x = (x1, x2, . . . , xN) is given by the product of the individual probabilities:
p(~x) =
N∏
n=1
1
Z
exp
−E(xn)
kBT
=
1
ZN
exp
−∑Nn=1E(xn)
kBT
. (2.4)
In words, the energy of the system is given by the sum of the energy over the particles.
2.2.2 Entropy
Entropy is a measure of disorder in a system. Consider a box with N particles. Suppose a
molecule can take on two conformations, A and B, with equal probability. Suppose k such
molecules populate our system. The entropy of this system state is proportional to the
logarithm of the number of ways N particles can be arranged so that k have conformation
A and N − k have conformation B. More precisely, the entropy is given by
S = kB log ΩN,k, (2.5)
where S is the entropy, kB is the Boltzmann constant, and Ω is the number of configurations.
The number of configurations, in this case, is given by the the number of ways to choose k
objects from a set of N , i.e.
(
N
k
)
= N !
k!(N−k)! . If k = 0 or k = N , the number of configurations
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is 1 and the entropy is 0. If N and k are sufficiently large, Sterling’s approximation can be
used to estimate the entropy:
S = kB log Ω(N, k) = kB log
N !
k!(N − k)! = kB (logN !− log k!− log(N − k)!)
≈ kB ((N logN −N)− (k log k − k)− ((N − k) log(N − k)− (N − k)))
= kB
(
N log
N
N − k + k log
N − k
k
)
. (2.6)
To find the maximum of the entropy, differentiate by k and solve for the critical points to
obtain
dS
dk
= 0 ⇐⇒ N − k
k
= 1 ⇐⇒ k = N
2
. (2.7)
Therefore, the entropy of the system is maximized when half the particles have conformation
A and half B. Since our intuition tells us the molecules will be divided about equally between
A and B, we may anticipate that maximizing the entropy has a relationship to most likely
system configurations.
Before moving on, I will introduce some terminology. A macrostate is a subset of all
system microstates that are indistinguishable. In the example above, the microstates of the
system are given by the vectors ~x = (x1, x2, . . . , xN , where xi is the conformation of particle n.
A microstate ~x belongs to the macrostate k if |{i : xi = B}| = k. The microstates belonging
to macrostate k are indistinguishable since, for purposes of well-mixed chemical kinetics, the
identity of the k molecules in configuration B has no effect on the system dynamics.
More generally, a macrostate may be composed of microstates with different energies
(i.e. different probabilities). Then the entropy of a macrostate is given by:
S = −kB
N∑
n=1
pn log pn. (2.8)
where pn is the probability of microstate n. This formulation works even if the microstates
have different energies. But for our purposes, it is usually assumed that each microstate in
the macrostate has the same energy. Note that if all N states have the same probability,
then the above formula reduces to our first definition S = kB log Ω.
36
2.2.3 Free energy
Suppose a macrostate X is defined by a set of microstates {x1, x2, . . . , xN}, where the energy
of each microstate is constant: E(xi) = E0. Now we ask what is the probability that the
system state is any of the microstates in X? Or, put another way, what is the probability
that the system belongs to macrostate X? The probability of any microstate is proportional
to exp −E0
kBT
. Since the microstates are disjoint, the probabilities are additive, therefore:
p(X) =
1
Z
N∑
n=1
exp
−E0
kBT
, (2.9)
where Z is the partition function for the set of system microstates. Since the energy of each
microstate is constant, we can rewrite the sum as:
p(X) =
N
Z
exp
−E0
kBT
=
1
Z
exp
−(E0 − kBT logN)
kBT
. (2.10)
Since N is the number of microstates in S, we see that the energy term in the numerator
has been replaced with the quantity E0 − TS(X), where S(X) is the entropy of macrostate
X. This leads to the definition of free energy for a macrostate X where each microstate has
the same energy E0:
F (X) := E0 − TS(X). (2.11)
Thus, the free energy F (X) can be interpreted as the logarithm of the probability that the
system state belongs to the macrostate X.
More generally, the free energy of a macrostate is the expected energy of the system
conditioned on the state belonging to a macrostate X.
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2.2.3.1 Free energy example: isomerization Suppose a system consists of N mole-
cules that take on one of two discrete conformational states, i.e. xn ∈ {A, B}. Let EA and EB
be the energies associated with a molecule is state A and B, respectively. The set of possible
microstate microstates is given by the set {~x ∈ {A, B}N}. The macrostate k is the subset of
microstates where exactly k molecules have conformation B. Recalling that the energy of a
system of particles is given by the sum of the energy of individual molecules, the free energy
of macrostate k is given by:
F (k) = (N − k)EA + kEB − TSk = (N − k)EA + kEB − kBT log Ωk
= (N − k)EA + kEB − kBT log
(
N
k
)
. (2.12)
So we see that the probability of the system being in macrostate k depends on both the
energy of isomerization and the entropy of the system.
2.2.3.2 Difference in free energy is all that matters Suppose macrostates X1, X2,
. . ., XN partition the microstates of a system. Let F1, F2, . . ., FN be the free energy of
the macrostates. We will attempt to show only differences in free energy matter, since
shifting the free energy terms by a constant factor has no effect on the probabilities of the
macrostates. Suppose the free energies are shifted by a constant value C, then:
p(Xi|C) =
exp −(Fi+C)
kBT∑N
n=1 exp
−(Fn+C)
kBT
=
exp −C
kBT
exp −Fi
kBT
exp −C
kBT
∑N
n=1 exp
−Fn
kBT
=
exp −Fi
kBT∑N
n=1 exp
−Fn
kBT
= p(Xi|C = 0). (2.13)
So the probabilities of the macrostates are not altered by a constant shift in free energy.
Consequently, we are free to choose a reference state and arbitrarily set the free energy to
zero.
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Consider the previous example, if the reference state is Sref = (N0, k0) = (1, 0), then the
relative free energy of S = (N, k) is:
∆F (N, k) := F (N, k)− F (1, 0)
=
(
(N − k)EA + kEB − kBT log
(
N
k
))
−
(
EA − kBT log
(
1
1
))
= (N − k)EA + (k − 1)EB − kBT log
(
N
k
)
. (2.14)
Since the reference is arbitrary, we can choose EA such that F (1, 0) = 0. Then ∆F (N, k) =
F (N, k).
The difference in free energy of the macrostate states (N, k) and (N, k + 1) is
∆Fk,k+1 := F (N, k + 1)− F (N, k)
=
(
(N − k − 1)EA + (k + 1)EB − kBT log
(
N
k + 1
))
−
(
(N − k)EA + kEB − kBT log
(
N
k
))
= EB − EA − kBT log
(
k!(N − k)!
(k + 1)!(N − k − 1)!
)
= (EB − kBT log(N − k))− (EA − TkB log(k + 1)) . (2.15)
2.2.3.3 Free energy of formation In the previous section we derived a formula for the
change in free energy when one molecule changes configuration in a system of N particles.
The formula can be divided into two terms, one for the “reactant”, i.e. the molecule in
configuration A prior to the change, and one for the “product”, i.e. the molecule in config-
uration B subsequent to the change. Each term can be interpreted as the free energy cost
of one molecule in that configuration, adjusted for the current quantity of molecules in that
configuration. This motivates the concept of free energy of formation, which is defined to
be:
∆Ff (X) := ∆F
◦
f (X) + kBT log(nX/n0), (2.16)
where ∆F ◦f (X) is the standard free energy of formation constant for a species X, nX is the
number of particles of species X, and n0 is a reference quantity for the standard free energy
of formation.
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2.2.4 Gibbs free energy
An NPT system has a fixed number of particles, constant pressure, and constant temperature.
These conditions often apply to biochemical or cell culture experiments, which are typically
performed in a test tube under atmospheric pressure and room temperature. In an NPT
system, free energy takes the form:
∆G := ∆H − T∆S, (2.17)
where S is entropy as before, and H is enthalpy, which is analogous to energy for an NPT
system.
The Gibbs free energy of formation of a species X is defined to be:
∆Gf (X) := ∆G
◦
f (X)+RT log([X]/c0) = ∆H
◦
f (X)−RT∆S◦f (X)+RT log([X]/c0), (2.18)
where ∆H◦f (X) is the standard heat of formation, ∆S
◦
f (X) is the standard entropy, [X] is
the concentration of X, and c0 is a reference concentration. The free energy of formation
can be interpreted as the free energy cost of constructing one unit of species X from atomic
constituents (i.e. the reference) in an NPT system with concentration [X].
The Gibbs’ free energy is perhaps the most important concept in chemical physics: an
NPT system tends towards minimizing the Gibbs’ free energy. Recalling that free energy is
related to the probability of a state, there is an intuitive connection between free energy and
equilibrium. The system prefers to reside in high probability states. Since the free energy is
proportional to the negative of the logarithm of probability, it makes sense that the system
would seek out states with minimum free energy.
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2.2.4.1 Reaction equilibrium The change in free energy due to a reaction is the vital
piece of information required to determine whether a reaction will proceed (on average)
in the forward or reverse direction. If the change is negative, then the reaction proceeds
forward. When the change is zero, the reaction is at equilibrium and has no tendency to
move forward or reverse. A negative change in free energy can be viewed as a “flow” towards
higher probability states. When the change in free energy is zero, then the reaction has
reached a local maximum in the probability distribution.
The change in free energy of a reaction can be calculated by computing the difference
between the free energy of formation of the products and reactants:
∆Grxn =
∑
p
νp
(
∆G◦f (p) +RT log([p]/c0)
)−∑
r
νr
(
∆G◦f (r) +RT log([r]/c0)
)
, (2.19)
where p ranges over the products, r ranges over the reactants, and the ν’s are stoichiometric
coefficients.
When reactants and products are at standard concentration c0, the change in free energy
reduces to:
∆G◦rxn =
∑
p
νp∆G
◦
f (p)−
∑
r
νr∆G
◦
f (r). (2.20)
This quantity is called the standard free energy change of the the reaction. Equation 2.19
can be reformulated using the standard free energy change:
∆Grxn = ∆G
◦
rxn +
∑
p
νpRT log([p]/c0)−
∑
r
νrRT log([r]/c0)
= ∆G◦rxn +RT log
∏
p([p]/c0)
νp∏
r([r]/c0)
νr
. (2.21)
So we see that the change in free energy is a constant and a term that accounts for non-
standard concentrations of reactants and products. The reaction quotient is the ratio of
product and reactant concentrations inside the logarithm:
Q :=
∏
p([p]/c0)
νp∏
r([r]/c0)
νr
. (2.22)
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The reaction is at equilibrium when the change in free energy is zero. Setting the free
energy change to zero, the relationship between equilibrium and Q is
∆Grxn = 0 ⇐⇒ ∆G◦rxn = −RT logQ ⇐⇒ exp
−∆G◦rxn
RT
= Q. (2.23)
So the reaction quotient at equilibrium is related to the standard change in free energy
via the Boltzmann factor. The value of Q at equilibrium is usually denoted by Keq, the
equilibrium constant.
exp
−∆G◦rxn
RT
= Keq. (2.24)
2.2.4.2 Detailed balance At equilibrium, the net flux across each reaction is zero in
an NPT system. This is the principle of detailed balance: the forward rate of each reaction
is balanced with the reverse rate. We will see in this section that satisfying detailed balance
introduces constraints among the equilibrium constants in the reaction network. And as a
further consequence, the kinetics parameters are constrained.
Consider a “loop” of reactions such that the system state after firing the sequence is the
same as the original state. Suppose r1, r2, . . ., rN are a sequence of reactions in an NPT
system, and let ~si be the stoichiometry vector for reaction i. If a sequence of reactions has
the property:
N∑
i=1
~si = ~0, (2.25)
then the reaction sequence forms a loop in the reaction network. If a reaction sequence forms
a loop in the reaction network, then we will see that the change in Gibbs’ free energy due
to firing the reactions is zero.
N∑
i=1
~si = ~0 =⇒
N∑
i=1
∆G◦rxn(i) = 0, (2.26)
where ∆G◦rxn(i) is the standard free energy change of reaction i. In words, Gibbs free energy
is conserved around loops in the reaction network.
Equation 2.26 is a simple consequence of the relationship between the standard change in
free energy and the reaction quotient at equilibrium. For precision, let’s define the reactant
vector ~ri, where the ri,j is the number of species j consumed by reaction i, and the product
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vector ~pi, where pi,j is the number of species j produced by reaction i. The reactant and
product vectors are related to the stoichiometry vector: ~si = ~pi − ~ri. Now let’s consider the
product of the equilibrium constants:
N∏
i=1
Keq,i =
N∏
i=1
∏Ns
j=1([xj]/c0)
pi,j∏
j([xj]/c0)
ri,j
=
N∏
i=1
Ns∏
j=1
([xj]/c0)
pi,j−ri,j =
N∏
i=1
Ns∏
j=1
([xj]/c0)
si,j
=
Ns∏
j=1
([xj]/c0)
∑N
i=1 si,j =
Ns∏
j=1
([xj]/c0)
0 = 1, (2.27)
where Ns is the number of species involved in the reaction loop. So the product of equilibrium
constants around a loop is equal to one. Now let’s use the relation between equilibrium
constants and standard change in free energy:
1 =
N∏
i=1
Keq,i =
N∏
i=1
exp
−∆G◦rxn(i)
RT
⇐⇒ 0 =
N∑
i=1
∆G◦rxn(i). (2.28)
Therefore, the sum of standard change in free energy is zero around any loop in the reaction
network. It also follows that the change in free energy for non-standard concentrations
equals zero. Starting with the change Gibbs’ free energy calculated from the free energy of
formation, we obtain:
N∑
i=1
∆Grxn(i) =
N∑
i=1
Ns∑
j=1
~si,j
(
∆G◦f (j) +RT log([xj]/c0)
)
=
N∑
i=1
Ns∑
j=1
~si,j∆G
◦
f (j) +RT
N∑
i=1
Ns∑
j=1
~si,j log([xj]/c0)
=
N∑
i=1
∆G◦rxn(i) +RT
Ns∑
j=1
(
N∑
i=1
~si,j
)
log([xj]/c0) = 0. (2.29)
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2.2.4.3 Detailed balance in the hemoglobin model The Hemoglobin state transi-
tion digram in Figure 2.1 has 4 simple loops. Each simple loop introduces one additional
constraint on the equilibrium parameters. Since the oxygen binding sites are indepen-
dent given the conformation of Hemoglobin (and concentration of free oxygen), we have
KR01 = KR12 = KR23 = KR34 and KT01 = KT12 = KT23 = KT34. So there are 13 − 6 = 7
equilibrium parameters and an additional 4 constraints due to the loop. Therefore, the
model has 3 free equilibrium parameters. Choosing the free parameters KR01, KRT1, KT01, the
remaining parameters are computed as follow:
KRT1 = KT01KRT0/KR01
KRT2 = K
2
T01KRT0/K
2
R01
KRT3 = K
3
T01KRT0/K
3
R01
KRT4 = K
4
T01KRT0/K
4
R01 (2.30)
2.2.4.4 Elementary kinetics and its connection to detailed balance So far, we
have elaborated the theory for systems at equilibrium. But is this relevant for systems that
are far away from equilibrium? If most biochemical models include processes that are driven
by external energy, e.g. ATP, why should we care about equilibrium principles? The answer
lies in the connection between detailed balance and elementary kinetics, the most common
theoretical model governing the kinetics of chemical reactions.
An elementary reactions is a chemical reaction in which the reactant species interact to
form the products in one step, i.e. there are no intermediate steps in the reaction mechanism.
The kinetic rate of an elementary reaction is given by the product of (i) a microscopic rate
constant, (ii) a combinatorial factor that counts the number potential reactant sets, and
(iii) a path factor describing the number of “reaction pathways” that a set of reactants may
follow. In general, if ~r is the reactant vector, the elementary reaction rate is:
rate = kη
Ns∏
i=1
ri∏
j=1
ni − (j − 1)
j
, (2.31)
where ni is the number of molecules of species i, ri is the reactant stoichiometry of species
i, k is the microscopic rate constant (per unit time), and η is the path factor.
44
For example, the bimolecular reaction A + B -> AB k has the elementary rate:
rate = knAnB, (2.32)
where the number of ways to select an A,B pair to react is nAnB. In contrast, the reaction
A + A -> AA k has the elementary rate:
rate = k
nA(nA − 1)
2
, (2.33)
since the number of ways to select an A,A pair is given by
(
nA
2
)
= nA(nA−1)
2
.
Most commonly, bulk rate constants, i.e. per concentration per time for bimolecular
reactions, are reported in the literature. However, a rate constant in “microscopic” units,
i.e. the propensity for an A,B particle pair to interact per unit time in the reactor volume,
is required for discrete stochastic simulations. The microscopic constant is obtained from
the bulk rate constant by dividing by the product of Avogadro’s number and the reactor
volume, NAV .
At equilibrium, the reverse rate balances the forward rate so there is no net flux through
the reaction. Consider the generalized elementary reaction:
Ns∑
i=1
xi
ri →
Ns∑
j=1
xj
pj k+, k− (2.34)
where ~r and ~p are the reactant and product vectors. At equilibrium the forward and reverse
rates are balanced:
k+η+
Ns∏
i=1
∏ri
j=1 ni − (j − 1)
ri!
= k−η−
Ns∏
i=1
∏pi
j=1 ni − (j − 1)
pi!
. (2.35)
Rearranging terms, we obtain:
k+η+
∏
i ri!
k−η−
∏
i pi!
=
∏
i
∏pi
j=1 ni − (j − 1)∏
i
∏ri
j=1 ni − (j − 1)
. (2.36)
For large species counts, the ratio of weighted rate constants is approximately proportional
to the reactant quotient:
(NAV )
∑
i(ri−pi) k+η+
∏
i ri!
k−η−
∏
i pi!
= (NAV )
∑
i(ri−pi)
∏
i ni
pi∏
i ni
ri
=
∏
i
(
ni
NAV
)pi
∏
i
(
ni
NAV
)ri = Q. (2.37)
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Hence, at equilibrium we have:
Keq = (NAV )
∑
i(ri−pi) k+η+
∏
i ri!
k−η−
∏
i pi!
. (2.38)
Since the path factor is a constant, the equilibrium constant constrains the ratio of the
elementary kinetic rate constants. Since the product of equilibrium constants around a loop
is one, and the ratio of rate constants is proportional to the equilibrium constant, we have:
1 =
N∏
i=1
Keq,i =
N∏
i=1
(NAV )
∑
j(rj−pj)
ki+ηi+
∏
j ri,j!
ki−ηi−
∏
j pi,j!
=
N∏
i=1
ki+ηi+
∏
j ri,j!
ki−ηi−
∏
j pi,j!
. (2.39)
So even when the system is away from the equilibrium, the elementary rates are constrained
by principles of free energy.
Finally, if the change in free energy around each loop is zero, then detailed balance is
automatically satisfied. For simplicity, absorb the multiplicity and combinatorial factors into
the rate constant. Then for any reaction i in a loop:
k′i−
k′i+
=
1
Keq,i
=
∏
j 6=i
Keq,j =
∏
j 6=i
k′j+
k′j−
=
∏
j 6=i
∏
l nl
pj,l∏
l nl
rj,l
=
∏
l nl
∑
j 6=i pj,l∏
l nl
∑
j 6=i rj,l
=
∏
l nl
ri,l∏
l nl
pi,l
=⇒ k′i+
∏
l
nl
ri,l = k′−
∏
l
nl
pi,l .
(2.40)
2.2.4.5 Methods for satisfying detailed balance Various methods exist for satisfying
detailed balance in reaction networks. Colquhoun et al. [96] presented a method that relies on
finding the minimum cycle basis of the state graph. The computational cost is > O((n+m)3),
where n is the number of undirected edges and m the number vertices [97]. Thus the cost
is prohibitive for large reaction networks found in combinatorial networks. Yang et al. [97]
reduced the cost by identifying the minimal reaction scheme, i.e. the sub-network excluding
energy-driven and irreversible reactions, as well as reactions in acyclic pathways. Szederkenyi
and Hangos developed a polynomial-time method posed as a linear programming task [98].
Gorban and Yablonsky extended detailed balance methods to networks with irreversible
reactions. Danos et al. [99], working in a restricted class of Petri net, provided criterion for
verification of detailed balance in a class of Petri nets.
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The methods above attempt to satisfy or verify detailed balance in a reaction network.
In contrast, the Allosteric Network Compiler (ANC) is a rule-based modeling language with
semantics for allosteric mechanisms [49]. During network generation, kinetic rates are cus-
tomized for each reaction to account for cooperative interactions. Thus, the reactions derived
from a rule are guaranteed to satisfy detailed balance.
2.3 MOTIVATING EXAMPLE
This chapter will develop energy-based modeling in parallel with a model of ligand-induced
receptor dimerization and phosphorylation. Henceforth, we will refer to this as the receptor
activation model. Figure 2.2 shows the contact map for the receptor activation model. A
contact maps shows the molecular domain structure, protein-protein interactions, and po-
tential post-translational modifications. The receptor activation pathway begins with ligand
binding the extracellular domain of the transmembrane receptor. Ligand binding drives the
receptors to form dimers, and the kinase domain of a dimerized receptor trans-phosphorylates
a residue on its partner receptor. Phosphorylation consumes one ATP, however we assume
that the concentration of ATP is held constant in the cytosol. (The receptor is said to be
active when it is phosphorylated.) Finally, a cytosolic phosphotase binds to the phospho-
rylated receptor at catalyzes dephosphorylation, returning the receptor to its inactive form.
The ligand-receptor module is based on the Macdonald-Pike model of cooperativity in EGF
ligand binding and receptor dimerization [88]. The complete model is listed in Appendix C.
The receptor activation model will motivate the methods, illustrating the benefits in
terms of simplified model specification and automatic satisfaction of thermodynamic balance
constraints. The receptor activation EBM is specified by 5 reaction rules (ligand binding,
receptor dimerization, transphosphorylation, phosphotase binding, and dephosphorylation)
and 8 energy patterns. The reaction rules have minimal context, meaning that only the sites
of the reaction center are queried by the rules. The cooperativity between sites, such as the
cooperativity of ligand binding and receptor dimerization, is encoded in the energy patterns.
In contrast, an equivalent plain BNGL model requires 10 reaction rules (not shown).
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Figure 2.2: Contact map of example energy model: receptor activation.
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Not only does the EBM require fewer rules, but each rule has minimal context and thus is
simpler to write and read. Furthermore, 3 thermodynamic balance constraints are implied
by the reaction rules. Whereas the modeler must manage the constraints manually in the
plain BNGL model, these are handled automatically in the energy BNGL model. Managing
thermodynamics constraints is especially challenging for larger models. The reaction network
generated by the energy model, or the equivalent plain BNGL model, includes 50 species
and 316 reactions.
2.4 THE THEORY OF ENERGY-BASED MODELING
In this section, I will develop the theory of energy-based modeling. First, we present a
method of accounting free energy of species by pattern matching. Then the change in free
energy of reactions are computed from the free energy of the reactant and product species.
Next, kinetic parameters are derived from the change in free energy and an activation energy
parameter. Finally, a software implementation in BioNetGen, energy BNGL or eBNGL is
described.
The union of free energy principles and rule-based models was first described by Ollivier,
48
et al. [49] and implemented in the Allosteric Network Compiler (ANC). Ollivier’s method was
generalized to arbitrary sources of cooperativity via pattern matching by Danos et al. [93].
The present work builds on this foundation by presenting (i) a general implementation of
energy modeling in BNG, (ii) fully energy-based kinetics, including pure catalysis, (iii) non-
equilibrium processes, (iv) a treatment of ring formation in oligomers.
2.4.1 Free energy accounting: a pattern-based approach
Energy patterns are molecular motifs where free energy is “stored”. For example, free en-
ergy can be stored in a bond, L(r!1).R(l!1); a molecule, ATP(); or a post-translational
site modification, R(y∼P!?); and so forth. Free energy can also be stored in coopera-
tivity between pairs of bonds, L(r!1).R(l!1,d!2).R(d!2); bonds and site modifications,
R(y∼P!1).Ph(s!1); etc. In general, free energy can be stored in arbitrary patterns. Each
energy pattern is associated with a parameter called the standard free energy of pattern for-
mation, or pattern energy for brevity. This parameter quantifies the amount of free energy
required to form 1 unit of the pattern under standard conditions.
Consider a simple system with molecule types A(b) and B(a). Suppose free energy is
stored in the bond motif A(b!1).B(a!1), with the pattern energy ∆G◦f = −45kJ/mol. If
we begin with 1 molar A(b), B(a) and A(b!1).B(a!1), then the free energy cost of forming
A(b!1).B(a!1) is −45 kJ/mol.
2.4.1.1 Computing species free energy The standard free energy of species forma-
tion, or species energy for brevity, quantifies the free energy cost of forming the species from
“atomic” constituents under standard conditions. Most often, our atomic components are
not physical atoms, but rather the smallest unit of resolution in the model. In most cases,
the “atoms” will be individual, unbound and unmodified macromolecules or other simple
molecules like ATP. The species energy is a function of the energy patterns embedded in
the molecular structure of the species. The energy is computed by counting the number of
energy pattern matches in the species then computing the sum over matches weighted by the
corresponding pattern energy. For example, if ∆G◦f (bond) is the pattern energy associated
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Figure 2.3: Energy patterns in example model: receptor activation model.
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with a type of bond, and the bond pattern is found 3 times in the species, then the pattern
contributes 3 ·∆G◦f (bond) units of free energy to the species.
More formally, let (Pn,∆G
◦
f (n))
Np
n=1 be an indexed set of BNGL patterns paired with
pattern energy parameters. Let x be a species and let emb(P, x) be the set of embeddings
of pattern P in the graph representing species x (see Appendix B for more details on graph
formalism). Then the standard free energy of species formation is given by:
G◦f (x) =
N∑
n=1
|emb(Pn, x) | ·∆G◦f (n), (2.41)
where |emb(Pn, x) | is the number of elements in the set of embeddings, i.e. the number time
the motif matches the species.
Figure 2.4 illustrates the process of computing species energy from pattern matches. In
this example, the standard free energy of species formation is computed for a phosphorylated
receptor with bound phosphotase. Three energy patterns are embedded in this species: the
phosphorylated receptor motif (RyP), the receptor-phosphotase motif (R Ph), and phospho-
rylated receptor-phosphotase motif (Rp Ph). Since each energy pattern matches the species
exactly once, the standard free energy of formation is computed by the sum of the pattern
energy parameters weighted by unity: G◦f (Rp) +G
◦
f (R Ph) +G
◦
f (RyP Ph).
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Figure 2.4: Species free energy of formation: an illustration.
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Table 2.1 lists energy patterns defined in the receptor activation model. There are several
types of motifs represented in the model. Free energy is stored in three bond motifs: the
ligand-receptor bond, receptor dimerization bonds, and the interaction of the phosphotase
(Ph) with the receptor tyrosine residue. Additionally, energy is stored in the phosphorylated
receptor tyrosine residue and ATP molecules. Finally, free energy is stored in cooperativity
among these motifs: association of a ligand to a receptor dimer, the association of two ligands
to a receptor dimer, and doubly ligated receptor dimers. Figure 2.3 illustrates the energy
patterns contained in the model.
Each energy pattern is associated with a non-dimensional standard free energy of pattern
formation parameter. If ∆G◦f has units of kJ/mol, the unitless parameter is obtained by
dividing by the product of temperature (K) and the Universal Gas Constant (kJ/mol/K).
However, if ∆G◦f has units of kJ/molecule, the Boltzmann constant kB (kJ/K) substitutes
for the Universal Gas Constant.
The reference free energy for the system is the ensemble of “atomized” proteins in the
unbound, unmodified state (L(r), R(l,y 0), Ph(y)) and the ADP() molecule. The free
energy of formation of a species is the difference in energy of the species (as computed from
energy patterns) and its atomic components in the reference state. The ATP() free energy
is with respect to the free energy of ADP().
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Table 2.1: Energy patterns block for receptor activation model.
begin energy patterns
# bond energy
L(r!1).R(l!1) G_LR/RT
R(d!1).R(d!1) G_RR/RT
R(y!1).Ph(y!1) G_RPh/RT
# state energy
R(y∼P!?) G_RyP/RT
# molecule energy
ATP() G_ATP/RT
# cooperativity
R(y∼P!1).Ph(y!1) G_RyP_Ph/RT
L(r!1).R(l!1,d!2).R(d!2) G_LRR/RT
L(r!1).R(l!1,d!2).R(l!3,d!2).L(r!3) G_LRRL/RT
end energy patterns
At minimum, an energy model should define energy patterns for bonds and site mod-
ifications (e.g. conformational change, post-translational site modification, etc.). Energy
patterns are not required for sites in the unbound, unmodified state since this is assumed
to be the reference. If an energy pattern is not defined for a bond or site modification, it
is assumed that the change in free energy is zero with respect to the reference. Usually it
is not necessary to associate an energy pattern with the molecule itself, unless it is con-
sumed or produced during the simulation. For example, free energy can associated with the
high-energy molecule ATP, which is consumed by many enzymatic reactions. (We will later
resolve the dangling issue of non-equilibrium processes such as those that consume ATP.)
In the receptor activation model, ADP() does not require an energy pattern since the free
energy of ATP() is defined relative to ADP().
2.4.1.2 Computing change in free energy due to reaction The change in free
energy due to a reaction is computed from the difference in free energy of the product and
reactant species. If ~rµ, ~pµ are the reactant and product vectors for a reaction µ, then the
standard change in free energy is given by the difference in the standard free energy of
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formation of the reactants and products (see Equation 2.20):
∆G◦f (µ) =
Ns∑
i=1
pµ,i∆G
◦
f (xi)−
Ns∑
i=1
rµ,i∆G
◦
f (xi) =
Ns∑
i=1
sµ,iG
◦
f (xi). (2.42)
where i ranges over species, xi is species i, and ~sµ is the stoichiometry vector.
The free energy change can be reformulated in terms of the change in the pattern matches.
Plugging in Equation 2.41 for ∆G◦f (xi) yields:
∆G◦f (µ) =
Ns∑
i=1
sµ,i
Np∑
j=1
|emb(Pj, xi) | ·G◦f (Pj) =
Np∑
j=1
σµ,jG
◦
f (Pj), (2.43)
where σµ,j =
∑Ns
i=1 sµ,i|emb(Pj, xi) | is the pattern stoichiometry of reaction µ. In words, the
standard change in free energy is a linear combination of pattern energies with coefficients
given by the pattern stoichiometry of the rule.
2.4.1.3 Free energy is conserved around loops in the reaction network Now
we will show that the change in free energy around a loop in the reaction network is zero.
Suppose µ1, µ2, . . . , µNr is a sequence of reactions such that the final system state is the
same as the initial. More precisely, if ~sn is the stoichiometry vector of reaction µn, and∑N
n=1 ~sn =
~0, then it follows that the standard change in free energy around the loop is zero:
Nr∑
n=1
∆G◦f (µn) =
Nr∑
n=1
Ns∑
i=1
sn,i
Np∑
j=1
|emb(Pj, xi) | ·G◦f (Pj)
=
Ns∑
i=1
(
Nr∑
n=1
sn,i
)
Np∑
j=1
|emb(Pj, xi) | ·G◦f (Pj) = 0. (2.44)
Therefore, the pattern-based accounting system guarantees that all loops in the reaction
network conserve free energy. In a later section we will derive kinetic parameters that are
compatible with the change in free energy and show that this procedure guarantees detailed
balance.
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2.4.2 Energy-based kinetics
The Arrhenius theory of reaction rates postulates that a rate constant has the form
k = C exp
−EA
RT
, (2.45)
where EA is the activation energy and C is a constant. The theory assumes that a high
energy transition state separates the reactant state from the product state. Assuming quasi-
equilibrium between the reactants and the transition state, the reactants occupy the transi-
tion state with probability
p(trans) =
exp (−(∆Gf (reac) + EA)/RT )
exp (−∆Gf (reac)/RT ) + exp (−(∆Gf (reac) + EA)/RT )
=
exp(−EA/RT )
1 + exp(−EA/RT ) . (2.46)
Assuming that the fraction of time spent in the transition state is small, this is approximately:
p(trans) ≈ exp −EA
RT
. (2.47)
Similar to the Michaelis-Menten equation, we now assume that the rate of reaction is pro-
portional to the fraction of time spent in the transition state. This yields the Arrhenius rate
in Equation 2.45.
Linear transition state theory [100], or linear TST, assumes that the activation energy is
linearly related to the standard change in free energy of a reaction. This assumption leads
an activation energy the following form:
EA := E0 + φ∆G
◦
rxn, (2.48)
where E0 and φ are free parameters. The parameters may be treated as global or local
to a subset of reactions, depending on the scope of the linear assumption. Ollivier et al.
adopted linear TST for the Allosteric Network Compiler. The scope of φ as a global or local
parameter was explored, and it was observed that a global φ was sufficient for test models
and, as an added benefit, reduced the likelihood of overfitting data. ANC does not explicitly
define the E0, rather this is inferred for each rule from a pair of baseline kinetic parameters,
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k+, k−. Although linear TST restricts the kinetic space, the assumption has been shown to
be adequate for a number of applications, e.g, [101].
The activation energy is typically set with respect to the forward reactions, i.e. the
difference between the transition state energy and the free energy of the reactants. The
activation energy for the reverse reaction is related to the forward reaction as follows:
E−A = E
+
A + ∆G
◦
rxn = E0 + (φ− 1)∆G◦rxn. (2.49)
Plugging the formula for E+A and E
−
A into the Arrhenius rate law, we find that the ratio
of forward and reverse rate constants is equal to the Equilibrium constant, as required by
equilibrium principles:
k+
k−
=
C exp (−(E0 + φ∆G◦rxn)/RT )
C exp (−(E0 + (φ− 1)∆G◦rxn)/RT )
= exp
−∆G◦rxn
RT
. (2.50)
Therefore, we find it appropriate to adopt a convention for computing the kinetic rate con-
stants as follows:
k+ = C exp
−(E0 + φ∆G◦rxn)
RT
k− = C exp
−(E0 + (φ− 1)∆G◦rxn)
RT
, (2.51)
where E0 and C are rule-specific parameters with scope of all reactions generated by the
rule, and φ is usually a global system parameter (it may be desirable at times to define
a unique φ for each reaction rule). Since biochemical systems are usually simulated at
constant temperature, we may absorb the constant C into the Boltzmann factor. Letting
E ′0 := E0 −RT logC, we can rewrite the kinetic constants:
k+ = exp
(
−E
′
0 + φ∆G
◦
rxn
RT
)
k− = exp
(
−E
′
0 + (φ− 1)∆G◦rxn
RT
)
, (2.52)
Consequently, it is usually sufficient to work with the single parameter E ′0 := E0−RT logC
rather than E0 and C individually. We will usually omit the prime from E
′
0 since it usually
will not lead to any ambiguity.
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The E0 parameter is interpreted as the activation energy for a reaction where ∆G
◦
rxn = 0.
The φ parameter is the rate distribution parameter. It determines how changes in ∆G◦rxn
are distributed between the forward and reverse rates. If φ = 1, then the reverse rate is
held constant while the forward rate adjusts to changes in ∆G◦rxn. When φ = 0, the forward
rate is held constant and only the reverse rate changes. At the special value φ = 1/2, the
rate parameters are treated symmetrically, in the sense that
k′+
k+
= k−
k′−
. Furthermore, when
φ = 1/2, E0 can be interpreted as the average of the forward and reverse activation energies:
E+A + E
−
A
2
=
(E0 + φ∆G
◦
rxn) + (E0 + (φ− 1)∆G◦rxn)
2
=
(2E0 + (2φ− 1)∆G◦rxn
2
= E0. (2.53)
The role of φ is illustrated in Figure 2.5. If we draw a line connecting the free energy of the
reactants to the free energy of the reactants, the transition state energy is E0 energy units
above a point on this line set by the parameter φ. By adjusting φ, the transition state is
defined with respect to the reactants, the products, or something in between.
Choosing E0 for a reaction rule may be non-intuitive for a modeler accustomed to kinetic
parameters. It may be more natural to choose a forward rate constant k+0 for the reaction
rule when no additional context is considered (i.e. compute the change in free energy for
the rule, rather than any specific reaction). Letting ∆G◦rule be the standard change in free
energy of the rule, the baseline forward activation energy is E+0A = E0 + φ∆G
◦
rule. Thus, we
can choose k+0 and φ and compute E0 as follows:
E0 = −RT log (k+0/C)− φ∆G◦rule. (2.54)
2.4.2.1 The limits of linear transition state theory A key limitation of the linear
transition state assumption is that reactions with the same change in free energy will always
have the same kinetic rate constants:
∆G◦rxn,i = ∆G
◦
rxn,j
=⇒ E+iA = E0+φ∆G◦rxn,i = E+jA =⇒ k+,i = C exp−E+iA /RT = k+,j. (2.55)
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Figure 2.5: Geometric interpretation of transition state energy. The transition state
energy of a reaction is a function of the free energy change due to the reaction and two
additional parameters E0 and φ. This figure illustrates a geometric interpretation of the
transition state energy. Let the x-axis correspond to a reaction coordinate where 0 is the
reactant state and 1 is the product state. Let the y-axis be the free energy coordinate. A
line is drawn between the points
(
0,∆G◦f (reactants)
)
and
(
1,∆G◦f (products)
)
. The φ
parameter selects a point along this line given by
(
φ,∆G◦f (reactants) + φ∆G
◦
rxn
)
. Finally,
the E0 parameter sets the “height” of the transition state at a fixed distance above the φ
point, specifically: ∆G◦f (trans) = ∆G
◦
f (reactants) + φ∆G
◦
rxn + E0.
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Therefore, pure catalytic effects, where the activation energy is lowered without shifting
the equilibrium, are not permissible within linear TST. For example, consider the reactions
S(a∼0) <-> s(a∼P) kp,km and S(a∼0).E <-> S(a∼P).E b*kp,b*km, where E is an en-
zyme and b > 1. Both reactions have the same equilibrium, but the reaction with enzyme
occurs at a faster rate. Such reaction pairs, generated by the same rule, are not possible
with the linear TST framework.
The Allosteric Network Compiler permits a workaround since the baseline forward and
reverse rate constants are both free parameters for each reaction rule. The modeler writes
two separate rules, one for the uncatalyzed reaction and one for the enzyme catalyzed re-
action, with different baseline kinetic parameters. While serviceable, this approach risks
the integrity of detailed balance in the resulting reaction network. The modeler must verify
that no violations of detailed balance have been introduced in the reaction network. For a
simple model, this will be a straightforward task. But for complex models, it may be quite
challenging.
I propose an alternative approach that is energy-balanced by construction and so avoids
the possibility of violating detailed balance. Let us generalize the baseline energy constant to
a function of the reactants, E0(~r), for the forward reaction, and a function of the products,
E0(~p), for the reverse reaction. Now the forward and reverse rate constants are computed as
follows:
k+ = C exp
(
−E0(~r) + φ∆G
◦
rxn
RT
)
k− = C exp
(
−E0(~p) + (φ− 1)∆G
◦
rxn
RT
)
. (2.56)
But we immediately encounter a problem. The ratio of rate constants will not necessarily
equal the equilibrium constant
k+
k−
= exp
−∆G◦rxn + (E0(~p)− E0(~r))
RT
= Keq ⇐⇒ E0(~r) = E0(~p). (2.57)
Consequently, we must restrict E0 to the class of functions that evaluate to the same value
on ~r and ~p. Formally, if NNs is the set of all species vectors for the model system, and ~s is
the stoichiometry vector of the reaction rule, then E0 ∈ {f : NNs → R | f(~y) = f(~y+~s)∀~y}.
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The set of constant functions is a trivial example of such a function. The set of functions
that depends only on the reaction context also satisfies this definition.
Given a reaction rule and a set of pattern-parameter pairs (Pi, Ei)
I
i=1, suppose that none
of the Pi overlaps the reaction center. Then E0 is computed as follows:
E0(~r) =
Ns∑
n=1
I∑
i=1
Ei · |emb(Pi, xn) |. (2.58)
Since the patterns do not overlap the reaction center, it follows that E0(~r + ~s) = E0(~r).
Therefore, this class of activation energy functions is compatible with the reaction equilib-
rium constants.
In eBNG, the baseline activation energy E0 may be set to a constant math expression or
any global or local function (i.e. a function of pattern matches). Prior to network generation,
functions are inspected for overlap with the reaction center. If possible overlap is detected,
network generation is aborted with an error message to the modeler. Thus, the limitations
of linear TST are removed without risk of violating detailed balance1.
See Section 2.5.8.1 for an model system that illustrates local activation energy functions.
2.4.3 Non-equilibrium reactions: adding free energy to the system
While NPT assumptions are applicable to a number of biochemical models, in general this
is a very limiting assumption. Most cellular signaling pathways, such as EGFR, involve
enzymatic reactions that consume energy in the form or ATP. The concentration of ATP
is held approximately constant in the cell by regulatory mechanisms. The production of
ATP is driven by the consumption of energy-rich substrates, e.g. glucose, etc., obtained
from the extracellular environment. At the scale of the test tube, the system is NPT if
we assume reagents are neither added or removed during the experiment. However, it is
impractical to model a system that includes the extracellular environment, nutrient uptake,
central metabolism, and so forth. Instead, the model is usually built on an implicit assump-
tion that the concentration of ATP, ADP, and so forth are held constant by some external
1At time of writing, local and global functions are supported by eBNG, but the check for overlap is not
yet implemented.
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mechanism. Hence, the system under study is not NPT, since an external free energy supply
is continuously pumped into the system.
Is it reasonable then, for models that include an external source of free energy, to enforce
the principle of detailed balance? And if so, how is free energy introduced to the system? A
simple thought experiment demonstrates that detailed balance principles do apply to such
systems, at least under the regime of elementary kinetics. Suppose the cell maintains an
ATP/ADP gradient by consuming energy obtained from the environment. Then imagine
that the cell finds itself starved of nutrients. Eventually, the cell would consume all its
energy reserves and ATP/ADP concentration gradient would be lost. Gradually the cellular
environment would tend toward an equilibrium. When equilibrium is achieved, detailed
balance must be satisfied. Hence, since the parameters are independent of concentration,
the elementary kinetic parameters of the model must satisfy any constraints imposed by
detailed balance.
So we have established that, ideally, elementary kinetic parameters should satisfy detailed
balance constraints, even for models that receive an external supply of free energy. But how
can we model the flow of external free energy into the system? The answer is right before us,
we simply need to make the implicit assumptions explicit. Let us suppose that an external
energy sources establishes a non-equilibrium ratio of a high-energy molecule, e.g. ATP, and
its low energy catabolite, e.g. ADP. Next, write mass-balanced, reversible reaction rules
that explicitly consume the high-energy molecule and produce the low-energy molecule. For
example, consider a phosphorylation reaction that consumes an ATP molecules. Such a
reaction is typically written R(y∼0) <-> R(y∼P) kp,km, with the consumption of ATP
implicit. We will make this assumption explicit by writing the mass balanced equation
R(y∼0) + ATP + H2O <-> R(y∼P) + ADP + Pi kp’,km’. To simplify the example, let
us omit the water and phosphate molecules: R(y∼0) + ATP <-> R(y∼P) + ADP kp’,km’.
The rates of the reaction are given by:
rate+ = k
′
+[R(y ∼ 0)][ATP]
rate− = k′−[R(y ∼ P)][ADP]. (2.59)
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The rate constants are related to the non-balanced rate constants by the relationship
k+ = k
′
+[ATP]
k− = k′−[ADP]. (2.60)
Therefore the true equilibrium constant is related to the steady-state constant by:
Kss =
k+
k−
=
k′+[ATP]
k′−[ADP]
=
[ATP]
[ADP]
Keq = rKeq, (2.61)
where r := [ATP]
[ADP]
is the ratio of ATP to ADP. As long as r  1, the quasi-steady state of
the reaction is far from equilibrium. But eventually r will decrease to equilibrium unless
an external source replenishes the ATP and deplenishes the ADP. This can be achieved by
fixing the concentration of ATP and ADP.
When the external energy consumption is treated implicitly, we find that the product of
equilibrium constants around reaction network loops is no longer unity:
N∏
n=1
k−,n
k+,n
=
N∏
n=1
rnk
′
−,n
k′+,n
=
N∏
n=1
rn
N∏
n=1
Keq,n =
N∏
n=1
rn, (2.62)
where rn is the quotient of concentrations of the implicit reactants and products. Note
that if one ATP is consumed per circuit, this corresponds to external free energy input of
∆G◦f (ATP → ADP) + RT log r per circuit, i.e. the cost of assembling ATP from ADP under
the conditions of r.
In conclusion, non-equilibrium biochemical processes can be implemented in a simple
fashion by (i) writing mass balanced rules, (ii) selecting kinetic parameters that satisfy
detailed balance, and (iii) fixed the concentration of high-energy molecules. In addition to
satisfying thermodynamic constraints, this approach has a few more advantages. First, the
detailed balance constraints eliminate a few free parameters. Second, the amount of free
energy “consumed” by an ATP-driven reaction is limited by the change in free energy of
ATP to ADP conversion. Third, mass balanced equations are true to the spirit of separating
the model from any approximations or coarse-graining prior to simulation. Finally, since
the reactions are reversible, it is possible to drive the reaction in the reverse direction if free
energy change of the reaction becomes negative, this may be important in some processes,
e.g. metabolism.
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2.4.4 Ring closure
There are two general types of binding reactions: bimolecular and unimolecular. A bimolec-
ular binding reaction involves two disconnected complexes forming a new bond to form a
single, larger complex. A unimolecular binding reaction involves a single complex in which
two distant sites form a new bond resulting in a ring structure. In the context of polymer-
ization, a bimolecular binding reaction is a chain elongation, while a unimolecular reaction
corresponds to ring formation. In terms of free energy, these reactions behave differently,
even if the types of binding sites are the same in both cases. Typically the ring closure
reaction is more favorable than chain elongation. This is due to the reduction in entropy
required to form a single complex from two separate complexes. Prior to chain elongation,
two complexes are free to diffuse in the reactor volume; subsequent to binding, the degree
of diffusional freedom is reduces since the position of the complexes has become coupled.
I will attempt to describe the distinction between chain elongation and ring closure using
the definition of free energy. Suppose that the binding reaction can be divided into two steps.
First, the freely diffusing molecules form an encounter complex, i.e. the molecules are close
enough to interact via electrostatic, hydrophobic, or other forces. Let us choose a radius
re and suppose the molecules have formed the encounter complex if the distance between
centers of mass is less than re. The change in free energy due to formation of the encounter
complex is primarily due to the change in entropy. In the second step, the molecules in the
encounter complex transition to the bound complex, i.e. the molecules “snap” together to
form a tight bond. The change in free energy due to the second step is mostly a change of
internal enthalpy and also internal entropy (a reduction of the internal flexibility of molecules
in the encounter complex). The change in free energy of the total reaction is now:
∆G◦elongation = ∆G
◦
1 + ∆G
◦
2 = (∆H
◦
1 − T∆S◦1) + (∆H◦2 − T∆S◦2) . (2.63)
Assuming that the change of enthalpy in step 1 is much less than the other terms, the total
change in free energy is approximately:
∆G◦elongation ≈ − T∆S◦1 + ∆G◦2. (2.64)
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Finally, since the change in entropy in step 1 is proportional to the log of the ratio of effective
volume of the encounter complex Ve =
4
3
pir3e and reactor volume, Vr, we have:
∆G◦elongation ≈ −RT log
Ve
Vr
+ ∆G◦2. (2.65)
This equation states that the chain elongation reaction has one free energy contribution
due to the reduction in degrees of translational freedom, and a second term due to the the
transition from the encounter complex to the bound state. Since Ve < Vr, the change in
entropy is positive (as expected) and increases with the size of the reactor. However, the
second term is independent of the reactor volume.
Let us proceed with the assumption that the change in free energy due to ring formation
is approximated by ∆G◦2, and the free energy change due to chain elongation is the sum of
contributions from forming the encounter complex and bond formation. Thus we arrived at
a relationship between elongation and ring closure:
∆G◦elongation ≈ −RT log
Ve
Vr
+ ∆G◦ring. (2.66)
Of course this is an approximation, but this formulation provides intuition for the relationship
between chain elongation and ring formation.
This leads us to a conundrum. Consider the following model:
begin energy patterns
A(x!1).B(y!1) dG_bond
end energy patterns
begin reaction rules
# bimolecular binding
A(x) + B(y) <-> A(x!1).B(y!1) Arrhenius(E0,phi)
# unimolecular binding
A(x).B(y) <-> A(x!1).B(y!1) Arrhenius(E0,phi)
end reaction rules
The first reaction rule is a type of chain elongation, while the second reaction rule is a ring
formation. Despite the topological difference, reactions generated from both rules will have
the same change in free energy: dG bond. This is an unsatisfying result, and so we must find
another source of free energy to differentiate chain elongation and ring formation. There
are two ways to proceed: add the ring complex to the list of energy patterns, or decompose
the change in free energy for bimolecular reactions into internal and diffusional free energy
changes.
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Let us proceed with the first approach and associate a free energy with ring structures.
Suppose, for example, molecules A and B (above) form a ring structure together with a third
molecule S. We can assign a free energy to the ring motif, with a negative value to promote
stability of the ring structure:
begin energy patterns
A(x!1).B(y!1) dG_bond
A(x!1,s!3).B(y!1,s!2).S(a!3,b!2) dG_ring
end energy patterns
Using the relationship between free energy of chain elongation and ring formation (Equa-
tion 2.66), a first estimation for the free energy associated with the ring is proportional to
the log of the ratio of the reactor volume to the encounter complex volume:
dG ring = RT log
(
Ve
Vr
)
. (2.67)
Since Ve < Vr, it follows that dG ring < 0 and the ring is more stable than the chain.
Based on Equation 2.52, the rate constants for chain elongation are related to those for ring
formation as follows:
k+,elong = k+,ring
(
Ve
Vr
)φ
k-,elong = k-,ring
(
Ve
Vr
)φ−1
. (2.68)
If φ = 1, the unbinding rates for rings and chains are the same. In that case, the entropic free
energy change due to encounter complex formation is absorbed entirely in the forward rate
constant. However, if φ 6= 1, the free energy of forming the encounter complex is distributed
between the forward and reverse rates. Here, the half life of a bond in a ring is different than
that in a chain. If φ < 1, the half life of a bond in a ring is longer than the equivalent bond
in a chain.
There is currently no facility in eBNG for directly associating a free energy change with
the molecularity of a reaction rule.
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2.4.5 Comparison to ANC
The Allosteric Network Compiler (ANC) [49] is a pioneering rule-based platform with formal
handling of allosteric cooperativity. While ANC is the foundation for eBNG, its limitations
are also the motivation for design choices in eBNG. This section outlines the major differences
between ANC and eBNG.
In ANC, cooperativity is modeled by pairwise site interactions within a molecule. Bio-
logically, this is motivated by allosteric mechanisms such as conformational switching and
post-translational modification. From the perspective of energy pattern formalism, this is
equivalent to restricting energy patterns to pairs of sites within a molecules. Thus, ANC
is not a generalized energy-modeling platform. Energy BNG extended the ANC concept to
arbitrary energy patterns. Any molecular motif can be associated with a free-energy term.
Thus it is possible to implement 3rd and higher order cooperativity. Additionally, cooperative
mechanisms can span multiple molecules.
ANC associates independent forward and reverse kinetic constants to each reaction rule.
These constants determine the baseline kinetics, i.e. the reaction rate when no cooperative
modifiers are present. The independent rate constants can be problematic if a model includes
more than one rule involving the same reaction center. In such a model, it is possible that
the choice of rate constants will lead to violations of detailed balance. Thus, ANC cannot
guarantee detailed balance is all cases. Energy BNG eliminates independent rate constants in
favor of an activation energy. Thus, the kinetics of eBNG are entirely posed in the Arrhenius
framework, rather than a mixture of kinetics and linear TST. As a consequence, an eBNG
model is guaranteed to satisfy detailed balance when multiple rules act on the same reaction
center. However, detailed balance can be violated intentionally by mixing traditional BNGL
reaction rules with Arrhenius rate laws. This is useful for implementing energy- driven or
irreversible reactions.
The kinetic modifiers in ANC are equivalent to linear transition state theory. As a con-
sequence, reactions with the same change in free energy will have the same kinetics. Thus,
it is not possible to implement pure catalytic enhancements (i.e. enhanced rate of reac-
tion without a change in equilibrium) unless the uncatalyzed and catalyzed reactions are
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implemented by separate rules. This approach, however, can be dangerous due to the possi-
bility of violating detailed balance. Energy BNG implements catalytic modifiers through the
functional activation energy mechanism. Baseline activation energy is function of the local
reaction context. Thus, enzyme binding, conformational switching, and post-translational
modifications can influence the energy barrier independent of changes in reaction free energy.
2.5 CONSTRUCTING ENERGY-BASED MODELS WITH BIONETGEN
Energy BNG (eBNG) is the software implementation of the theory described in the pre-
vious section. Energy BNG is a superset of the BioNetGen language, hence any feature
of BioNetGen may be included in an eBNG model. However, there is no guarantee that
an energy-based model mixed with plain BNGL will satisfy detailed balance. This section
describes the process of constructing an energy-based model in eBNG using the receptor
activation model (Figure 2.2) as an illustration.
2.5.1 Block structure
An energy-based model, like other BioNetGen models, is specified in a plain text file with
.bngl extension. A model begins with the directive begin model and ends with end model.
The model is composed of a set of blocks, which describe objects of a given type. Each block
starts with the directive begin <blockname> on a new line, followed by a number of object
definitions, and ends with end <block name>. All blocks available in a plain .bngl are
available in energy models. In addition, energy models should include the energy patterns
block. The allowed blocks are, in recommended order: parameters, molecule types,
compartments, seed species, observables, functions, reaction rules, and energy
patterns. Blocks may be omitted if no object of the corresponding type is defined in
the model. At the end of the model, a set of actions may be specified, such as simulate(),
that are performed after the model is parsed by BioNetGen.
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With the exception of the new energy patterns block, the syntax for each block is the
same as plain BNGL. The reader is referred to the BNG book chapters [60, 61] for further
documentation.
2.5.2 Preliminaries
Since energy features were not available prior to BNG-2.2.4, we will require version 2.2.4
or greater for the receptor activation model. This is accomplished by calling the version
action at the beginning of the model.
version("2.2.4")
It is useful to tell BioNetGen the quantity units of the reference concentration for stan-
dard free-energy. BNG is capable of adjusting free-energy parameters for non-standard
conditions using compartment volumes and the number of molecules per quantity unit. For
example, if the reference quantity is 1 mole, there are NA molecules per reference quantity.
If the reference is 1 molecule, there is 1 molecule per reference quantity. The quantity units
are specified by setting the option NumberPerQuantityUnit:
setOption("NumberPerQuantityUnit",6.0221e23)
2.5.3 Model parameters
Model parameters, as well as math expressions derived from parameters, are defined in
the parameters block. An energy model will typically be parameterized with free-energy
parameters, rather than kinetic parameters. But otherwise, the block is no different than a
plain BNGL model. Some of the parameters for the receptor activation model are listed in
Table 2.2. Free-energy parameters will be described later, when energy patterns and reaction
rules are presented.
2.5.4 Compartments
Compartments are recommended, but not required in an energy model. The benefit of
using compartments, even for models with only one compartment, is that eBNGL is able
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Table 2.2: Parameters block for receptor activation model.
begin parameters
# fundamental constants
RT 2.577 # kJ/mol
NA 6.022 e23 # /mol
PI 3.142 # Pi , no units
# Geometry parameters
rad_cell 1e-4 # radius of cell , dm
cell_dens 1e9 # density of cells , /L
width_PM 1e-7 # effective width of membrane , dm
# Compartment volumes
volEC 1/ cell_dens # vol. extracellular space , L
volPM 4*PI*rad_cell ^2* width_PM # virtual vol. of plasma membrane , L
volCP 4/3*PI*rad_cell ^3 # vol. of cytoplasm , L
# initial concentrations
conc_L_0 20e-9 # mol/L
count_R_0 24000 # molecules/cell
conc_Ph_0 10e-9 # mol/L
conc_ATP_0 1.0e-3 # mol/L
conc_ADP_0 0.1e-3 # mol/L
...
end parameters
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Table 2.3: Compartments block for receptor activation model.
begin compartments
EC 3 volEC # extra -cellular space
PM 2 volPM EC # plasma membrane
CP 3 volCP PM # cytoplasm
end compartments
to adjust the free-energy terms for non-standard concentrations. The receptor activation
model has three compartments: extracellular space, plasma membrane, and cytoplasm. The
compartments block for this model is shown in Table 2.3.
2.5.5 Molecule types and seed species
The first step in building an energy model, as is the case for rule-based models in general,
is describing the types of molecules that will populate the system. It is recommended, but
not mandatory, to name each molecule type in the molecule types block. Furthermore, the
domain structure of macromolecules, including binding domains, potential post-translational
modifications, and conformational states, should be described. The procedure for specifying
molecule types is the same for energy models as plain BNGL. The contact map in figure 2.2
shows the domain structure of molecules in the receptor activation model.
Next, the initial population of molecular species is specified in the seed species block.
Each line in the seed species block describes the structure of a molecular species (i.e. species
pattern) and the initial quantity. It is recommended that seed species quantities have units
of molecule counts rather than concentrations. This will permit simulation of the model as
a continuous system (i.e. ODE) or a discrete stochastic system (i.e. SSA).
In the receptor activation example, there are 5 molecule types: the ligand molecule type,
which has a receptor binding domain; the membrane receptor molecule type, with a ligand-
binding domain, a dimerization domain, an a phosphorylation site; a cytosolic phosphotase
(Ph), with receptor interaction site; and ATP and ADP, which are both simple molecules
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Table 2.4: Molecule types block for receptor activation model.
begin molecule types
L(r) # ligand
R(l,d,y∼0∼P) # trans -membrane receptor
Ph(y) # phosphotase
ATP() # ATP
ADP() # ADP
end molecule types
without domain structure. The molecule types block is shown in Table 2.4.
The initial system state is described in the seed species block. In the receptor acti-
vation model, unbound, unphosphorylated transmembrane receptor is placed in the plasma
membrane (PM); unbound phosphotase, ATP, and ADP are placed in the cytoplasm (CP),
and free ligand is placed in the extracellular space (EC). The quantity of each species is
specified with units of molecule counts. The seed species block is shown in Table 2.5.
Observe that ATP and ADP are prefixed by the $ symbol in Table 2.5. The $ symbol
indicates that the quantity of the species in held constant during the simulation. ATP and
ADP quantities are held constant in this model to mimic the cellular environment in which
concentration of ATP and ADP are tightly regulated.
Table 2.5: Seed species block for receptor activation model.
begin seed species
L@EC(r) conc_L_0*NA*volEC
R@PM(l,d,y∼0) count_R_0
Ph@CP(y) conc_Ph_0*NA*volCP
$ATP@CP () conc_ATP_0*NA*volCP # ATP quantity held constant
$ADP@CP () conc_ADP_0*NA*volCP # ADP quantity held constant
end seed species
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Table 2.6: Observables block for receptor activation model.
begin observables
Molecules Lfree L(r)
Molecules Ltotal L()
Molecules Rbound L(r!1).R(l!1)
Molecules Rdimer R(d!1).R(d!1)
Molecules RyP R(y∼P!?)
Molecules Rtotal R()
Molecules RyP_Ph R(y!1).Ph(y!1)
Molecules PhTotal Ph()
end observables
2.5.6 Model outputs: observables
The observables block in an energy model has the same syntax and function as plain
BNGL. Each item in the observables block specifies an output of the model. Observables are
defined by a set of patterns that match species in the system. The value of the observable
is the sum over patterns of all matches weighted by the species population.
The receptor activation model includes a variety of observables, such as free ligand
(LFree), dimerized receptor (Rdimer), and phosphorylated receptor (RyP). Although the to-
tal ligand and receptor are expected to be constant during a simulation, observables Ltotal
and Rtotal are included in order to verify mass conservation in the model. The observables
block for the receptor activation model is listed in Table 2.6.
2.5.7 Energy patterns
Energy patterns and the associated standard free energy of pattern formation parameters
are specified in the energy patterns block. The syntax of each energy pattern is
Pattern Expression
where Pattern is a BNGL pattern graph that describes a molecule motif and Expression
is a parameter name or constant math expression that specifies the standard free energy of
pattern formation. For in-depth discussion on choosing energy patterns, see Section 2.4.1.1.
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2.5.8 Reaction rules
Reaction rules in an energy model are are similar a standard rule, but with a key distinction:
the reactions generated by the rule do not necessarily share the same rate constant. Thus, an
energy-based rule is like a template for reaction rules, where the rate constant for each specific
rule is derived from analysis of the reaction specific context. More specifically, reaction rate
constants are derived from the standard change in free energy of the reaction, along with an
activation energy parameter and rate distribution parameter. These interpretation of these
parameters was discussed in Section 2.4.2.
Energy-based rules have several advantages over plain rules. First, an energy-based
rule provides a mechanism for lumping a set of rules that have the same reaction center.
Consequently, an energy model has fewer rules than an equivalent plain RBM. Second, since
the context is accounted for later, an energy-based rule usually does include any additional
context. This simplifies the process of writing each rule. Finally, the method for computing
change in free energy guarantees that free energy is conserved around loops and detailed
balance is satisfied. In sum, energy-based rules result in a model with fewer rules that are
simple to read and write and satisfy detailed balance constraints.
Energy-based rules are implemented in eBNG by assigning the Arrhenius rate law type.
All energy-based rules (with exceptions for computational efficiency) should be reversible,
since we assume the system has an equilibrium. Unlike a plain BNGL rule, a single Arrhenius
rate law is sufficient for the forward and reverse rule. Consider the following ligand-receptor
binding rule in the receptor activation model.
L(r) + R(l) <-> L(r!1).R(l!1) Arrhenius(phi,E0 LR/RT).
The reactant patterns and product patterns follow the same syntax conventions as all BNGL
rules. This is an energy-based rule since it has the Arrhenius rate law, which is sufficient for
the forward and reverse reactions. Parameters for the Arrhenius rate law will be discussed in
the next section. In consideration of the energy patterns defined for the model, this energy-
based rule encodes three plain reaction rules, each corresponding to a different reaction
context and rate constant.
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L(r) + R(l,d) <-> L(r!1).R(l!1,d) kp1 ,km1
L(r) + R(l,d!1).R(l) <-> L(r!2).R(l!2,d!1).R(l,d!1) kp2 ,km2
L(r) + R(l,d!1).R(l!2,d!1).L(r!2) \
<-> L(r!3).R(l!3,d!1).R(l!2,d!1).L(r!2) kp3 ,km3
All the rules have the same reaction center: the l site of the receptor binds (or unbinds) the
r site of the ligand. But the rules differ in context: ligand binding an undimerized receptor,
ligand binding an un-ligated receptor dimer, and ligand binding a singly-ligated receptor
dimer. Note that eBNG does not explicitly enumerate the set of reaction rules encoded
by an energy rule; instead, the reactions are generated directly. The task of inferring the
minimal set of reaction rules that are equivalent to the energy-based rule is left for the future.
Reaction rules with elementary or functional rate laws may be mixed with energy-based
rules. However, there is no guarantee that reactions generated by such rules will satisfy
detailed balance. Therefore, it is best to avoid non-energy-based rules unless the reaction
consumes or produces energy external to the model system (e.g. degradation, synthesis,
ATP consuming reactions) and the modeler wishes to treat the reaction outside the free
energy framework. But, as discusses previous, it also possible to naturally integrate energy
consuming rules into the energy framework.
The reaction rules block with the complete set of energy-based rules for the receptor
activation model is listed in Table 2.7. Note that this model is purely energy-based and
therefore detailed balance will be satisfied.
2.5.8.1 Catalytic enhancement via functional activation energy In this section,
I will illustrate a reaction rule that encodes both catalyzed and non-catalyzed reactions. We
will temporarily deviate from the receptor activation example and consider the following
model system:
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begin seed species
S(a∼0∼P,e) S0
E(s) E0
end seed species
begin energy patterns
S(e!1).E(s!1) G_S_E/RT
S(a∼P) G_SaP/RT
end energy patterns
begin observables
Molecules SE S(e!1).E(s!1)
end observables
begin reaction rules
S(e) + E(s) <-> S(e!1).E(s!1) Arrhenius( E1, phi )
S%x(a∼0)x <-> S%x(a∼P) Arrhenius( E2-E2cat*SE(x), phi )
end reaction rules
The second reaction rule describes the site modification S(a∼0) -> S(a∼P). Two reactions
are generated from this rule, an uncatalyzed reaction and an enzyme catalyzed reaction.
S(a∼0,e) <-> S(a∼P,e) Arrhenius( E2 , phi )
S(a∼0,e!1).E(s!1) <-> S(a∼P,e!1).E(s!1) Arrhenius( E2 + E2cat , phi )
Both reactions have the same change in free energy, G SaP/RT. Under linear TST, both
reactions would be assigned the same rate. But the activation energy is defined by a local
function E2+E2cat*SE(x) that queries for the presence of the enzyme. If the enzyme is
present, the activation barrier is lowered by E2cat. Since the enzyme is present on both
sides of the reaction, the local function evaluates to the same value for the reactants and the
products.
2.5.9 Energy parameters
The kinetics of an energy model are derived from three types of parameters: standard free-
energy of pattern formation (for brevity, pattern free-energy), baseline activation energy, and
rate distribution parameters (see Sections 2.4.1 and 2.4.2). The pattern free-energy param-
eters are paired with energy patterns in the energy patterns block. Baseline activation
energy and rate distribution parameters are specified in the Arrhenius type rate laws as-
sociated with each reaction rule. Energy and kinetic parameters for the receptor activation
model are listed in Table 2.8.
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2.5.10 Simulating energy-based models
Energy-based models can be simulated using any of the network-based methods supported
in BioNetGen. Prior to simulation the reaction network must be generated by calling the
generate network action. After network generation, the model system can be simulated as
a continuous, deterministic system with simulate ode; or as a discrete stochastic system
with simulate ssa. Alternatively, a custom model integrator can be exported to MATLAB
as either an m-file script or MEX code by calling writeMfile() or writeMexfile(), respec-
tively. The m-file integrator is implemented via MATLAB’s ode23s integrator, while the
MEX code integrator is based on the SUNDIALS CVODE library. The MEX code integrator is
typically much faster, and is recommended for heavy computational tasks such as parameter
estimation.
Network-free simulators (e.g. NFsim) do not support energy BNGL models. Support for
energy models may be become available in the future; but at present, network-free methods
for energy models do not exist.
2.6 MODEL SELECTION AND CALIBRATION WITH THE ENERGY
LASSO
In the previous section we assumed that the relevant energy patterns were known in advance.
In practice, the structural factors contributing to free energy may not be well understood.
Thus we need a method to select energy patterns and calibrate the associated parameters.
In this section, I present the Energy Lasso, a method for inferring energy patterns from
experimental data.
The reader may recognize this as a model selection problem. Given a base model with-
out cooperative interactions, what set of cooperativity energy patterns provides the best
explanation of the experimental data? Although adding more energy patterns will improve
the fitness of the model, it also introduces extra parameters that increase the likelihood of
overfitting the data. The ideal model includes just enough energy patterns to explain the
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experimental data, but no more.
2.6.1 Selecting energy patterns
Suppose we begin with a set of P energy patterns that could be present in the system. One
approach is to consider all 2P variations of the model corresponding to all subsets of energy
patterns. The Bayes factor is the probability of a model given the experimental data. It
provides the basis for rigorous Bayesian model selection [102, 103]. We could proceed by
computing the Bayes factor for each model variant and choosing the model with the greatest
probability. This approach has been applied to biological systems where the number of
variants under consideration is relatively small [16]. But this computationally intensive
method does not scale well as the number of energy patterns increases. For example, if we
consider 10 energy patterns, then over 1000 Bayes factors must be computed. Clearly, an
alternative is required if we are to consider a large number of energy patterns.
LASSO is a method for simultaneous model selection and parameter calibration [104].
Rather than consider each discrete model variation separately, each possible mechanism is
considered simultaneously. The strength of each mechanism is governed by an associated
parameter. When the parameter is set to zero, the mechanism is effectively absent from
the model. Each parameter has a Laplace prior probability, which is centered on zero and
provides a preference for zero-valued parameters. But the prior also has large tails, which
permits the parameter to deviate far from zero if the data likelihood improves sufficiently.
Thus, the LASSO drives parameters to zero, effectively disabling a mechanism, unless the
experimental data provides strong support for a non-zero value.
To provide more rigor, an overview of Bayesian probability is required. Bayesian parame-
ter estimation begins with Bayes’ rule, which states that the probability that a parameter set
generated a given set of experimental observations is proportional to the product of the prior
probability of the parameters and the likelihood of the experimental observations assuming
the parameter set generated the data:
p(~θ|X) = p(X|
~θ) · p(~θ)
p(X)
, (2.69)
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where ~θ is a vector of model parameters and X is the experimental data.
For LASSO, the prior probability is given by the Laplace distribution:
p(~θ|λ) =
∏
p
exp
(
−|θp|
λ−1
)
, (2.70)
where p is an index that ranges over the number of parameters. The log-posterior probability
then takes the form:
log p(~θ|X,λ) = log p(X|~θ) + log p(~θ|λ)− log p(X|λ). (2.71)
Since the last term is constant with respect to ~θ, the log posterior is proportional to:
log p(~θ|X,λ) ∝ log p(X|~θ)− λ
∑
p
|θp| . (2.72)
So we see the log-likelihood of the data is penalized by a term that depends on the absolute
value of the parameters weighted by λ. Thus, LASSO is also known as L1-regularization,
since it is equivalent to a penalty proportional to the absolute value of parameters.
Given a model and experimental data, the posterior distribution can be sampled by
Markov chain Monte Carlo (MCMC) methods. The Metropolis algorithm [105] is a sim-
ple but effective algorithm for sampling parameters from the posterior distribution. More
sophisticated sampling methods, such as simulated annealing [106, 107] and parallel tem-
pering [108, 109], are often employed since the chain converges towards the stationary dis-
tribution more rapidly in many practical applications. Once the parameter distribution is
obtained, predictions of model behavior with uncertainty estimates can be obtained by sim-
ulating the model with parameter samples from the posterior. Under the combination of
LASSO and Bayesian parameter estimation, important model mechanisms are revealed by
significant differences between the Laplace prior and the posterior distribution of a parame-
ter.
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2.6.2 The energy lasso method
The energy lasso combines energy-based modeling with the LASSO approach to model selec-
tion. The modeler begins with a base model without cooperative interactions. Next, a set of
cooperativities are postulated in terms of energy patterns that refer to two or more molecular
sites. Finally, the model is calibrated to experimental data using the LASSO method, where
Laplace priors are associated with each parameter associated with an energy pattern. The
LASSO selects the energy patterns that are supported by the experimental data. Inspection
of the posterior parameter distributions reveals the important mechanisms. Specifically, an
energy pattern is important if the the posterior distribution has escaped the envelope of the
Laplace prior.
The energy lasso provides a systematic approach to selection of energy patterns and
calibration of parameters that does not depend on the biases of the modeler. Due to the
computational cost of other approaches, a modeler is limited to consideration of a few cooper-
ative mechanisms while others are excluded from the model. If the model output is sensitive
to these choices, the drawn conclusions will incomplete (at best) or invalid (at worst). The
energy lasso, in contrast, permits consideration of a large number of mechanisms and allows
the experimental data to determine which will be included in the final model.
For example, in a model of the EGF receptor, Kholodenko et al. [17] assumed that only
one cytosolic protein can bind a receptor at a time. This is equivalent to a large negative
cooperativity between the simultaneous binding partners. In contrast, Blinov et al. [52]
assumed that binding of intracellular factors occurs independently (i.e. no cooperativity).
Both models made assumptions about the nature of the cooperativity that may influence
the results and conclusions. Under the energy lasso, an energy pattern could be associated
with simultaneous binding patterns and the calibration/selection procedure will determine
whether the cooperativity is present or not.
The energy lasso enables consideration of many cooperative mechanisms and reduces
modeler bias. But it does introduce its own systematic bias via the Laplace prior. Since pa-
rameters are penalized for deviating from zero, the parameter distribution is skewed relative
to the distribution obtained from only the data likelihood. Despite this, the energy lasso
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bias should be preferable to making arbitrary choices about cooperative mechanisms. The
energy lasso is also preferable to calibrating the most complex variant of the model without
regularization, since the abundance of free parameters may lead to overfitting [110].
79
Table 2.7: Reaction rules block for receptor activation model.
begin reaction rules
# ligand binding
L(r) + R(l) <-> L(r!1).R(l!1) Arrhenius(phi ,E0_LR/RT)
# receptor dimerization
R(d) + R(d) <-> R(d!1).R(d!1) Arrhenius(phi ,E0_RR/RT)
# Ph binding
R(y) + Ph(y) <-> R(y!1).Ph(y!1) Arrhenius(phi ,E0_RPh/RT)
# trans -phosphorylation
R(d!1).R(d!1,y∼0) + ATP \
<-> R(d!1).R(d!1,y∼P) + ADP Arrhenius(phi ,E0_catRR/RT)
# dephosphorylation by phosphatase
R(y∼P!1).Ph(y!1) \
<-> R(y∼0!1).Ph(y!1) Arrhenius(phi ,E0_catPh/RT)
end reaction rules
Table 2.8: Free energy and activation energy parameters for the receptor activation model.
begin parameters
...
# standard free energy of formation , kJ/mol
G_LR -47.5
G_RR -11.9
G_RPh -41.5
G_RyP 51.1
G_ATP 51.1
G_RyP_Ph 5.9
G_LRR -5.9
G_LRRL -11.9
# baseline activation energy , kJ/mol
E0_LR -11.9
E0_RR -5.9
E0_RPh -17.8
E0_catRR -11.9
E0_catPh 5.9
# rate distribution parameter , no units
phi 0.5
end parameters
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3.0 MODELING COMPARTMENTAL BIOCHEMICAL SYSTEMS
Rule-based modeling (RBM) was motivated by the multi-domain structure of biological
macromolecules and the local nature of interactions. The compartmental topology of the cell,
however, can also have profound effects on the regulation of cellular processes by controlling
both the reactions that can occur and the rate at which they do so. In this chapter we
describe compartmental BNGL (cBNGL), which extends BNGL to enable explicit modeling
of the compartmental organization of the cell and its effects on system dynamics1. By
making localization a queryable attribute of both molecules and species and introducing
appropriate volumetric scaling of reaction rates, the effects of compartmentalization can
be naturally modeled using rules. These properties enable the construction of new rule
semantics that include both universal rules, those defining interactions that can take place
in any compartment in the system, and transport rules, which enable movement of molecular
complexes between compartments.
3.1 INTRODUCTION
Proteins in cellular regulatory systems can interact in a combinatorial number of ways to
generate myriad protein complexes [44]. These interactions, because of the multicomponent
composition of proteins, can be modeled by rules that specify the classes of reactions that
1This chapter is a adapted from a conference proceeding with co-authors Leonard Harris and James
Faeder [111]. My contribution to the work includes design of the language extension, software implemen-
tation, and composition of the draft manuscript. Leonard Harris contributed substantially to manuscript
composition and is co-first-author. James Faeder contributed to design of the language extension, software
implementation, and manuscript revisions.
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can occur and define reaction networks that account comprehensively for the consequences of
protein-protein interactions [54]. The assumption underlying this modeling approach, which
is consistent with the modularity of regulatory proteins [40], is that interactions are governed
by local context, that is, properties of the components of the interacting molecules that are
proximal to the site of interaction. As long as this is the case, rule-based models can achieve
a compact description of a network with a large (even infinite) number of complexes [54].
The complex spatial topology of the cell, however, can also have profound effects on
the regulation of cellular processes by controlling both the reactions that can occur and
the rate at which they do so. Membranes are key players not only because they separate
molecules in different compartments but also because they mediate the flow of material and
information from one compartment to another [112]. Chemical reactions that occur at a
cell membrane also have an enhanced rate because of the drastically smaller volume of the
membrane compartment, a thin fluid layer roughly 100-1000 times smaller than the volume
of the cell [113,114]. The spatial localization of a reacting species in a biochemical network
is thus a critical property that affects its reactivity. A rule-based model of the network must
therefore describe, either implicitly or explicitly, its effects on the constituent reactions. The
main goal of this paper is to describe an extension to an existing rule-based modeling language
for biochemical systems that explicitly represents the topology of cellular compartments, the
localization of species to specific compartments, and the effects of localization on biochemical
reaction rates.
BioNetGen is an open-source software package that provides tools and a language [the
BioNetGen language (BNGL)] for rule-based modeling of biochemical systems [60]. The syn-
tax and semantics of the language are formally rooted in graph theory [66], but the language
itself is simple, intuitive, and accessible to modelers with a wide range of mathematical back-
grounds. BNGL is similar to the κ-calculus, which has also been developed as a language
for rule-based modeling [68]. A review of tools for rule-based modeling can be found in [54],
although a number of new entries have appeared more recently [69,76–78,80,115–117].
BNGL does not currently allow explicit representation of cellular compartments and
does not systematically account for the effects of spatial localization either in the selection
of species that can undergo reactions or in the calculation of reaction rates. The effects of
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localization can be modeled in an ad hoc manner but it obscures the generality of molecular
interactions, may require additional restrictions [such as the include and exclude com-
mands [50]], and may require extensive enumeration of complexes in the rules. In this paper,
we describe an extension of BNGL, which we call compartmental BNGL (cBNGL), that
enables explicit modeling of the compartment topology of the cell and its effects on system
dynamics. We show that by introducing a compartment topology, making localization a
queryable attribute of both molecules and species, and introducing appropriate volumetric
scaling of reaction rates the effects of compartmentalization can be naturally included in a
rule-based model. The outline of the remainder of the chapter is as follows. In Sec. 3.2, we
motivate our introduction of cBNGL with a schematic cell regulatory model that captures
many essential features of intracellular biochemistry. The compartmental extension of BNGL
is then described in Sec. 3.4. In Section 3.5, we summarize the strengths and weaknesses of
cBNGL and compare it to various related approaches.
3.2 A COMPARTMENTAL MODEL OF THE CELL
The function of a signal transduction pathway is to detect an extracellular signal, relay
this information inside the cell, and induce an appropriate change in cell function [112]. In
Figure 3.1, we present a model of receptor-mediated signaling coupled with nuclear transport
and transcriptional gene regulation that highlights the role of compartmental localization
and transport. This example model will be used throughout the chapter to motivate and
illustrate cBNGL.
Signaling is initiated when an extracellular ligand (L) is detected by membrane-localized
receptors (R) that bind the ligand (R1; Fig. 3.1). Because L can bind to itself (R2), ligand-
bound receptors can dimerize (also R2) and be brought inside the cell by endocytosis (R3–5),
a process in which a small region of the plasma membrane is pinched off, forming a small
bubble called an endosome [112]. Localizing a receptor complex to an endosome has the effect
of trapping the ligand and receptor molecules in a small volume, which reduces entropy and
enhances the free energy of binding. Note that during receptor internalization the receptor
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Figure 3.1: A compartmental model of the cell. The model couples simplified processes of
signal transduction, nuclear transport and transcriptional regulation in a single eukaryotic
cell. The system consists of four volume compartments: extracellular (EC), cytosol (CP),
endosomal (EN) and nuclear (NU). These are separated by three membrane surfaces: plasma
(PM), endosomal (EM) and nuclear (NM). The model is presented as a pathway that pro-
ceeds from ligand (L) binding to expression of protein P2. The underlying rule-based model
defines a set of 354 reactions between 78 species. Bonds between molecules are shown as black
lines. Black arrows between species represent reactions. Gray arrow labels correspond to
the rule number that describes the reaction (see model files at www.bionetgen.org/wsc09).
Black integer-valued arrow labels represent reaction stoichiometry (if not equal to unity).
DNA promoters are pictured as a double helix icon.
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complex moves from PM to EM, bound ligands move from EC to EN, and receptor-bound
molecules in CP remain in CP.
Receptor dimerization brings the cytoplasmic domains of receptors into close proximity,
allowing transautophosphorylation of a tyrosine amino acid by the receptors’ catalytic do-
mains (R6–7). Inactive transcription factor (TF) can bind phosphorylated receptors (R8),
leading to transautophosphorylation of TF in complexes containing receptor dimers (R10–11).
Phosphorylated TF tends to unbind from the complex (R9) and has a high affinity for form-
ing dimers (R12). Dimerized TF forms an active transcription factor that is escorted into
the nucleus, through a nuclear pore, by an importin (Im) molecule (R24, R28). Inside the
nucleus, the TF dimer binds to a promoter on DNA activating transcription of mRNA (R13),
which is transported out of the nucleus to the cytosol (R16) and translated into P1 (R18).
Cytosolic P1 is also escorted into the nucleus by Im (R28), where it binds a second promoter
to activate transcription (R15, R17, R19) and expression (R30) of a second protein (P2).
3.3 REPRESENTING COMPARTMENTS IN PLAIN BNGL
This section will briefly overview BNGL and highlight aspects relevant to compartmental-
izing the reaction network. BNGL has been more thoroughly elsewhere in this document
(Section 1.4.3).
Molecules, the basic building blocks of a BioNetGen model, are declared in the molecule
types block. Molecules may contain components, which represent the functional elements
of molecules and may bind other components, either in the same molecule or another. Com-
ponents may be associated with state variables with a finite set of possible values, each
representing a conformational or chemical state of a component, such as phosphorylation
status. The name of the molecule type is given first followed by a comma-separated list of
its components in parenthesis. The allowed values of state variables are indicated by ‘∼’ fol-
lowed by a value, as in L(r,d,loc∼EC∼EN), which declares a ligand molecule L that contains
a receptor binding component r, a dimerization component d, and a location component loc
that takes on values EC or EN.
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The seed species block defines the species initially present in the system. For example,
the line
L(r,d,loc∼EC) Lig0
specifies that the initial amount of free ligand monomers in EC is Lig0, a model parameter.
Molecular complexes may also be specified, as in
L(r,d!1,loc∼EC).L(r,d!1,loc∼EC),
where a bond linking the d components of each L molecule is indicated by a shared bond
label, !1.
The reaction rules block contains rules that define how molecules interact. A rule is
comprised of a set of reactant patterns, a transformation arrow, a set of product patterns,
and a rate law. A pattern is a set of molecules that select species through a mapping
operation [66]. The match of a molecule in a pattern to a molecule in a species depends only
on the components specified in the pattern (including wildcards), so that one pattern may
select many different species. The ‘+’ operator separates two reactant patterns that must
map to distinct species (i.e., they may not reside in the same complex). The ‘.’ operator
separates molecules that are part of the same species. The transformation arrow may be
either unidirectional (->) or bidirectional (<->). Five basic types of operations are carried
out by the rules in the example system of Sec. 3.2: binding and unbinding of two molecules
through a specified pair of components, transformation of a state variable, synthesis, and
degradation. An example of a binding rule is
R8: R(tf∼pY) + TF(d∼Y,r,loc∼CP) <-> \
R(tf∼pY!1).TF(d∼Y,r!1,loc∼CP) kp R TF/vol CP, km R TF
where the underlined portions identify the reaction center, which is the set of components
modified by the rule. (R8 indicates that this is rule #8 in the BNGL model file.) This rule
specifies that any R molecule containing an unbound, phosphorylated tf component may
bind to a r component of an unphosphorylated TF in CP. Here, the tf component of R is
bound to the r component of TF by the addition of an edge labeled 1, indicated by the two
bond labels (!1) in the products.
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kp R TF/vol CP and km R TF specify the rate constants in the forward and reverse direc-
tions. (Assuming that the bimolecular rate constant is given in standard units of M−1 s−1,
kp R TF is that value divided by Avogadro’s number.) In this case, the rate constant for
the forward direction is a formula comprised of a bimolecular rate constant divided by the
volume of CP. Parameters in BNGL have no explicitly defined units and bimolecular rate
constants are generally given on a per molecule per cell basis. BNGL supports elementary
(Ele) rate laws as well as two non-elementary types, Michaelis-Menten (MM) and saturation
(Sat) [60].
Several examples are provided in the model files at www.bionetgen.org/wsc09.
3.4 COMPARTMENTAL BNGL
As discussed in Sec. 3.1, compartmental models such as the one in Fig. 3.1 can, in princi-
ple, be modeled using standard BNGL. For example, we have seen in Sec. 3.3 that in order
to specify location in BNGL a component (loc) can be added to the component lists for
molecules. Rules can then be written with the appropriate location states as context for the
interacting molecules. In the common case where identical interactions can take place in
different compartments, this means that multiple versions of the same interaction rule must
be enumerated. Each will differ by only the values of the location labels and, in the case
of bimolecular interactions, by the volume-dependent rate constant. Besides being tedious,
this approach obscures the generality of interactions specified by a rule. In more complex
cases, for example when there are many different ways that a particular molecule can be
tethered to a membrane, the required enumeration will be prone to error; it is exactly such
enumeration that the rule-based approach was developed to avoid. A similar situation can
arise in transport reactions that depend only on the presence of a particular molecule or
component state; a different rule is required for each possible stoichiometry of the trans-
ported complex. In cBNGL, this enumeration is avoided by introducing localization as a
property of both molecules and species, with the localization of a species being a derived
property of the localization of its constituent molecules. Species localization also permits
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restricting the scope of rule application to reactants in the same or adjacent compartments
and the determination of volume-dependent rate constants for bimolecular and higher-order
reactions. The local nature of molecular bonds also imposes natural topological constraints
on complexes. If a molecule is tethered to the plasma membrane, then it cannot be trans-
ported to the nucleus without first breaking the tether. Rule application is restricted to
adhere to these constraints. In the following, we describe cBNGL in detail. The complete
syntax for cBNGL in extended Backus-Naur form is included in Appendix A.
3.4.1 Units
Species counts are assumed to be in population units or moles, not concentrations, in keeping
with standard BNGL [60]. Rate constants for bimolecular reactions, however, are assumed
to be given in units of volume/time2 and Michaelis constants for MM and Sat rules in units of
volume−1 (this assumes that the appropriate factor of Avogadro’s number, NA, is included
in the value, e.g., kbi/NA and KM×NA). This allows for the specification of universal reac-
tion rules that apply across compartments and whose rates are automatically scaled by the
appropriate compartment volume (see Sec. 3.4.5.1).
3.4.2 Compartment topology
Cellular topology, as depicted in Fig. 3.2A, implies that the compartment graph, in which
nodes represent compartments and directed edges represent containership, is a tree (Fig-
ure 3.2B). The structure is essentially the same as the compartment structure used in the
Systems Biology Markup Language (SBML) [118]. Rules for defining compartment topolo-
gies in cBNGL are as follows:
1. A surface compartment must either be an outermost compartment (i.e., no containing
compartment) or be contained by a single volume compartment.
2. A volume compartment must either be an outermost compartment or be contained by a
single surface compartment.
2If molecule counts are considered explicitly, bimolecular rate constants for cBNGL have units of
/time/(#/volume). However, we usually operate under the convention that counts are unitless.
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3. A surface compartment may contain only a single volume compartment.
4. A volume compartment may contain multiple surface compartments.
Compartments in cBNGL are declared in a compartments block analogous to other blocks
used in BNGL (see Sec. 3.3). The syntax of each line in the block is
[index] compartment name dimension volume [containing compartment]
where the square brackets denote optional arguments. compartment name is a standard
BNGL name (see Faeder et al. [60]), dimension is either 2 or 3 depending on whether
the compartment is a surface (e.g., plasma membrane) or a volume (e.g., cytoplasm) and
volume is the compartment volume, in units consistent with those used for bimolecular rate
constants in the parameters block. For a surface compartment, the volume is the product of
the surface area and an effective width, which accounts for the enhancement of a reaction rate
relative to its value in three-dimensional space [113]. containing compartment is the name
of the parent compartment, if applicable (e.g., CP is contained by PM). The full topology
specification for the example system of Sec. 3.2 is shown in Fig. 3.2C.
3.4.3 Molecule location
Each instance of a molecule in cBNGL has a compartment attribute, obviating the need for
the location (loc) components of Sec. 3.3. Ligand molecules, for example, are declared in the
molecule types block of a cBNGL input file as L(r,d). In species, molecules must be given
a location, specified using what we call postfix notation, e.g., L(r,d)@EC, which specifies a
free ligand molecule in EC. Postfix notation may also be used in patterns to specify the
location of a molecule, as in L(r)@EC. This will match ligand molecules in EC with a free r
site.
3.4.4 Species location
Complexes can be built in cBNGL from molecules in the same way as in standard BNGL.
For example, a freely diffusing ligand dimer in EC is specified as
L(r,d!1)@EC.L(r,d!1)@EC.
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begin compartments
  EC  3  vol_EC                # extracellular fluid
  PM  2  sa_PM*eff_width  EC   # plasma membrane
  CP  3  vol_CP           PM   # cytoplasm
  NM  2  sa_NM*eff_width  CP   # nuclear membrane
  NU  3  vol_NU           NM   # nuclear space
  EM  2  sa_EM*eff_width  CP   # endosomal membrane
  EN  3  vol_EN           EM   # endosomal space
end compartments  
Figure 3.2: Compartment topology of cell model in cBNGL (A) Illustration of a
cell model with extracellular (EC), cytoplasmic (CP), nuclear (NU) and endosomal (EN)
volumes and plasma (PM), endosomal (EM) and nuclear (NM) membrane surfaces. (B)
Representation of the compartment topology by a directed graph. Volumes are represented
by circles and membranes by arcs. A directed edge points from C1 to C2 if compartment C1
is immediately outside of compartment C2. (C) cBNGL specification of the topology shown
in B.
Complexes can comprise molecules in adjacent compartments, as in the pattern
L(r!1)@EC.R(l!1)@PM,
but are currently not allowed to span multiple surface compartments. Complexes may then
span, at most, a single surface compartment and its two adjacent volume compartments.
The localization of a species is a global property of a species that is based on the location
of each element comprising the species.
Definition 1 (Species localization).
A species X is said to be localized to a volume compartment V if, and only if, all of the
molecules in X reside in V. Conversely, X is said to be localized to a surface compartment
S if any molecule in X resides in S. Species cannot be formed that span multiple surface
compartments.
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Species can be referenced in cBNGL using a prefix notation that specifies their location in
line with the above definition. For example, the ligand dimer species above can be written
alternatively as @EC:L(r,d!1).L(r,d!1). Prefix and postfix notations can also be used
together, as in
@PM:R(l!3,tf∼pY).L(r!3,d!1)@EC.L(r!2,d!1)@EC.R(l!2,tf∼Y)
where both R molecules are located in PM. More examples of species and patterns in cBNGL
are shown in Fig. 3.3.
3.4.5 Reaction rules
Rules in cBNGL are written using the same basic syntax as in standard BNGL (Sec. 3.3).
The key difference is the possible specification of compartment localization for molecules
or species in the reactant and product patterns. When compartments are omitted a rule is
considered universal, acting on all sets of matching reactants that are in the same or adjacent
compartments. If compartments are specified, we refer to the rule as scope-restricted. In-
corporating compartments into the modeling language also requires the introduction of new
types of rules for modeling compartment-to-compartment transport. Currently, transport
rules are always scope-restricted because both the source and destination compartments
must be specified. Lifting this restriction will require more extensive modification of the
current BNGL syntax.
3.4.5.1 Universal reaction rules The utility of universal rules is that they simplify
the specification of compartmental models. As discussed above, specifying such models in
standard BNGL requires use of location components and enumeration of different versions
of the same rule in different compartments. This is avoided in cBNGL by using universal
rules. In addition, cBNGL automatically applies the restriction that reactants be in the same
or adjacent compartments and applies the correct volumetric scaling to rate constants and
other reaction parameters for bimolecular and higher-order reactions. No scaling is required
for first order reactions. For elementary bimolecular reactions with the rate constant given in
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Figure 3.3: Species and patterns in cBNGL. (i) Species declaration for a ligand dimer
localized in the extra-cellular space (EC) using compartment prefix notation. (ii) Species
declaration of a receptor-dimer complex. The species is localized to the plasma membrane
(PM) but two of the member molecules are in the EC. (iii) A pattern that matches all TF
dimers that are phosphorylated at site d and localized to the cytosol (CP). This pattern
is not a species since components r and im of TF are not declared. (iv) A pattern that
matches complexes localized to the PM containing R and TF with additional context. Site
l is shown as a filled black circle, indicating that R must be bound to some, unspecified
molecule through site l.
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units of volume/time, the rate constant is divided by the volume of the reactant compartment
with the highest dimension [50,113]. (The obvious generalization for higher-order reactions,
dividing by the product of the N−1 highest-order compartment volumes, is implemented
but its use is not recommended .) Note that volumetric scaling is performed for all rules not
just universal ones.
An example of a universal rule from the cBNGL specification of the compartmental model
in Sec. 3.2 is ligand dimerization:
R2: L(d) + L(d) <-> L(d!1).L(d!1) kp LL, km LL
Figure 3.4A illustrates the six instances of this rule along with the appropriate scaling factors.
Universal rules can also describe the synthesis of molecules, as in
R14: DNA(p1!+) -> DNA(p1!+) + mRNA1() k transcribe
The created molecule is placed is in the same volume as the reactant or, for bimolecular
reactions, in the same volume used for scaling the rate constant (higher-order synthesis
reactions are not currently supported). In the above rule, mRNA1 is placed in the same
compartment as the DNA, which is always NU. Specifying a different localization for mRNA1
would override this behavior.
3.4.5.2 Scope-restricted rules Scope restriction limits application of a rule to species
in a particular compartment through the specification of localization in reactant patterns.
An example of a scope-restricted reaction rule in the compartmental model of Sec. 3.2 is
R11: TF(d∼pY)@CP -> TF(d∼Y)@CP k TF dephos
which specifies that dephosphorylation of transcription factors can only take place in the
cytoplasm, which might be the case if an implicitly modeled phosphatase were localized
there.
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Figure 3.4: Universal rules and transport in cBNGL (A) Six instances of the universal
rule for ligand dimerization. The single rule describes: (i) free ligand dimerization in the
extracellular space (EC) and (ii) in the endosomal space (EN); (iii) free ligands binding to
receptor-bound ligands at the plasma membrane (PM) and (iv) at the endosomal membrane
(EM); and (v) receptor-bound ligand dimerization at PM and (vi) at EM. The rates for the
individual reaction instances are automatically scaled by the volume of the reaction com-
partment (see Sec. 3.4.5.1). (B) Four types of transport reactions. (i) R5: @EN:L -> @EC:L.
Volume-to-volume species transport. Free ligand dimers are recycled from the endosome
to the extracellular space. (ii) R3: @PM:R.R -> @EM:R.R. Surface-to-surface species trans-
port. Receptor-dimer complexes are internalized by endocytosis. Molecules in the dimer
complex are transported along with the dimer. Molecules in PM are transported to EM,
molecules in the adjacent EC are transported to EN and molecules in CP remain in CP. (iii)
R16: mRNA@NU -> mRNA@CP. Single molecule transport. (iv) R29: Im@CP.NP <-> Im@NU.NP.
Molecule transport with cargo. Importin bound to a nuclear pore is transported into the
nucleus along with any bound cargo (specified by MoveConnected keyword; not shown).
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In scope-restricted rules it is possible for a reactant pattern to match a species that upon
application of the rule would create a product that does not match the product pattern. For
example, consider a scope-restricted version of the ligand dissociation rule:
@PM:L(d!1).L(d!1) -> @PM:L(d) + @PM:L(d)
The pattern on the left-hand side matches receptor-ligand complexes that contain either one
or two membrane-bound receptor molecules. Only those containing two receptor molecules,
however, will result in two product species localized to PM after the bond between ligands
is broken. BioNetGen checks that products of rule application match the product patterns,
aborting the application if they do not.
3.4.5.3 Transport rules There are currently four classes of transport rule supported
by cBNGL (see Fig. 3.4B): (i) molecule transport, (ii) cargo-carrying (trafficking) transport,
(iii) volume-to-volume species transport, and (iv) surface-to-surface species transport.
Molecule transport is the simplest of these: the compartment designations of explicitly
specified molecules are changed upon application of the rule. cBNGL allows molecules to
transport volume-to-volume across a surface, volume to adjacent surface, and surface to
adjacent volume. Surface-to-surface molecule transport is not permitted. Application of a
molecule transport rule is rejected if the transport results in a bond that spans non-adjacent
compartments. The rule in the compartmental model of Sec. 3.2 that transports mRNA
from the nucleus to the cytoplasm is
R16: mRNA1@NU -> mRNA1@CP k mRNA to CP
In cargo-carrying transport, movement of a specified molecule causes simultaneous trans-
port of connected molecules that are in the same compartment. Many cellular systems con-
tain molecules that can bind and transport cargo between compartments, and these may bind
a variety of molecules and complexes. In nuclear transport, for example, importin proteins
bind to different protein molecules and escort them through the nuclear pore [112]. This
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type of molecule transport behavior is designated by adding the MoveConnected keyword to
a molecule transport rule, as in the example
R29: Im(fg!1)@CP.NP(fg!1) <-> Im(fg!1)@NU.NP(fg!1) \
k Im cross NP, k Im cross NP MoveConnected
Here, an importin molecule in CP, bound through its fg site to a nuclear pore (NP), is trans-
ported into and out of NU along with its cargo, which can be a TF dimer or a P1. Thus,
the MoveConnected keyword allows one to write a single rule that encompasses all possi-
bilities without enumerating them. A precise description of the effect of a MoveConnected
declaration requires the following definition:
Definition 2 (Compartment-connected component).
For a molecule M in compartment C, the compartment-connected component is the set of all
molecules within the complex X, of which M is a member, that are connected to M by a path
fully contained within C.
Only molecules in the compartment-connected component of the explicitly transported mole-
cule(s) in a rule are co-transported. Molecules that are in the same compartment as the
trafficking molecule but are connected to it through a path that passes through another
compartment are not co-transported. This situation may arise because trafficking molecules
often bind to surface molecules that may already be bound to other molecules in the same
compartment as the trafficking molecule. Species transport rules change the locations of
all molecules within a species rather than just a single molecule. These rules are specified
using prefix compartment notation. Volume-to-volume species transport is straightforward:
the compartment designations for all molecules in the volume-localized species are changed
to the same destination compartment. An example is ligand recycling from EN to EC (see
Fig. 3.4B):
R5: @EN:L -> @EC:L k recycle
Surface-to-surface species transport is more involved because species localized to surfaces
can contain molecules that reside in adjacent volume compartments. These molecules must
be correctly assigned to a new compartment during transport. In cBNGL, surface-to-surface
transport rules map molecules in volume compartments in a manner consistent with endo-
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and exocytosis (see Fig. 3.1). During endocytosis, molecules exterior to the invaginating
membrane move into the newly-formed compartment, whereas molecules interior to the in-
vaginating membrane remain in the same compartment. Surface-to-surface species transport
is defined as follows:
Definition 3 (Surface-to-surface species transport). A species transport rule @S1:P ->
@S2:P, where P is any pattern and S1, S2 are surface compartments separated by volume
compartment V, transports the molecules in the complex that matches P as follows:
1. Molecules located in the originating surface S1 move into the destination surface S2.
2. Molecules located in the volume V remain in V
3. Molecules located in V1 (the compartment adjacent to S1 but not S2) move into compart-
ment V2 (the compartment adjacent to S2 but not S1)
This type of transport is restricted to surface pairs that share an adjacent volume compart-
ment. In the example of Sec. 3.2, receptor endocytosis (internalization) is modeled by the
rule
R3: @PM:Rec.Rec -> @EM:Rec.Rec k R endo
3.4.6 Comparison with BNGL
We have developed both BNGL and cBNGL versions of the compartmental model of Sec. 3.2.
Each produces a network of 78 species and 354 reactions, giving identical numerical results
(data not shown). The BNGL specification requires 45 rules whereas the cBNGL specification
requires 30 rules, with most of the difference coming from the rules for ligand dimerization,
receptor-ligand binding, endosome recycling and nuclear transport. Complete input files for
this model system along with instructions for downloading a cBNGL version of BioNetGen
can be found at www.bionetgen.org/wsc09.
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3.5 DISCUSSION
cBNGL introduces a compartment topology composed of membranes and volumes, a new
molecule property, molecule localization, which ties molecules to a compartment, and a new
global property of species, species localization, which allows queries to determine whether a
species is tethered to a membrane or freely diffusing in solution. The new @ syntax allows
a modeler to construct species and pattern matches in the context of the compartment
topology. The new concepts of species and molecule localization provide a basis for the
construction of new semantics for universal and transport rules.
Universal rules, which do not query localization explicitly, describe reactions that can
occur between any set of matching species that are able to interact. Such rules reflect the
usual biological scenario where the co-localization of reactants is a sufficient condition for
the reaction to proceed. In cases where a reaction occurs in specific locations, the modeler
may scope restrict a pattern in a rule to a single compartment by adding location context.
The compartment to use in scaling of bimolecular reaction rates is determined from the
dimensionality of the reactant compartments: a surface compartment is used only when both
reactants are localized to the membrane; otherwise, the three-dimensional compartment is
used. In both cases the rate is divided by the compartment volume, which naturally yields
a large rate enhancement when both reactants are localized to the membrane [113,114].
Transport rules allow the expression of a wide variety of biological transport phenomena.
Molecule transport enables the description of simple diffusion across a membrane, translo-
cation mediated by a membrane transporter, and insertion of a molecule into a membrane.
Species transport rules allow the transport of an entire species based on a pattern match to
part of the species complex. Volume-to-volume species transport rules allow concise repre-
sentation of biological scenarios where transport across a membrane is facilitated by an escort
molecule. Cargo-carrying transport coupled with a binding reaction at the membrane permits
chaperone mediated species transport with a saturable rate. Surface-to-surface species trans-
port rules allow transport of membrane-bound complexes to and from a contained membrane
compartment in a manner the preserves complex structure and correct topological relation-
ships. A common example of such a process in biology is receptor-mediated endocytosis,
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where an active receptor complex initiates vesicle formation and internalization.
3.5.1 Related work
Formal modeling in cellular systems has focused on three related, but largely disjoint, areas
of biological expression: biochemistry of structured molecules, membrane-mediated biochem-
istry, and dynamic membrane systems. Rule-based modeling languages κ-calculus and BNG
focus on the biochemistry of structured molecules but lack a natural approach to compart-
ments and membranes [60, 68]. The Stochastic Simulation Compiler (SSC), another rule-
based platform, allows static compartments, diffusion between compartments, and modeling
of spatial and geometric effects, but lacks the notion of a membrane [119]. BioCham, a
modeling platform with facilities for model checking, describes biochemistry through rules
over unstructured objects and includes compartments and basic transport [79].
Several platforms have been constructed with a focus on membrane-mediated reactions.
Cytosim, a formal language for describing reactions in the context of a membrane structure,
includes a syntax and rule set that describe integral and peripheral membrane proteins,
membrane recruitment reactions, and transport [120]. Cytosim’s reactions, however, are
limited to transformations of unstructured objects. Little b, a modular framework for bio-
logical modeling, includes rule-based modeling features and static membrane structures [117].
Molecules can be localized to the cytosolic or extracellular face of membranes and interact
with molecules in the adjacent volume. Rules are provided for basic molecular transport reac-
tions. Simmune, a multiscale platform tying rule-based molecular interactions to macroscopic
cell behavior, models cells as a plasma membrane containing cytosolic compartment [115].
Membrane proteins in Simmune may have cytosolic and extracellular domains that inter-
act with the adjoining volumes. While Simmune includes dynamic cell division and death,
the topology of the cell is fixed and cellular models that required nested compartments for
organelles and not handled.
Cardelli pioneered the formal description of dynamic membrane systems with the intro-
duction of Brane Calculi [121, 122], which formally express biological membrane processes,
including division, fusion and phagocytosis, but do not include description of biochemical
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reactions. BioAmbients, based on the stochastic pi-calculus and ambients calculus, provides
a language and simulation platform for dynamic compartments with structured molecular
interactions [123]. It thus begins to bridge the biology of membranes and molecules, but
treatment of membrane-mediated biochemistry is lacking. Similarly, Beta Workbench im-
plements dynamic compartments through the abstraction of beta binders, an interface that
wraps a collection of biological processes and controls external communication [116]. Nesting
of beta binders is not permitted, so modeling cells with organelle structures is beyond its
scope.
Recent efforts in the process algebra literature have made considerable progress in merg-
ing rule-based modeling with dynamical membrane systems. Laneve and colleagues [124]
proposed bio-κ, a restricted variant of the κ-calculus combined with syntax and seman-
tics for dynamic membrane reactions. Membranes can contain molecules and interact with
adjacent volumes. While the rule-based capability of bio-κ is limited, the biological ex-
pressivity includes phagocytosis, fusion, fission and molecule translocation. Damgaard et
al. [125] developed C-calculus, which introduces the concept of a channel, a type of bond
that connects topologically related volumes. C-calculus is able to express complex biological
phenomena that combine membrane and molecule interactions, such as clathrin-dependent
vesicle formation. It can also describe chaperone-mediated transport. Though rich in their
expressive capabilities, the primary shortcomings of these approaches are their current lack
of freely-available end-user simulation software.
In Table 3.1, we compare the capabilities of cBNGL with the various modeling approaches
cited above.
Although none of the platforms cover the full range of capabilities, cBNGL has the
advantage of being able to describe a wide variety of biological phenomena associated with
compartmentalization and membranes in a language that is fully compatible with the freely-
available BioNetGen suite of modeling and simulation tools.
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Table 3.1: Comparison of modeling software for compartmental biochemical sys-
tems.
Species Dynamic
Platform Rule-based transport Membranes compartments Software
Beta Workbench [116] X limited X X
bio-κ [124] X X X
BioAmbients [123] X X X
BioCham [79] limited X† X
Brane calculi [121,122] X X
C-calculus [125] X X X X
cBNGL [111] X X X X
Cyto-Sim [120] X X
Little b [117] X X X
Simmune [115] X limited X X
SSC [119] X X
† Allows compartment volumes to change dynamically but cannot create nor delete compartments.
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3.5.2 Limitations
While cBNGL encompasses a wide variety of membrane and transport phenomenon, there are
important limitations. The compartment topology is static, so cell division, vesicle budding
and fusion are not described. Thus, surface-to-surface transport rules capture only the aver-
age rates of molecular transport and not the turnover of individual vesicles. Compartment
volumes are also fixed, so dynamic changes in volume cannot be described. Furthermore,
transport reactions are not universal but tied to specific, named compartments. In a bi-
ological setting, transport typically depends on the presence of specific channels, pores or
transport proteins in the separating membrane rather than the physical properties of the
specific compartments. As a practical matter, we also note that our implementation of cB-
NGL for the particle-based simulation methods referred to in Sec. 3.1 is in progress. Future
work will address each of these issues.
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4.0 HYBRID PARTICLE/POPULATION SIMULATION METHOD
Network-based approaches to modeling and simulating biochemical reaction systems, such
as those based on ordinary differential equations, require enumerating all species and re-
actions that can potentially exist in a system. The applicability of these approaches is
limited, however, by the problem of combinatorial complexity, an explosion in the number of
species and reactions due to protein-protein interactions and post-translational modifications
in biochemical systems. Rule-based modeling (RBM) avoids this problem by representing
molecules as structured objects and encoding their interactions as pattern-based rules. Rule-
based models can, on the one hand, be used to generate fully-enumerated reaction networks
or, alternatively, simulated directly using particle-based kinetic Monte Carlo methods. The
latter “network-free” approach produces exact stochastic trajectories with a computational
cost that is independent of network size. However, memory and run time costs increase
linearly (or worse) with the number of particles being simulated, limiting the size of sys-
tem that can be feasibly handled. Here, we present a hybrid particle/population simulation
method that combines the best attributes of both the network-based and network-free ap-
proaches1. The method takes as input a rule-based model augmented with a user-specified
subset of species to treat as population variables rather than as particles. The model is then
transformed by a process of partial network expansion into a form that can be simulated us-
ing a population-adapted network-free simulator. We have implemented the transformation
method within the open-source rule-based modeling platform BioNetGen and the resulting
1 This chapter is a adapted from a manuscript with co-authors Leonard Harris and James Faeder. My
contribution to the work includes development of the method, software implementation, analysis, and com-
position of the draft manuscript. Leonard Harris and James Faeder contributed to algorithm design and
composition of the final manuscript. The manuscript was under review when this dissertation was deposited.
A preprint is available in the arXiv (http://arxiv.org/abs/1301.6854).
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hybrid model can be simulated using the particle-based simulator NFsim. Benchmark tests
show that significant memory savings can be achieved using the new approach and a mone-
tary cost analysis provides a practical measure of its utility. We also consider the possibility
of applying accelerated-stochastic simulation methods, such as τ leaping, to the population
subnetwork of the hybrid model in order to improve run time efficiency.
4.1 INTRODUCTION
4.1.1 Rule-based modeling
Cell signaling encompasses the collection of cellular processes that sample the extracellular
environment, process and transmit that information to the interior of the cell, and regulate
cellular responses. In a typical scenario, molecules outside of the cell bind to cognate re-
ceptors on the cell membrane, resulting in conformational change or clustering of receptors.
A complex series of protein binding and biochemical events then occurs, ultimately leading
to the activation or deactivation of proteins that regulate gene expression or other cellular
processes.
A typical signaling protein possesses multiple interaction sites with activities that can
be modified by direct chemical modification and by the effects of modification or interaction
at other sites. This complexity at the protein level leads to combinatorial complexity at
the level of signaling networks [44], posing a major barrier to the development of detailed
and comprehensive models using standard approaches that require explicit enumeration of all
species and reactions in a network [44,54,126]. This problem of scalability has motivated the
development of rule-based modeling languages, such as the BioNetGen language (BNGL) [60,
127] and Kappa [67,68], which provide a rich yet concise description of signaling proteins and
their interactions. The biochemical state-space explosion problem is avoided by representing
interacting molecules as structured objects and using rules to encode their interactions. In the
graph-based formalisms of BioNetGen and Kappa, molecules are represented as graphs and
biochemical interactions by graph-rewriting rules. A rule can define either a single reaction
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or a class of reactions that share a common set of transformations (e.g., formation of a bond
between molecules) and system-state requirements (e.g., that one or more components have
a particular covalent modification). Rules are local in the sense that only the properties of
the reactants that are transformed or are required for the transformation to take place affect
their ability to react.
An important characteristic of rule-based models is that they can encode both finite and
infinite reaction networks. If the network is finite and “not too large” then the network
can be generated algorithmically [59–61, 66, 127] and simulated using a variety of network-
based simulation methods (e.g., Refs. [25,37,38]). However, the rule-based methodology also
provides a formalism for simulating models with prohibitively large or infinite state spaces.
Such a “network-free” approach involves representing molecular complexes as particles and
applying rule transformations to those particles at runtime using a kinetic Monte Carlo
update scheme [55,57]. This avoids enumeration of combinatorially-large state spaces because
only the current configuration of the system and its potential transformations are tracked.
As a result, network-free methods can efficiently simulate complex systems beyond the reach
of network-based methods [53, 55, 57]. However, because every molecule in the system is
instantiated, network-free methods may require large amounts of computational memory,
a potential limiting factor for simulating large systems such as the regulatory networks of
a whole cell [5, 128]. A typical eukaryotic cell, for example, contains on the order of 103–
104 protein-coding genes, 104–105 mRNA molecules, and 109–1010 protein molecules [8,129],
along with much larger numbers of metabolites, lipids, and other small molecules. Simulating
a cell at this level of detail using network-free methods would be impractical. There is a
need, therefore, to develop approaches that reduce the memory requirements of network-free
methods.
4.1.2 Computational complexity
Network-based exact-stochastic simulation methods, like Gillespie’s stochastic simulation
algorithm (SSA) [25,27,28], treat species as lumped variables with a counter (i.e., a popula-
tion). Several variants with different time complexities exist. The cost scaling in the number
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of reactions is of special interest for combinatorial models, where the number of reaction can
become very large. The direct method [25] has linear time cost (per event) in the number
of reactions. The Gibson-Bruck “next reaction” method [29] has logarithmic cost under the
assumption that the number of dependencies per reaction is bounded by d. However, d often
increases with the number of reactions. In that case, the scaling is O
(
d logR
)
, where R is
the number of reactions. The logarithmic classes approach [30] has constant cost under the
same assumptions (d is bounded); but when d is not bounded, the scaling is linear in d. The
total time cost per simulation is given by the product of the time cost per event and the
number of events. The number of events depends on the number of reactions, rate constants,
number of particles, and volume. There is no simple generalization, but the total number
of events scales linearly with simulated volume if total concentrations are fixed, i.e. parti-
cle number increases proportionally with volume. For “typical” models, the direct method
with optimizations often outperforms methods with lower asymptotic complexity [31]. The
space cost of SSA methods is either O
(
R
)
if all reactions are updated at each step (direct
method), or O
(
d ·R) if a dependency tree is implemented (Gibson-Bruck). Most notable for
our purposes, the space cost is constant in the number of particles.
Network-free methods, on the other hand, have a time complexity that depends on the
number of rules rather than the number of reactions. The time cost per reaction event is
approximately linear in the number of rules [53]. This explains their utility for models that
encode very large or infinite networks with a relatively small number of rules. However, being
exact-stochastic methods themselves, their total time complexity remains linear (or worse for
gel-phase systems [55,130]) as the simulated volume increases (again, total concentrations are
fixed, i.e. the number of particles increases proportionally with the reactor size). Moreover,
since network-free methods represent every molecule in a system as an individual particle, the
space complexity is linear in the number of particles. Thus, the efficient time complexity for
network-free algorithms with respect to network size is gained at the expense of an increase
in space complexity with respect to particle number. This limits the size of system that can
be feasibly simulated using network-free methods. In Table 4.1, we summarize the time and
space complexities of the SSA and network-free algorithms with respect to particle number
and network/rule set size.
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Table 4.1: Time and space complexity for the SSA and network-free algorithms.
Scaling is shown with respect to particle number, P , and number of reactions, R, or rules, R˜.
Time complexity is shown per event. Total time cost of a simulation depends on the product
of cost per event and number of events. The number of events in fixed length simulation
depends on a number of factors, including rate constants, number of particles, and reactor
volume; thus, it is difficult to generalize. Complexity of SSA also depends on d, the average
number of dependencies per reaction. Since d often increases with R in combinatorial models,
the assumptions of logarithmic and constant time algorithms do not always hold.
Particles (P ) Rxns (R) or Rules (R˜)
SSA Time (per event) O
(
1
)
O
(
R
)
a, O
(
d logR
)
b, O
(
d
)
c
SSA Space O
(
1
)
O
(
R
)
d, O
(
d ·R)e
NF Time (per event) O
(
1
)
, O
(
P
)
f O
(
R˜
)
NF Space O
(
P
)
O
(
R˜
)
adirect method [25,31]
bGibson-Bruck [29]
clogarthmic classes [30]
dno dependency graph
edependency graph
fpolymerizing systems in gel phase [55,130] (see Figure 4.4B).
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4.1.3 Combining network-based and network-free approaches
The key idea pursued in this work is that memory consumption can be reduced in network-
free simulators by representing large numbers of identical molecular complexes as single vari-
ables with population counters rather than as many individual particles. However, retaining
the ability to address combinatorial complexity requires retaining the particle representation
for complexes that are comprised of many molecules and/or have complex substructures.
Here, we present an approach, termed the hybrid particle/population (HPP) simulation
method, that accomplishes this. Given a user-defined set of species to treat as population
variables, the HPP method partially expands the network around the population species
and then simulates the partially-expanded model using a population-adapted particle-based
method. By treating complex species as structured particles, HPP capitalizes on the near-
constant time complexity with respect to network size characteristic of the network-free
approach. However, for the subset of species treated as population variables, we take advan-
tage of the constant memory requirements of the network-based methods.
The paper is organized as follows. First, we provide brief descriptions of the example
systems and performance metrics that we use to quantify the utility of the new method.
We then present the HPP simulation method, which is the main contribution of this paper.
Results of various performance analyses follow, which demonstrate that significant reductions
in memory usage are possible using the new approach with little effect on simulation run
time. Finally, we conclude with a discussion of the practical consequences of our work and
some possible enhancements to the method.
4.2 METHODS
4.2.1 Example models
We have tested the performance of the HPP method by applying it to four example models,
summarized in Table 4.2 and discussed in further detail below. All of the models are biologi-
cally relevant and are either taken directly from the literature or are based on models that are
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Table 4.2: Summary of example models used to test HPP performance. Number
of particles is for a NFsim simulation of a full cell volume (f=1). Fractional cell volumes as
low as 0.001 and as high as 1 are used in the performance analyses (see below for details).
Particles Population Rules after
Model Rules Reactions Species (f=1) species PNE t end (s)
TLBR [45,53,130] 4 ∞ ∞ 5.3×106 2 9 500
Actin [53,131] 21 ∞ ∞ 1.2×106 2 25 1000
FcRI [47,53,132] 24 58 276 3744 6.9×106 1 / 6 25 / 38 2400
EGFR [19,52,133] 113 415 858 18 950 2.2×106 29 159 1200
taken from the literature. Complete BNGL model files, as well as HPP (partially-expanded)
versions, are provided as Texts S4–S12 of the supporting information.
4.2.1.1 Trivalent-ligand bivalent-receptor The trivalent-ligand bivalent-receptor
model (TLBR) is a simplified representation of receptor aggregation following multivalent
ligand binding. TLBR has biological relevance to antigen-antibody interaction at the cell
surface, where bivalent IgE-FcRI receptor complexes aggregate in the presence of multiva-
lent antigen [45]. A theoretical study of the TLBR system was presented by Goldstein and
Perelson [45], who derived analytical conditions for a solution-gel phase transition in terms
of binding equilibrium constants, free ligand concentration, and receptors per cell. A more
recent study considered the effects of steric constraints and ring closure on the solution-gel
phase transition in the TLBR system [130].
Despite its simplicity, the TLBR system experiences a state-space explosion near the
solution-gel phase boundary. A computational study by Sneddon et al. [53] reproduced
the analytical results of Goldstein and Perelson using the BNGL-compliant network-free
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simulator NFsim [53]. Due to large excesses of ligand and receptor under certain conditions,
TLBR is a natural test case for HPP. We simulated the TLBR system using HPP with
free ligand and receptor treated as population species. All simulations were performed with
parameters as defined in Monine et al. [130], which lie within the solution-gel coexistence
region. A cell-scale simulation assumed 1 nl extracellular volume per cell (106 cells/ml) with
8.3 nM ligand and 3×105 receptors per cell. Simulations were performed at fractional cell
volumes, f , ranging from 0.001 to 0.1 with a lumping rate constant k lump= 10 000/s (see
below). Results are shown in Figure 4.4.
4.2.1.2 Actin polymerization Actin polymerization plays a key role in cell morphology
and motility [134, 135]. Roland et al. [131] presented a dynamic model of actin polymeriza-
tion featuring filament elongation by monomer addition, stabilization by ATP hydrolysis,
and severing mediated by actin depolymerizing factor (ADF)/cofilin. Sneddon et al. [53]
presented a rule-based formulation of the Roland et al. model and replicated their results us-
ing NFsim. The model features an excess of actin monomer and ADF molecules. Therefore,
we speculated that substantial memory reduction is possible using the hybrid approach. We
applied HPP to the Sneddon et al. rule-based model of actin dynamics (hereafter referred
to as the Actin model) with actin monomer and ADF treated as population species. A
cell-scale simulation assumed 1 pl intracellular volume with 1 µM actin monomer and 1 µM
ADF/cofilin. Simulations were performed at fractional cell volumes, f , ranging from 0.01 to
1 with a lumping rate constant k lump=10 000/s. Results are shown in Figure 4.5.
4.2.1.3 FcRI signaling FcRI is a membrane receptor that binds IgE antibodies. Sig-
naling through FcRI regulates basophilic histamine release in response to IgE antibody-
antigen interaction [136]. Faeder et al. [46,47] developed a rule-based model of FcRI receptor
assembly and activation in which receptor dimerization/clustering is mediated by chemically
cross-linked IgE, which serve as multivalent ligands. Dimerized receptors are also transpho-
sphorylated, leading to Syk and Lyn recruitment and phosphorylation. Sneddon et al. [53]
presented several extensions of the Faeder et al. model, including the gamma2 variant with
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two γ phosphorylation sites. Particle-based NFsim simulations of the gamma2 model were
found to be substantially faster than network-based SSA simulations.
Due to the excess of free ligand, the HPP method was applied to the gamma2 model to
reduce memory consumption. The method was applied with two different sets of population
species. In the first case, only free ligand was treated as a population species (FcRI:1).
In the second, cytosolic Lyn and all four phosphorylation states of cytosolic Syk were also
treated as populations (FcRI:6). A cell-scale simulation assumed 1 pl intracellular volume
with 1 nl extracellular space per cell (106 cells/ml), 10 nM ligand, and 4×105 receptors per
cell. Simulations were performed at fractional cell volumes, f , ranging from 0.001 to 0.1
with a lumping rate constant k lump=10 000/s. Results are shown in Figure 4.6.
4.2.1.4 EGFR signaling A model of signaling through the epidermal growth factor
receptor (EGFR), beginning with ligand binding and concluding with nuclear phospho-ERK
activity, was constructed by combining three existing models: (i) a rule-based model of
EGFR complex assembly [52]; (ii) a Ras activation model [133]; (iii) a pathway model of
Raf, MEK and ERK activation [19]. Ras activation was coupled to the EGFR complex
assembly by treating receptor-recruited Sos as the Ras GEF. Activated Ras was coupled to
the Raf/MEK/ERK cascade through RasGTP-Raf binding and subsequent phosphorylation
of Raf. Parameters for the combined model were obtained from the respective models.
However, parameters governing Ras-GEF (i.e., Sos) activity had to be changed from their
original values [133] in order to account for the known GEF-mediated activation of Ras [137].
Specifically, we used KM,GDP=KM,GTP=1.56×10−7 M and D=1000 (unitless).
Free EGF and Raf-, MEK-, and ERK-based species were treated as population species
in the hybrid variant. Ras-based species were also treated as populations except for those
that include a Sos molecule. A cell-scale simulation assumed 0.94 pl cytosolic and 0.22 pl
nuclear volume, with 0.94 pl extracellular space, 10 nM ligand, and 4×105 receptors per
cell. Simulations were performed at fractional cell volumes, f , ranging from 0.01 to 1 with
a lumping rate constant k lump=100 000/s. Results are shown in Figure 4.7.
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4.2.2 Performance metrics
HPP was evaluated for peak memory use, CPU run time, and accuracy as compared to
particle-based NFsim simulations. For models where network generation is possible (FcRI
and EGFR), comparisons were also made to SSA simulations (as implemented in BioNetGen
[60]). All benchmarks were performed on a 2 × Intel Xeon E5520 @ 2.27 GHz (8 cores, 16
threads, x86 64 instruction set) with 74 GB of RAM running the GNU/Linux operating
system. To ensure that each process had access to 100% of the compute cycles of a thread,
no more than 12 simulations were benchmarked simultaneously. In all cases, reported results
are based on ≥7 independent simulation runs.
4.2.2.1 Peak memory Peak memory usage was evaluated by peak virtual memory al-
location reported by the operating system with the command: cat /proc/<PID>/status.
For all benchmark models, peak memory was achieved early in the simulation and remained
steady throughout (data not shown).
4.2.2.2 CPU run time CPU run time was evaluated using clock time as a metric. Clock
time was recorded using the Time::HiRes Perl module. Run time included initialization as
well as the simulation phase. Partial network expansion for HPP simulations was a one time
cost, typically a few seconds, and was not included in the benchmark.
4.2.2.3 Accuracy Simulation accuracy was quantified using several approaches. For all
models, the total number of reaction firings was recorded for each simulation run (firings
of population-mapping rules were subtracted from the total in HPP simulations). Based
on 40 independent samples each of NFsim and HPP (and SSA for the FcRI model), we
tested the null hypothesis that none of the methods produce a larger number of firings under
the Mann-Whitney U test [138, 139]. Distributions were visualized as box plots showing
minimum values, maximum values, and quartiles.
For the TLBR and Actin models, equilibrium distributions for key observables were also
compared. These include the number of receptor clusters in the TLBR model and the length
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of actin polymers in the Actin model. 10 000 samples were collected over 100 000 seconds of
simulated time. Distributions were compared by binning samples (20 bins) and performing
a two-sample chi-squared test [140]. For the FcRI and EGFR models, trajectories for
key observables were collected from 40 simulation runs each. Moving averages and 5–95%
frequency envelopes were plotted for sampling windows of 10 s. Due to complications of
autocorrelation, a statistical test was not applied to the dynamic trajectory comparison.
Instead, the results were plotted for inspection by eye.
4.2.3 Software implementation
HPP and NFsim simulations were run using NFsim version 1.11, which is available for
download at http://emonet.biology.yale.edu/nfsim. All simulations (SSA included)
were invoked through BioNetGen version 2.2.4, which implements the hybrid model gen-
erator and is distributed with NFsim 1.11 (see Refs. [60, 61] and Secs. S3.1.5 and S4.1 of
Text S1 for details on running simulations with BioNetGen). NFsim and BioNetGen source
code are available at http://code.google.com/p/nfsim and http://code.google.com/
p/bionetgen, respectively. The most recent implementation of the hybrid model generator
can be found in the BioNetGen-2.2.4-stable distribution (see generate hybrid model()
in the BNGAction.pm module at http://code.google.com/p/bionetgen/source/browse/
bng2/Perl2/BNGAction.pm). Additional documentation for BioNetGen can be found at
http://bionetgen.org.
4.3 RESULTS
4.3.1 A hybrid particle/population simulation approach
In this section, we first present an algorithm for transforming a rule-based model into a
partial-network system. We then describe a population-adapted network-free simulation
protocol that can be applied to that system. We refer to the combination of these meth-
ods as the hybrid particle/population (HPP) simulation method. The basic work flow is
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Figure 4.1: Basic workflow of the HPP simulation method. Given a rule-based model
and a user-specified set of population-mapping rules (which define the population species),
partial network expansion (PNE) is performed to generate a hybrid version of the original
model. The hybrid model is then passed to the population-adapted version (1.11 or later)
of the network-free simulator NFsim, which generates the time-evolution trajectories for all
observable quantities specified in the original model.
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provided in Figure 4.1. The transformation method has been implemented within the open-
source rule-based modeling package BioNetGen [60, 61, 127] and the resulting hybrid model
can be simulated using version 1.11 (or later) of the network-free simulator NFsim [53]. The
reduction in computational memory requirements offered by HPP is an important step to-
wards the practical simulation of systems approaching the size and complexity of a whole
cell [5, 128].
For convenience, we will adhere in this paper to the BNGL syntax, which is summarized
in Section 1.4.3 of the introductory chapter. A complete description of the syntax and
semantics of BNGL can be found in Refs. [60, 61, 111]. For the theoretical foundations of
BioNetGen see Ref. [66] and Appendix B.
4.3.1.1 Population species and population-mapping rules Given a rule-based
model, the first step in the HPP approach is to select a subset of species to treat as “lumped”
population variables. Currently, this is left as a task for the modeler (an optimal strategy
114
for selecting species for population lumping is a topic for future research; see “Discussion”).
Generally speaking, however, species that maintain a large population throughout the du-
ration of the simulation are good candidates. It is also best to choose species that contain
only a small number of components and/or participate in only a few reaction rules, since
the time complexity of the simulation algorithm is strongly correlated with the size of the
expanded rule set (Table 4.1). A receptor with many phosphorylation and binding sites,
for example, is usually best treated as a particle because treating it as a population species
would require enumerating a large number of species and reactions through partial network
expansion (Section 4.3.1.2).
The next step is to map each (structured) species selected for lumping to an associated
unstructured species, which we refer to as a population species . Population species differ
from standard BNGL species in that they possess a property, called a count, which records
their current population. The mapping is accomplished using a population-mapping rule,
which follows the same syntactic conventions as a standard BNGL rule. For example,
Egf(r) -> pop Egf() k lump
maps the unbound EGF ligand Egf(r) to the unstructured population species pop Egf().
The rate parameter here is termed the lumping rate constant. The basic idea is that during
the course of a simulation complexes may dissociate and release instances of structured
species that have been selected for lumping, Egf(r) in this case. The population-mapping
rules gather these instances back up into the population species. The lumping rate constant
thus determines how long these unlumped particles persist in the system. Its value should
ideally be set to infinity as the HPP method is formally exact only for an infinite lumping rate.
However, if infinity is not an option in the network-free simulator being used (currently it is
not in NFsim) then setting it to a value that is “large” with respect to the model dynamics
will suffice (see Figs. 4.4–4.7, panels C and D). Note that the action of the above rule is to
delete the Egf(r) molecule and increment by one the counter of the pop Egf() molecule
(only a single instance of a population species ever exists in the simulation environment).
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4.3.1.2 Partial network expansion The ultimate goal of the HPP method is to re-
place in the simulation environment large numbers of indistinguishable particles with small
numbers of lumped objects containing population counters (the population species), thus
significantly reducing memory usage. In order to accomplish this without losing information
regarding the dynamics of the system, we must partially expand the rule set until all reac-
tions in which the population species appear as reactants are enumerated. We refer to this
procedure as partial network expansion (PNE).
The PNE algorithm is comprised of three basic steps, applied to each reaction rule in a
model:
1. For each reactant pattern, identify all matches of the pattern into the (structured) species
selected for lumping. Also collect a self-match of the reactant pattern unless it equals a
species selected for lumping (see below).
2. Derive an expanded set of rules by applying the original rule to all possible combinations
(the Cartesian product) of the reactant pattern matches collected in step 1.
3. For each derived rule, replace each reactant and product pattern that equals a species
selected for lumping with its unstructured population counterpart.
The result is an expanded rule set consisting of three general types of rules: (i) particle rules,
comprised of reactant patterns that exclusively match particles; (ii) mixed particle/popula-
tion rules, which operate on a mixture of particles and population species; (iii) pure pop-
ulation reactions , which operate exclusively on population species. The expanded rule set
has the property that every possible action of the original rules on the population species is
enumerated while actions on particle objects remain pattern-based (i.e., non-enumerated).
A formal basis for the PNE algorithm, with pseudocode, is provided in Appendix E.
Note that the set of particle rules in the expanded rule set is just the set of reaction
rules in the original model, less those that exclusively match structured species selected for
lumping. This is a consequence of excluding self-matches in Step 1 of the PNE algorithm for
reactant patterns that equal structured species selected for lumping. The reason why this is
done is that, for large k lump, there will almost never exist any instances of the structured
species in the system. As mentioned above, the role of the population-mapping rules is to
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gather instances of structured species selected for lumping up into the population species.
A large value of k lump means that this will be accomplished almost instantaneously. As
such, rules involving those reactant patterns need not be retained since they will (essentially)
never fire. Removing them decreases the size of the partially-expanded rule set and improves
the efficiency of the method. Note, however, that for the sake of completeness we have
implemented an “exact” PNE method in BioNetGen (version 2.2.3 or later) that retains all
of the self-matches and, hence, gives exact results for any value of k lump (see Appendix F
for instructions on how to call this method). For a select number of examples, we have
confirmed that both methods give statistically identical results for sufficiently large k lump
and that the exact method is less efficient (data not shown).
PNE is best illustrated through an example. In Figure 4.2, we present a simple rule-
based model of receptor activation (for brevity, parameters, initial populations, and output
observables are omitted; see Appendix G.1 for the complete model in BNGL format). The
model includes a ligand, L, its cognate receptor, R, and three cytosolic proteins, A, B, and C,
that are recruited to the phosphorylated receptor. The 16 rules (six unidirectional and five
reversible), describing ligand-receptor binding, receptor phosphorylation/dephosphorylation,
and protein recruitment, encode a reaction network comprised of 56 species and 287 reactions.
In applying the HPP method, eight species are selected for lumping: free ligand, free A, B and
C, and complexes of A, B and C that exclude the receptor. Receptor complexes are treated
as particles because there are many possible receptor configurations (48 total).
In Figure 4.3, a step-by-step application of PNE to rule 11f (forward) of Figure 4.2 is
presented. First, both reactant patterns are matched to the structured species selected for
lumping. Reactant pattern 1 has one match, while reactant pattern 2 has two. Note that
since neither reactant pattern exactly equals a species (i.e., is isomorphic to one) the self
match (identity automorphism) is added to the reactant match list in both cases. This is re-
quired for generating mixed particle-population rules, where one reactant is an unstructured
population species and a second is a structured particle.
Next, the rule is applied to each possible reactant set (the Cartesian product of the
reactant match lists). This results in a set of six derived rules. The structured species are
then replaced in these rules by their associated unstructured population species, resulting in
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Figure 4.2: Simple receptor activation model in BNGL format. Abridged; see Ap-
pendix G.1 for the complete model.
Molecule Type Description
1 L(r) extracellular ligand
2 R(l,a∼0∼P,b∼0∼P) membrane receptor with two phosphorylation sites
3 A(r,b∼0∼P) cytosolic molecule (recruits to phosphorylated receptor)
4 B(r,c) cytosolic molecule (recruits to phospho-receptor or phospho-A)
5 C(b) cytosolic molecule (binds to B)
Reaction Rule Rate constant(s) Description
1 L(r) + R(l) <-> L(r!1).R(l!1) kp1,km1 receptor-ligand binding
2 L(r!1).R(l!1,a∼0) -> L(r!1).R(l!1,a∼P) k2 site a phosphorylation
3 L(r!1).R(l!1,b∼0) -> L(r!1).R(l!1,b∼P) k2 site b phosphorylation
4 R(a∼P) -> R(a∼0) k3 site a dephosphorylation
5 R(b∼P) -> R(b∼0) k3 site b dephosphorylation
6 R(a∼P) + A(r) <-> R(a∼P!1).A(r!1) kp4,km4 phosphorylated R binding A
7 R(b∼P) + B(r) <-> R(b∼P!1).B(r!1) kp5,km5 phosphorylated R binding B
8 B(c) + C(b) <-> B(c!1).C(b!1) kp6,km6 B and C binding
9 R(a∼P!1).A(r!1,b∼0) -> R(a∼P!1).A(r!1,b∼P) k7 recruited A phosphorylation
10 A(b∼P) -> A(b∼0) k8 A dephosphorylation
11 A(b∼P) + B(r) <-> A(b∼P!1).B(r!1) kp9,km9 phosphorylated A binding B
Population-mapping rules:
Structured species Population species Lumping rate constant
1 L(r) -> P1() k lump
2 A(r,b∼0) -> P2() k lump
3 A(r,b∼P) -> P3() k lump
4 A(r,b∼P!1).B(r!1,c) -> P4() k lump
5 A(r,b∼P!1).B(r!1,c!2).C(b!2) -> P5() k lump
6 B(r,c) -> P6() k lump
7 B(r,c!1).C(b!1) -> P7() k lump
8 C(b) -> P8() k lump
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Figure 4.3: Partial network expansion (PNE) applied to Rule 11f of Figure 4.2.
Reaction rule: A(b∼P) + B(r) -> A(b∼P!1).B(r!1) kp9
Description: “Bind component sites b∼P and r”
1: Find Reactant Pattern (RP) Matches
Matches to RP 1 Population species Matches to RP 2 Population species
1 A(b∼P) identity automorphism 1 B(r) identity automorphism
2 A(r,b∼P) P3() 2 B(r,c) P6()
3 B(r,c!1).C(b!1) P7()
2: Rule Expansion: Apply rule to each reactant set in the Cartesian product of reactant matches
1 A(b∼P) + B(r) -> A(b∼P!1).B(r!1) kp9
2 A(b∼P) + B(r,c) -> A(b∼P!1).B(r!1,c) kp9
3 A(b∼P) + B(r,c!1).C(b!1) -> A(b∼P!2).B(r!2,c!1).C(b!1) kp9
4 A(r,b∼P) + B(r) -> A(r,b∼P!1).B(r!1) kp9
5 A(r,b∼P) + B(r,c) -> A(r,b∼P!1).B(r!1,c) kp9
6 A(r,b∼P) + B(r,c!1).C(b!1) -> A(r,b∼P!2).B(r!2,c!1).C(b!1) kp9
3: Rule Rewriting: Substitute structured species graphs with unstructured population species
1 A(b∼P) + B(r) -> A(b∼P!1).B(r!1) kp9
2 A(b∼P) + P6() -> A(b∼P!1).B(r!1,c) kp9
3 A(b∼P) + P7() -> A(b∼P!2).B(r!2,c!1).C(b!1) kp9
4 P3() + B(r) -> A(r,b∼P!1).B(r!1) kp9
5 P3() + P6() -> P4() kp9
6 P3() + P7() -> P5() kp9
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one pure particle rule (the original rule), three mixed particle/population rules, and two pure
population reactions. Including the population-mapping rules, the hybrid model contains a
total of 42 rules, more than the original 16 but significantly fewer than the 287 reactions of
the fully expanded network. The complete partially-expanded HPP model for this system
can be found in Appendix G.2.
4.3.1.3 Population-adapted network-free simulation Since an HPP model is prop-
erly a rule-based model, network-free simulation algorithms are readily adapted to the HPP
method by the addition of: (i) a population count property for each molecule object; (ii)
a transformation that performs population increments and decrements; (iii) a method for
calculating population-weighted propensities (rates). The population-weighted propensity
of an expanded rule R˜µ is given by the formula
aµ =
kµ
sµ
Mµ∏
r=1
(
X∑
x=1
ρ(x)ηµ,r(x)
)
, (4.1)
where kµ is the rate constant, sµ is the symmetry factor (see Ref. [60, Note 4.21 ]), Mµ is
the number of reactant patterns in the rule (i.e., the molecularity), X is the total number of
complexes in the system, ρ(x) is the population of complex x (unity in the case of particles),
and ηµ,r(x) is the number of matches of reactant pattern r into complex x.
Note that in the case of symmetric population reactions [e.g., pop A() + pop A() ->
A(a!0).A(a!0)], the possibility of a null event must be calculated in order to prevent self
reactions. This is accomplished by rejecting the event with probability 1/ρ(x). Furthermore,
since population species have zero components, if complex x is a population species and
ηµ,r(x) = 1 (can only equal 0 or 1), then ηµ,r(y) = 0 for all y 6= x. This property is useful
because it guarantees that a reactant pattern matches either particles or population species
exclusively, never a mixture of both. Thus, once a rule has been selected to fire, the particles
to participate in that rule can be selected from a uniform distribution rather than from a
population-weighted distribution.
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Figure 4.4: HPP performance analysis for the TLBR model. (A) peak memory usage
(left : absolute, right : relative to NFsim); (B) CPU run time (left : absolute, right : relative to
NFsim); (C) number of reaction events fired during a simulation (f=0.01); (D) equilibrium
distribution of number of clusters (f=0.01).
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Figure 4.5: HPP performance analysis for the actin polymerization model. (A) peak
memory usage (left : absolute, right : relative to NFsim); (B) CPU run time (left : absolute,
right : relative to NFsim); (C) number of reaction events fired during a simulation (f=0.01);
(D) equilibrium distribution of actin polymer lengths (f=0.01).
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Figure 4.6: HPP performance analysis for the FcRI signaling model. (A) peak
memory usage (left : absolute, right : relative to NFsim); (B) CPU run time (left : absolute,
right : relative to NFsim); (C) number of reaction events fired during a simulation (f=0.01);
(D) time courses (means and 5–95% envelopes; f = 0.01) for γ-phosphorylated receptor
(top) and receptor-recruited, α-phosphorylated Syk (bottom). SSA time courses are virtually
indistinguishable and have been omitted for clarity.
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Figure 4.7: HPP performance analysis for the EGFR signaling model. (A) peak
memory usage (left : absolute, right : relative to NFsim); (B) CPU run time (left : absolute,
right : relative to NFsim); (C) number of reaction events fired during a simulation (f =
0.05); (D) time courses (means and 5–95% envelopes; f = 0.05) for activated Sos (top) and
phosphorylated ERK (bottom). Due to high computational expense, SSA statistics were not
collected in (C) and (D).
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4.3.2 Performance analyses
4.3.2.1 Peak memory use and CPU run time Figures 4.4–4.7, panels A, show ab-
solute and relative (with respect to NFsim) peak memory use as a function of cell fraction,
f , for all models considered. We see that in all tested cases HPP requires less memory than
NFsim. For NFsim, we see the expected linear relationship (Table 4.1) between peak mem-
ory use and system size (see below). For HPP, peak memory use also scales linearly but with
a smaller slope. This is expected because as the system size increases a portion of the added
particles, and hence memory cost, is always absorbed by the population subnetwork. We
also see that the relative memory benefits of HPP go to zero at the smallest cell fractions.
This is because opportunities for compression decrease as species populations approach zero.
In cases where network generation is possible (FcRI, Figure 4.6A; EGFR, Figure 4.7A),
we see for the SSA the expected constant relationship between memory usage and system
size (Table 4.1). The SSA also requires more memory than both NFsim and HPP for all
cell fractions considered. This is due to the high memory cost of the dependency update
graph [31] (standard in SSA implementations), which scales with the product of the number
of reactions in the network and the average connectivity per reaction.
Note that, for NFsim, the second-to-last points in the absolute memory usage plots
(panels A, left) actually lie slightly above the linear trend in all cases. This is due to the fact
that memory is allocated in NFsim in logarithmically growing intervals (a common approach
in software design) up to a threshold, after which allocation occurs in intervals of a constant
size. Basically, at the second-to-largest volumes memory allocation is still in the logarithmic
phase, where greater excesses of memory are likely to be allocated (the largest volumes are
in the constant phase). To address this, we have rerun simulations for all models at all
cell fractions using a custom compiled version of NFsim that allocates memory in smaller
intervals. The data confirm that the memory scaling for NFsim with system size is in fact
linear (data not shown).
Figures 4.4–4.7, panels B, show absolute and relative (with respect to NFsim) CPU run
times as a function of cell fraction. Generally speaking, HPP and NFsim run times are
comparable in all cases, indicating that the reductions in memory use seen in Figs. 4.4–
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4.7, panels A, are not achieved at the cost of increased run times. In fact, HPP is slightly
faster than NFsim in most cases. This is because operations on population species (e.g.,
increment/decrement) are less costly than the graph operations applied to particles (e.g.,
subgraph matching). Also note in Figure 4.4B the expected quadratic relationship between
run time and system size for the TLBR model (Table 4.1), which is due to the solution-gel
phase transition [55, 130]. In Figs. 4.6B and 4.7B, we see that the SSA is slower than both
NFsim and HPP for all cell fractions considered. The difference is most pronounced at small
cell fractions and is much more significant for EGFR than for FcRI. This is as expected since
previous work [53] has shown that network-free methods significantly outperform network-
based stochastic methods when population levels are small and network sizes are large (the
EGFR network is significantly larger than the FcRI network; Table 4.2).
Finally, we see in Figure 4.6B that the CPU run time increases as we increase the number
of species treated as populations in the FcRI model, even though the memory usage remains
constant (Figure 4.6A). This is interesting because it suggests that the FcRI:1 variant, with
free ligand as the only population species, is near-optimally lumped for the cell fractions
considered. Evidently, the population levels of the lumped cytosolic Lyn and Syk species
in the FcRI:6 variant never get large enough to provide significant memory savings (any
savings that are achieved are offset by the additional mixed rules and reactions added to the
rule set).
4.3.2.2 Accuracy Figures 4.4–4.7, panels C, show distributions of the number of reac-
tion firings per simulation run for each of the simulation methods considered. For all models,
the distributions, as illustrated by box plots, are similar for NFsim, HPP, and SSA (the latter
for FcRI only; Figure 4.6C). The two-sided Mann-Whitney U test [138, 139] was unable to
reject the null hypothesis at the 5% significance level for all models (TLBR: p=0.25; Actin:
p= 0.90; FcRI: p= 0.27; EGFR: p= 0.07), providing strong evidence that HPP produces
statistically identical numbers of reaction firings to both NFsim and SSA.
Figures 4.4–4.7, panels D, compare distributions obtained from NFsim and HPP simu-
lations of all models. In Figure 4.4D, we show equilibrium distributions of the number of
receptor clusters in the TLBR model (f = 0.01). In Figure 4.5D, equilibrium distributions
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of polymer lengths in the Actin model are shown (f = 0.01). In both cases, we could not
reject the null hypothesis of the equivalence of the NFsim and HPP distributions (TLBR:
p= 0.50; Actin: p= 0.66). In Figure 4.6D, time courses for γ-phosphorylated receptor and
receptor-recruited, α-phosphorylated Syk are shown (f=0.01). In Figure 4.7D, time courses
for membrane-recruited (active) SOS and nuclear phospho-ERK are presented (f = 0.05).
Although we did not perform any statistical tests, visual inspection of the trajectories shows
that in all cases the NFsim and HPP results are virtually identical.
4.4 DISCUSSION
We have presented a hybrid particle/population simulation approach for rule-based models
of biological systems. The HPP approach is applied in two stages (Figure 4.1): (i) trans-
formation of a model into an equivalent hybrid form by partially expanding the network
around a selected set of population species; (ii) simulation of the transformed model using
a population-adapted network-free simulator. The method is formally exact for an infinite
population lumping rate constant, but can produce statistically exact results in practice
provided that a sufficiently large value is used (Figs. 4.4–4.7, panels C and D). As currently
implemented, the primary advantage of the HPP method is in reducing memory usage dur-
ing simulation (Figs. 4.4–4.7, panels A). Importantly, this is accomplished with little to no
impact on simulation run time (Figs. 4.4–4.7, panels B).
4.4.1 Monetary cost analysis
In order to frame our results within a real-world context, we have estimated the cost of simu-
lation based on hourly rates of on-demand instances on the Amazon Elastic Compute Cloud
(EC2). In Figure 4.8, we show the hourly cost (per “effective compute unit”) of simulation
as a function of required memory per simulation (details of the calculation can be found in
Appendix D). Also included in the plot are values for HPP (0.3 GB), NFsim (2.1 GB), and
SSA (22.0 GB) simulations of the EGFR model at cell fraction f=1 (Figure 4.7A).
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Figure 4.8: Cost of running simulations on the Amazon Elastic Compute Cloud
(EC2). The minimum cost as a function of memory requirement was calculated based on
January 2012 pricing of all Standard , High-CPU , and High-Memory EC2 instances [141].
Also included are values for NFsim, HPP, and SSA simulations of the EGFR model at cell
fraction f=1.
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The EC2 offers various “instance types” with different CPU and memory resources,
including High-CPU and High-Memory varieties. Our calculations show that below 1.82 GB
of required memory High-CPU instances are the most cost effective. Above this threshold
High-Memory instances are the better option. We see that the HPP simulation falls below
this cutoff while both NFsim and SSA lie above. There is a quantifiable benefit, therefore,
to reducing memory usage in this case. HPP simulations on the EC2 would be ∼2.5 and
∼33 times less expensive than NFsim and SSA, respectively (HPP is slightly faster than
NFsim and significantly faster than SSA; see Figure 4.7B). The whole-cell EGFR model
thus provides a tangible illustration of the benefits of reducing memory load for dynamic
simulations of large biochemical models, approaching the scale of a whole cell.
These benefits are further accentuated by the fact that common model analysis tech-
niques such as parameter estimation (e.g., Ref. [142]), sensitivity analysis (e.g., Ref. [143]),
and statistical model checking (e.g., Ref. [144]), typically entail running a large number
(thousands or more) of independent simulation trials. These trials can be distributed across
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a computer cluster and run independently, which is efficient because there is little need for
interprocess communication. However, typical hardware configurations have a fixed num-
ber of processor cores with a large, common pool of memory. If each independent process
consumes a large amount of memory, then it may be impossible to fully utilize each CPU
core. Reducing memory requirements can thus also improve the effective use of cluster and
cloud-based computing resources.
Finally, realistic simulations of whole-cell dynamics require accounting for the highly
crowded and inhomogeneous environment of the cell interior. A common approach is to dis-
cretize a system into multiple well-mixed subvolumes, with reactions taking place within, and
diffusion occurring between, each subvolume [145, 146]. However, doing so can significantly
increase the number of objects (species, reactions, rules, etc.) that must be represented and
retained in memory during the course of a simulation. The ability to reduce memory usage
is thus of particular value in the case of spatial simulations as well. We expect that HPP can
be successfully applied to spatial models without modification and can provide several-fold
reductions in memory use without substantial impact on run time.
4.4.2 Future directions
We have shown that peak memory use for HPP scales linearly with system size with a
slope that is smaller than for NFsim (Figs. 4.4–4.7, panels A). Moreover, when network
generation is possible, HPP memory use at the system sizes considered is significantly less
than for SSA, which has approximately constant scaling (Figs. 4.6A and 4.7A). However,
the linear scaling of HPP and constant scaling of SSA means that with further increases in
the system size there will invariably come a point where HPP memory use exceeds that of
SSA. Intuitively, we understand that this is because species that are rare at small volumes,
and hence chosen to be treated as particles, become plentiful at large volumes. Since we
require that population species be selected a priori , there is no way to address this problem
currently without intervention by the user.
We propose to develop an enhanced version of HPP that tracks the populations of particle
species and automatically lumps them into population species when their number exceeds a
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certain threshold. PNE would be performed every time a new species is lumped, meaning
that the memory load would never exceed that of the fully-expanded network. In Figure 4.9,
we provide a qualitative sketch of how the memory usage of such an “automated HPP”
(aHPP) method would scale with system size for a model with a finite network. Included
for comparison are HPP, NFsim, and SSA scalings as well. For infinite networks (such as
TLBR and Actin), we expect aHPP memory use to scale somewhere between constant and
linear (no worse than HPP) at large volumes, depending on the model.
Furthermore, the cost analysis of Figure 4.8 illustrates that if, in addition to reducing
memory usage, simulation run times can be decreased, then even greater monetary benefits
are possible. There has been much research into methods for accelerating stochastic sim-
ulations of chemical reaction networks. These include τ leaping [28], originally proposed
by Gillespie [32] and improved upon by Gillespie and others [33, 34, 37, 147–151]. The HPP
method provides a unique opportunity for the application of τ -leaping approaches because,
unlike in pure particle-based methods, there exists a partial network of reactions that act
on population species. We believe that it would be relatively straightforward to integrate
a τ -leaping method into the HPP by applying it exclusively to the population subnetwork
while retaining the network-free approach in the particle-based component. We have re-
cently implemented a τ -leaping variant in BioNetGen, known as the partitioned-leaping
algorithm [37], and are actively working on integrating it with the HPP.
Importantly, the integrated τ -leaping/HPP method will involve calculating different time
steps for the particle and population subcomponents of the system and setting the global time
step, τ , to the smaller of the two. As such, if the fastest dynamics in the model are contained
within the particle-based component, then accelerations in the population subnetwork will
be limited. However, if the fast dynamics are due to the presence of a large population
of identical particle species (i.e., suboptimal lumping), then automated lumping, i.e., via
aHPP, could alleviate the problem. This further emphasizes the value of the proposed aHPP
method. Optimizing both memory usage and speed of simulation will not only decrease the
time to results but will impact, in a tangible way, the cost of doing computational research.
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Figure 4.9: Memory use vs. simulated volume for different simulation methods,
including a hypothetical “automated HPP” (aHPP). For finite networks, aHPP mem-
ory use plateaus once the entire reaction network has been generated. For infinite networks,
the scaling at large volumes should fall somewhere between constant and linear (no worse
than HPP) depending on the model.
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5.0 APPLICATION: SEPSIS AND HEMOADSORPTION TREATMENT
Sepsis is a serious illness characterized by the combination of infection and systemic inflam-
mation. Hemoadsorption (HA) is an experimental treatment for sepsis in which the patient’s
blood is circulated through a device packed with porous beads that adsorb a range of small
molecules, including inflammatory cytokines. HA has been shown to be effective at improv-
ing survival in a rat model of sepsis [152, 153]; however, the mechanism of efficacy remains
uncertain. In this chapter, I present models of sepsis and HA and attempt to elucidate a
casual mechanism for treatment efficacy1.
I proposed a causal mechanism for improved survival of sepsis with HA treatment. The
hypothesis supposes that inflammatory mediators produced at the site of infection escape
into the circulation, where they are transported to distant organs. Distant organs become
inflamed, leading to widespread neutrophil recruitment and a reduction in circulating neu-
trophil levels. Lower circulating levels reduces availability of neutrophils at the site of in-
fection. Consequently, the infection is not adequately suppressed, eventually resulting in
death. HA prevents this cascade by removing inflammatory mediators from the blood, re-
ducing systemic inflammation and preventing the drop in circulating neutrophils. Higher
circulating levels leads to improved recruitment to the site of infection and promotes clear-
ance of pathogen.
To determine the plausibility of the hypothesis, I developed a compartmental rule-
based model of sepsis and HA (sepsis model 1, Section 5.3). The model includes three
organ compartments, peritoneum, blood, and other tissue, that are populated by pathogen,
1Models and analysis presented in this chapter were developed under the supervision of Gilles Clermont
and Robert S. Parker. Experimental work was performed by our collaborators in the laboratory of Dr. John
Kellum. The statistical analysis herein is my own and may differ slightly from any experimental publications
that result from their work.
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macrophage, neutrophils. A pro-inflammatory cytokine and its inhibitor regulate the re-
cruitment of neutrophils, which eliminate the pathogen. The HA device is modeled as a
first-order removal of cytokine from the blood compartment. A set of parameters was iden-
tified for which HA treatment rescues the in silico animal from septic death. Simulations
predicated that HA efficacy was associated with improved circulating neutrophils levels,
lower systemic neutrophil recruitment, and increased neutrophil recruitment to the site of
infection.
Drawing on these simulation results and other lines of evidence, experimental collab-
orators devised a set of experiments to measure inflammatory mediators and white blood
cells in the lung, blood, and peritoneal compartment of septic rats. Experiments indicated
that HA leads to significantly reduced neutrophil infiltration in the lung and, although the
difference did not reach a significance threshold, increased recruitment to the peritoneum.
Contrary to our simulations, circulating neutrophils were not depleted in sham animals, nor
increased with HA treatment.
Since experimental results did not support a drop in circulating blood neutrophils, the
original hypothesis was modified. Based on input from experimental colleagues, I hypothe-
sized that the ratio of local to systemic chemokine was the key driver for neutrophil recruit-
ment. Reduction of chemokines in the blood via HA increases the ratio, leading to better
recruitment to the site of infection and improved survival. At the same time, lower levels of
blood cytokines reduces systemic inflammation and contributes to improved survival.
To test the modified hypothesis, I formulated a model that incorporates the chemokine
ratio mechanism (sepsis model 2, Section 5.5) and calibrated to experimental data. Simula-
tions predict that HA leads to a short-term drop in circulating cytokines and chemokines,
which rebound to normal levels within a few hours. Despite the fast rebound, the effect on
neutrophil recruitment was sufficient to rescue the in silico animal from a septic death tra-
jectory. However, the model was unable to reproduce the increase in peritoneal neutrophils
observed in laboratory experiments. Thus, I conclude that while the chemokine ratio hy-
pothesis is a plausible mechanism for improved survival with HA, further laboratory and
modeling work is required to elucidate the biological mechanisms underlying sepsis and HA
treatment.
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5.1 SEPSIS AND INFLAMMATION: AN INTRODUCTION
Inflammation is the body’s natural and essential response to infection and trauma. Inflam-
mation recruits an innate immune response to fight off infection and initiates the adaptive
immune response [154]. Macrophage cells reside in tissues and serve as sentinels. Macrophage
detect pathogen and cellular damage signals through surface receptors that are complemen-
tary to conserved bacterial proteins (such as LPS) and host proteins associated with cell
damage [155]. Upon detection, macrophage secrete a variety of pro-inflammatory cytokines
and chemoattractants into the local interstitial space. TNF and interleukin-1 (IL-1) are two
important pro-inflammatory cytokines. TNF and IL-1 alert nearby cells to the presence of
danger.
Pro-inflammatory signals trigger changes in the local vasculature. Nearby blood vessels
dilate and become more permeable. This physiological change increases blood flow and in-
creases the influx of proteins that target pathogen. Endothelial cells, which express receptors
for TNF and IL-1, begin to express neutrophils adhesion molecules [156]. Neutrophils are
a white blood cell that circulates in the blood stream [157]. Neutrophils express molecules
that bind to activated endothelial cells, causing the neutrophil to roll slowly along the vessel.
Chemokines, including (IL-8), trigger tight binding of neutrophils to the endothelium. After
tight binding, neutrophils migrate into the inflamed tissue following chemokine signals.
After migration, neutrophils bind pathogen via surface receptor, and then internalize
and digest the pathogen (a process called phagocytosis). Neutrophils also release a variety
of toxic chemicals into the interstitium that inhibit bacterial growth, but also cause damage
to local tissues. Tissue damage may lead to further inflammation (positive feedback), but
also triggers anti-inflammatory events to minimize host damage.
Pro-inflammatory signals trigger a subsequent wave of anti-inflammatory signals. TNF,
for example, binds to receptors expressed on macrophage and activates the production of the
potent anti-inflammatory IL-10 [158]. IL-10 binds to receptors on a variety of cells, including
macrophage, and inhibits the production of pro-inflammatory signals. This negative feedback
plays an important rule in limiting inflammation.
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5.1.1 Sepsis
Properly regulated inflammation is localized to the site of infection and trauma. Due to
infection in the blood or other pathological conditions, acute inflammation can become
systemic, spreading throughout the body. Sepsis, a systemic inflammatory response triggered
by infection, is one such pathology [159]. An estimated 751,000 incidents of severe sepsis
occur annually in the United States with 51% of cases receiving treatment in the ICU and
28.6% mortality [160]. Severe sepsis may lead to the failure of multiple organ systems
[160,161]. The cascade of organ failures may occur even while the infection is suppressed by
antibiotics, demonstrating that uncontrolled inflammation is destructive to organ tissues.
The mainstay of sepsis treatment has been source control, antibiotic treatment, fluid
resuscitation and organ support. Recent recommendations added very few additional op-
tions to this therapeutic approach [162]. Numerous attempts at controlling the ill effects
of the inflammatory response in sepsis using immunomodulation such as anti-inflammatory
treatments (e.g. anti-TNF antibodies, low dose corticosteroids, etc.) have largely failed
to improve patient outcome despite promise in pre-clinical trials; hence, there is ongoing
controversy as to the merit of immunomodulation in severe sepsis [162, 163] and reticence
to pursue development of interventions based on simple rationales. An opportunity exists
for model-based intervention design in sepsis and other complex diseases where standard
approaches have not delivered expected advances.
5.1.2 Cecal-Ligation and Puncture: animal model of sepsis
Cecal-ligation and puncture (CLP) is a laboratory model of clinical sepsis [164]. The cecum
of an animal, typically a rodent, is surgically ligated and punctured with a needle [165]. The
punctured cecum initiates a polymicrobial infection in the peritoneal cavity of the animal,
leading to sepsis, shock, and typically death [166]. CLP has been described as the “gold
standard” of animal sepsis models, although sensitivity to the parameters of the procedure
result in poor reproducibility if the protocol is not performed consistently [166].
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5.1.3 Hemoadsorption: a potential treatment for sepsis
Hemoadsorption (HA) is a blood purification treatment that has been shown to improve
short term survival in septic rat models [152, 153]). A portion of the septic animal’s blood
is circulated through an ex vivo circuit including the HA device: a column packed with
small adsorptive beads. Key inflammatory cytokines responsible for the propagation of the
inflammatory response, including TNF, interleukin(IL)-6, and IL-10, are captured by the
device [152]. A calibrated model of cytokine capture was presented by DiLeo et al. [167,168]
There is preliminary evidence [169] that existing HA devices directly interact with circulating
WBCs, the distal effectors of systemic inflammation. Research is ongoing to characterize the
specific nature of the interaction between the HA device and subpopulations of WBCs.
5.2 MODELING INFLAMMATION, A SURVEY
The complexity of the inflammatory response, and the lack of clinical progress in treating
sepsis, make it an ideal candidate for systems modeling. A survey of inflammation modeling
approaches is presented here, with a focus on host-pathogen models of acute inflammation.
5.2.1 Equation models
The simplest models of sepsis are abstract representations of pro and anti-inflammatory feed-
back loop as small systems of ordinary differential equations [20,21,23]. These abstract mod-
els reproduce multiple physiological outcomes observed in clinical sepsis, including healthy
resolution, septic death, and aseptic death. Though useful for theoretical purposes, calibra-
tion to experimental data is not possible since biological observables are not represented in
the model.
Phenomenological models of inflammation with variables corresponding to biological en-
tities have been constructed using larger systems (8-18 equations) of ODEs [22, 170]. The
inclusion of biological observables provides a quantitative connection between the model
and biology that is not possible with abstract models. The mathematical form is based on
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heuristics, often Michaelis-Menten or Hill-type functions, inferred from biological relations
reported in the literature. Model parameters are calibrated to experimental measurements
obtained in vivo. This type of model is useful for engineering applications, such as process
control, where calibration and efficient simulation are required. The number of parameters
in these models is large compared to the available in vivo data. Integrating supplemental
data from in vitro or in vivo experiments would be ideal, but the phenomenological nature
of these models limits the applicability of data obtained under different experimental con-
ditions. ODE models are amenable to dynamic analysis techniques, but typically restricted
to a few parameters of interest.
The ODE models described above do not represent spatial aspects of sepsis. Sepsis,
however, is a process that occurs in the context of a complex physiological space. To re-
flect this fact, a course-grained representation of organ physiology was implemented in a
compartmental ODE model of acute inflammation presented by Reynolds [171]. The model
represents organs as well-mixed compartments connected by a vascular compartment. Cell
migration and cytokine diffusion are included as mathematical transport terms that link
compartments. The coarse representation of space sacrifices spatial detail to obtain rapid
simulations. The Reynolds model inspired the compartmental model presented later in this
chapter (Sec. 5.3).
Compartmentalized ODEs can be written by hand, but the task becomes tedious as the
number of compartments increase. Reactions are typically common to many or all compart-
ments, requiring the modeler to write similar equations repeatedly. This avoid the tedious
and error-prone process of writing compartmentalized ODEs, the compartmental model can
be specified with a set of universal reaction rules and a compartmental topology. Then the
reaction network can be algorithmically constructed via the network generation algorithm.
Compartmental BNGL, presented in Chapter. 3, is one such framework for compartmental
rule-based modeling [111].
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5.2.2 Agent-based models
Agent-based models (ABM) are a common choice for modeling spatial phenomenon. IN con-
trast to ODE models, which lump populations into a single variable, agent models represent
members of the population as individuals, i.e. agents. ABMs are useful for simulating sys-
tems where the state space dimensionality is too large for network based simulation methods.
A typical agent simulation includes a 2-D or 3-D space in which agents move about. One or
more cell types are represented as agents, each with its own list of instructions that define
motion and other cell behaviors. Additionally, background layers may be implemented to
simulate biochemical gradients. Simulations are typically implemented with a fixed-time step
sequence rather than exact stochastic methods. ABMs have been used to study acute in-
flammation [172], the formation of diabetic foot ulcers [173] and the formation of granulomas
in tuberculosis [174].
ABMs have disadvantages in certain situations. Spatial simulations are often burdened
by tedious computations of diffusion and agent movements. If spatial details are not the
primary concern of the model, this computational overhead may be unsatisfactory. Agent
models are fundamentally stochastic; therefore multiple simulations are required to determine
the average behavior of the model and its variance. This compounds the computational
burden, especially during parameter estimation and sensitivity analysis. ABM, which lacks
the concept of a bond, cannot represent complexes of agents unless the modeler defines an
agent class for each possible complex. This is a severe limitation when modeling systems
with combinatorial possibilities for binding configurations (e.g. signal transduction).
5.2.3 Discrete-state models
Discrete-state models are simple and often useful for qualitative modeling. A set of discrete
variables represent biological entities or behaviors, e.g. phosphorylated protein, or cell mi-
gration. In a two-state model, a 0 value indicates that the biological referent is inactive, e.g.
transcription factor is not activated, while a value of 1 indicates activity, e.g. the transcrip-
tion factor is active. The state of each variable is computed by a logical formula in terms of
influencing variables. Discrete state models can be simulated, without further specification,
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using an iterative update scheme. These models can encode dynamic behaviors typical of
equation models, including bistability and oscillations. But the connection to continuous
time is tenuous. Discrete-state modeling has been applied to a variety of biological phenom-
ena. Thakar et al. [175], for example, constructed a boolean model of host-level inflammation
that was able to reproduce a number of qualitative observations.
The Kauffman-Glass [176] treatment uses a discrete-state model to induce a piecewise
linear system (PLS) with continuous dynamics. This scheme requires a set of threshold
parameters, and kinetic parameters for each partition of state-space. Dynamics are linear
in each partition, but the kinetic parameters switch when the trajectory crosses a partition
boundary. The PLS approach handles continuous variables and time in a more natural way
than discrete models, but at the expense of additional parameters.
5.3 A RULE-BASED MODEL OF SEPSIS WITH HEMOADSORPTION
Two experiments reported in the literature motivated the development of a compartmental
model of sepsis. Kellum and colleagues studied the efficacy of extra-corporeal blood purifi-
cation via a hemoadsorption (HA) device for the treatment of sepsis in a CLP rat model. In
the study, rats were subjected to CLP and either received 4 hours of HA treatment beginning
18 hours post CLP or sham treatment with an empty cartridge. HA treated animals had a
higher survival rate and lower levels of circulating cytokines in comparison to sham treated
animals [152,153]. Despite the efficacy of HA treatment, it is unclear why cytokine capture
improves survival. The authors propose that broad-spectrum filtration of cytokines reduces
systemic inflammation and the risk for multiple organ dysfunction and death.
In a second study, Alves-Filho et al. compared cytokine levels and neutrophil recruitment
in lethal and sublethal models of peritoneal sepsis in rats. The study found that lethal
sepsis, in comparison to sublethal sepsis, is associated with increased levels of circulating
cytokines, increased neutrophil recruitment to the lung, and decreased neutrophil counts in
the peritoneum [177].
Building on the work of Alves-Filho et al., I developed a mechanistic hypothesis for the
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efficacy of HA treatment. In response to CLP, high levels of cytokines are produced and
spill over from the site of infection into the blood. High levels of cytokines in the blood lead
to poor neutrophil recruitment to the site of infection and high levels of system neutrophil
recruitment. The immediate effect of HA treatment is a reduction of cytokine levels in the
blood. Following the logic of Alves-Filho, this restores neutrophil recruitment to the site of
infection and minimizes systemic recruitment. Thus, clearance of the infection is improved
while damage to organs from systemic inflammation is minimized.
The hypothesis as stated so far is incomplete, as the link between high levels of cy-
tokine and reduced recruitment to the site of infection is unclear. There are several possible
hypotheses, but I proceeded with perhaps the simplest hypotheses: excess cytokine in the
blood activates endothelium systemically, leading to wide-spread, non-specific neutrophil
recruitment to tissue and depletion of circulating neutrophils. Due to lower levels of circu-
lating neutrophils in the blood, fewer neutrophils are available for recruitment to the site of
infection.
5.3.1 Model construction
In order to test the hypothesis, I developed a model of sepsis with blood, peritoneum and
“other tissue” compartments. These three compartments are the minimum required to repre-
sent infection and systemic inflammation: a site of infection, distant tissues that may become
inflamed, and the blood circulation, which transports mediators between tissues. The central
focus of the model is recruitment of neutrophils from the blood to inflamed tissues and the
subsequent elimination of pathogen by phagocytosis. Recruitment is mediated by cytokines
produced in response to pathogen and the endothelial cells activated by those cytokines. I
assume that the adaptive immune response is not relevant on the time scale of experiments
(3 days) and may be excluded from the model.
This model, titled sepsis model 1, is summarized in Figure 5.1. The model is constructed
in compartmental BNGL (cBNGL), a rule-based language. Tissues are represented by com-
partments, while cells and signaling molecules are treated as agents in those compartments2.
2I will use the term agent throughout this section since the usual BNGL terminology, i.e. molecule, is
confusing in this context.
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Sepsis model 1 is composed of 27 reaction rules, corresponding to a reaction network with
134 species and 545 reactions. The model has a total of 27 free parameters. Reaction
rules are depicted graphically in Figure 5.2 and the complete BNGL source code is listed in
Appendix H.1.
5.3.1.1 Compartments The model consists of three organs: blood, peritoneum, and
other tissue. Each organ is represented by a 3-dimensional compartment in cBNGL: B,
P, and T, respectively. The peritoneum and other tissue are separated from the blood by
endothelial layers, which are represented by 2-dimensional compartments: eP and eT. The
peritoneal compartment is the site of bacterial infection, while other tissue represents an
organ that is free of active infection but may be affected by systemic inflammation. For
example, other tissue may represent the lung. The model assumes that infection is contained
in the peritoneum and does not spread to the blood or other tissue.
The volume of the organ compartments are constant during the simulation. The volume
of blood in a 250g rat is about 14 ml and, assuming hematocrit of .45, the plasma volume
is 7.8 ml. The effective volume of the peritoneum and other tissue are set by tunable
parameters. The surface area of each endothelial layer is proportional to the volume of the
respective organ compartment.
Compartments are assumed to be well-mixed. Although organs are in fact heterogeneous
and diffusion limited, the well-mixed assumption is reasonable since (i) available data is not
spatially resolved and (ii) every subvolume of an organ is close to the blood supply and
thus similarly coupled to the blood compartment. Other modelers have chosen to apply the
well-mixed assumption in similar contexts.
5.3.1.2 Agents The model is populated by four types of cells: pathogen, tissue macro-
phage, endothelial cells, and neutrophils. Each cell type is represented by a BNGL agents:
Path, Mphage, Endo and Neutr. The behavior of each agent is governed by a set of rules,
described in the next section. The components of each cell type represent sites for cell-cell
interaction, ligand binding sites, or physiological states (such as activated or inactive. The
agent type block (i.e. “molecule types”) is listed below.
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Figure 5.1: Schematic of sepsis model 1. The agents are macrophage, Mphage (M); endothelial
cells, Endo (E); neutrophils, Neutr (N); bacterial pathogen, Path (P); pro-inflammatory
cytokine, IL1 (C); and IL-1 receptor antagonist, IL1ra (A). See Section 5.3.1 for a complete
description of the model.
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Figure 5.2: A complete list of rules for sepsis model 1, depicted graphically. Each rule is
composed of a set of reactant patterns on the left-hand side and the product patterns on
the right-hand side. Reversible rules are indicated with a double arrow. If a component of
an agent is not shown in the reactant pattern, then the state of that component does not
influence the reaction.
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begin molecule types
Path(ph) # pathogen
Mphage(p) # macrophage
IL1(b) # ligand (IL1)
IL1ra(b) # receptor antagonist (IL1ra)
Neutr(p,e) # neutrophil
Endo(n,a∼0∼1∼2,r,r,r) # endothelial cell
end molecule types
Pathogen are restricted to the peritoneal compartment, where the infection is initiated
at t = 0 with a dose pathogen. The Path agent contains one component ph that serves as a
site for cell-cell interaction between the pathogen and phagocytic host cells.
Tissue macrophage, represented by the Mphage agent, are present in the peritoneum and
other tissue, but absent from the blood. The total concentration of Mphage is constant during
model simulations. Mphage has one component, p, that serves as site for cell-cell interaction
with pathogen.
Endothelial cells, Endo, reside in the endothelial barriers of the peritoneum and other
tissue. Like tissue macrophage, the total surface concentration is held constant during the
simulation. The agent type for endothelial cells is Endo(a∼0∼1∼2,n,r,r,r). The a site
represents the activation state of the endothelial cell. A state value of 0 represents inactive,
1 represents activating, and 2 represents a fully activated cell. The n component serves as
a site for cell-cell interaction with neutrophils in the blood. Endothelial cells only interact
with neutrophils after activation by IL1 [178]. The r site represents a surface receptors that
binds IL1 and IL1ra. The cell contains 3 receptor sites, which permits a graded response
depending on the level of ligand saturation. Endothelial activation is initiated when at least
two receptor sites are occupied by IL1. A endothelial cell, in fact, contains thousands of
receptors, but it is not feasible to represent the cell in this detail.
Neutrophils, Neutro, initially populate the blood compartment, which contains a source
of neutrophil. Unlike other cells in the model, neutrophils can migrate to other compart-
ments. The neutrophil molecule type is Neutr(p,e), where p is a site for cell-cell interaction
with Path and e is a site for cell-cell interaction with Endo cells.
The model contains two small signaling molecules: Interleukin-1, IL1, and its receptor
antagonist, IL1ra. Interleukin-1 is pro-inflammatory cytokine that mediates the activation
of endothelial cells [179]. IL-1ra binds to the same receptor as IL-1 and blocks signaling [180,
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181]. The agent types are IL1(b) and IL1ra(b), where b is the site for receptor binding. IL1
and IL1ra can reside in the peritoneum, blood, and other tissue. Both molecules can “leak”
between the compartments, which is the primary mechanism for the spread of inflammation
in the model. Although, in fact, a large number of cytokines and chemokines organize
the inflammatory response, I chose to focus on a single pro-inflammatory mediator and
its anti-inflammatory receptor antagonist. This choice was made for two reasons. First, the
network of interactions among mediators is complex and not fully understood. Consequently,
calibrating a model with multiple cytokines and chemokines would not be possible without
a large amount of data. Second, since the model is exploratory, a single pro-inflammatory
mediator and its anti-inflammatory partner may serve as an abstract representation of the
complete pro/anti-inflammatory circuitry.
5.3.1.3 Rules The complete set of agent rules for the sepsis model are depicted in Figure
5.2. I will describe the rules for each agent type in the model.
Pathogen grow according to a logistic rate law. Logistic growth is implemented with two
rules: one describing pathogen growth via cell division at a rate proportional the pathogen
population, and a second describing population pressure. Pathogen are captured and elimi-
nated by local macrophage and neutrophils (described later).
# pathogen rules
Path(ph) -> Path(ph) + Path(ph) sP_P # growth
Path(ph) + Path(ph) -> Path(ph) dP_P # population pressure
The total quantity of tissue macrophage is held constant during the simulation. Tissue
macrophage irreversibly bind pathogen according to a second-order process and eliminate
the pathogen at a first order rate. While bound to pathogen, macrophage produce cytokines
in the local compartment.
# macrophage rules
Path(ph) + Mphage(p) -> Path(ph!1). Mphage(p!1) bMP
Mphage(p!1). Path(ph!1) -> Mphage(p!1). Path(ph!1) + IL1(b) sL_M
Path(ph!1). Mphage(p!1) -> Mphage(p) dP_M
The total quantity of endothelial is held constant during a simulation. The receptor
sites on endothelial cells bind reversibly to IL1 and IL1ra ligand in the peritoneal or tissue
compartment adjacent to the the endothelial layer. Binding follows a bimolecular rate law
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and each receptor site has identical kinetics. When receptor IL1 site occupancy is two or
greater, endothelial cells enter the delayed activation state in a first order rate. (IL1 does
not contribute to activation and thus acts as a competitive inhibitor.) Once in the delayed
activation state, the endothelial cell becomes activated at a first order rate. Activated
endothelial cells bind irreversibly to neutrophils in the blood compartment according to a
bilinear rate law and mediated neutrophil migration into tissue. Activated cells return to
the inactive state at a first order rate.
# endothelial rules
IL1(b)@P + Endo(r) <-> IL1(b!1)@P.Endo(r!1) bLE , uLE
IL1(b)@T + Endo(r) <-> IL1(b!1)@T.Endo(r!1) bLE , uLE
IL1ra(b)@P + Endo(r) <-> IL1ra(b!1)@P.Endo(r!1) bLE , uLE
IL1ra(b)@T + Endo(r) <-> IL1ra(b!1)@T.Endo(r!1) bLE , uLE
Endo(a∼0,r!1,r!2). IL1(b!1). IL1(b!2) \
-> Endo(a∼1,r!1,r!2). IL1(b!1). IL1(b!2) aE_L # activation , step 1
Endo(a∼1) -> Endo(a∼2) aE # activation , step 2
Endo(a∼2) -> Endo(a∼0) dE # deactivation
Endo(n,a∼2) + Neutro(e)@B -> Endo(n!1,a∼2). Neutro(e!1)@B bEN
Endo(n!1) @eP.Neutro(e!1)@B -> Endo(n)@eP + Neutro(e)@P tN_E
Endo(n!1) @eT.Neutro(e!1)@B -> Endo(n)@eT + Neutro(e)@T tN_E
Neutrophils are produced in the blood compartment at a constant rate. As above,
neutrophil bind irreversibly to activated endothelial cells according to a bilinear rate law.
Neutrophils bound to endothelial cells migrate into the adjacent compartment under a first
order rate law. Since neutrophils only bind to endothelial cells from the blood compartment,
neutrophil trafficking is one-way from blood to peritoneum or other tissue. Neutrophils bind
to pathogen in the local compartment under a bilinear rate law, and, as above, the pathogen
are eliminated in a first order rate after binding. Neutrophils decay in a first order rate
that is constant and independent of compartment. Neutrophil that have migrated to the
peritoneum or other tissue produce IL1ra in the local compartment at a first order rate.
# neutrophil rules
Path(ph) + Neutro(p,e) -> Path(ph!1). Neutro(p!1,e) NP
Path(ph!1). Neutro(p!1) -> Neutro(p) dP_N
Neutro@P -> Neutro@P + IL1ra(b)@P sA_N
Neutro@T -> Neutro@T + IL1ra(b)@T sA_N
0 -> Neutro(p,e)@B sN_B
Neutro -> 0 dN DeleteMolecules
IL1 is produced at a first order rate by macrophage that are bound to pathogen. IL1
“leaks” between peritoneum and blood, and between other tissue and blood in a first order
146
rate proportional to surface area of the relevant endothelial barrier. Forward and reverse rates
are constrained such that equal concentrations are achieved in adjacent compartments at
equilibrium. In the blood, cytokine is eliminated at a first-order rate to model the elimination
of cytokine by the kidney, liver and other mechanisms. As above, cytokine in the peritoneum
and other tissue bind reversibly to receptor sites on endothelial cells.
IL1ra is produced at a first order rate by neutrophils in the peritoneum and lung com-
partment. As with IL1, IL1ra leaks between the peritoneum and blood, and between other
tissue and blood in a first order rate proportional to surface area of the relevant endothelial
barrier. IL1ra in the peritoneum and other tissue binds irreversibly to receptor sites on
endothelial cells, but does not active endothelial cells. IL1ra, like IL1 is eliminated in the
blood according to a first order rate law.
#IL1 , IL21ra rules
IL1(b)@P <-> IL1(b)@B tL_PB , tL_BP # IL1 leak P<->B
IL1(b)@T <-> IL1(b)@B tL_TB , tL_BT # IL1 leak T<->B
IL1ra(b)@P <-> IL1ra(b)@B tL_PB , tL_BP # IL1ra leak T<->B
IL1ra(b)@T <-> IL1ra(b)@B tL_TB , tL_BT # IL1ra leak T<->B
IL1(b)@B -> 0 dL # IL1 blood elim.
IL1ra(b)@B -> 0 dL # IL1ra blood elim.
5.3.2 Calibration and simulation
5.3.2.1 CLP protocol Cecal-ligation and puncture (CLP) was simulated by initializing
the model system with a non-zero quantity of pathogen in the peritoneum at time zero.
The severity of was adjusted by increasing or decreasing the quantity of initial pathogen at
time zero. Pathogen is assumed to be contained in the peritoneum during the course of the
simulation.
5.3.2.2 HA protocol HA treatment was modeled as a first-order cytokine (IL1 and
IL1ra) elimination rate in the blood compartment. Although HA treatment in the labora-
tory was limited to a 4 hour regimen, simulations were performed under the assumption of
continual HA. Given a typical HA flow of 0.8 ml/min [153] and hematocrit of .45, the rate
of plasma flow through the device is about 26.4 ml/hr. Assuming 7.8 ml of plasma in a 250g
rat [182], the flow rate per unit plasma is 3.38 /hr. The cytokine capture efficiency of the
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HA device is known to drop in a time-dependent fashion [167, 168], but 100% capture was
chosen as a first approximation suitable for this exploratory work. Since the natural half-life
of cytokine in the blood is on the order of 30 minutes [183] (elimination rate 1.4 /hr), the
HA device increases the elimination of cytokine by about two to three fold.
5.3.2.3 Calibration Parameters were based on estimates obtained in experimental liter-
ature, where available. Remaining parameters were selected from physiologically-reasonable
ranges. The complete set of parameter values are listed in the model in Appendix H.1. The
model was based on a 250g rat with 74.2 ml of interstitial fluid, including 7.8 ml of blood
plasma [182]. Of the non-plasma interstitial fluid, 7.8 ml were assigned to the peritoneal
fluid, P, and the remaining to other tissue T. Concentration units were arbitrary units /ml
for cells, and pM for IL-1 and IL-1ra. Based on a pharmacokinetic study of TNF−α in rats
that reported half-life in the range of 15-23 minutes [183], baseline elimination rate of IL-1
and IL-1ra were set to 1.4 /hr. IL-1 and IL-1ra dissociation constants were 150 pM [180].
Neutrophil decay rate corresponded to a half-life of 12 hours, since neutrophil life span was
reported to be 8 hours in the blood and longer in tissues [184]. Pathogen capture rate per
neutrophil was about 12 /hr for the pathogen doses simulated. Upon capturing a pathogen,
phagocytosis completes with half-life of 15 minutes. Macrophage/pathogen interaction pa-
rameters were set to the same values as neutrophil/pathogen parameters. Pathogen growth
rate corresponded to a doubling-time of 4 hours.
5.3.2.4 Simulation The reaction network of the cBNGL model generated in BioNetGen
version 2.2.4. The reaction network was then translated to a system of ODEs via the
BioNetGen writeMexfile() method and integrated with SUNDIALS CVODE 2.6.0 using
the stiff solver option. Subsequent analysis was performed in MATLAB.
5.3.2.5 Model outcomes For a given severity of CLP, P0, and blood cytokine elim-
ination, dL, a simulation was classified as non-lethal if the concentration of pathogen fell
below 1 a.u./ml prior by day 7 post-CLP and remained below that threshold through day
10. Otherwise the simulation was classified as lethal. For the selected parameter set, an
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aseptic lethal condition, i.e. pathogen falls returns to zero while inflammation remains high,
was not observed. Hence there was no need to define an aseptic lethal group.
5.3.3 Model simulation results
Sepsis model #1 was simulated with increasing initial pathogen dose to reproduce the re-
sults Alves-Filho et al. reported for lethal and sublethal sepsis. Neutrophil recruitment and
cytokine levels versus initial pathogen dose are shown in Figure 5.3. Panel A shows max-
imum neutrophil recruitment to the peritoneum and other tissue, and the minimum level
of circulating neutrophils during the course of a 7 day simulated septic event. Peak neu-
trophil recruitment to the peritoneum occurs at pathogen dose P0 ≈ 300 a.u./ml, and then
decreases slightly as pathogen increases towards the lethal threshold at P0 = 1638 a.u./ml.
Panel B shows the maximum cytokine concentration in the peritoneum, blood, and other
tissue over the course of the simulation. Cytokine levels increased in all organ compart-
ments with increasing pathogen dose, until cytokine levels plateau at the lethal threshold.
Simulated results for both cytokine and neutrophils agree qualitatively with experimental
measurements obtained in lethal and sublethal murine CLP models [177]. However, the
reduction in peritoneal neutrophils in lethal versus sublethal sepsis was about 4-fold in ex-
periments, but only about 15% in sepsis model 1. This suggests that additional mechanisms,
such as defective neutrophil rolling and adhesion [177], may be play an important role in the
observed results. Nonetheless, model results indicate that circulating neutrophil depletion is
a possible contributor to decreased peritoneal neutrophil recruitment in lethal sepsis.
Next, sepsis model 1 was simulated with increasing blood cytokine elimination rate in or-
der to explore the effect of HA treatment on neutrophil recruitment, cytokines, and survival.
Neutrophil recruitment and cytokine levels versus blood cytokine elimination rate are shown
in Figure 5.4. All simulations were performed with initial pathogen dose P0 = 1638a.u./ml.
Baseline blood cytokine elimination rate was dL = 1.4/hr, corresponding to a natural half-life
of 30 minutes in the blood. HA was simulated by increasing the blood cytokine elimination
rate. Panel A shows maximum neutrophil recruitment to the peritoneum and other tissue,
and minimum level of circulating neutrophils, versus the blood cytokine elimination rate as a
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Figure 5.3: Neutrophil recruitment and IL-1 increases in the peritoneum and other tissue,
while levels of circulating neutrophils decrease, as initial pathogen dose, P0, increases. (A)
Maximum neutrophil recruitment to peritoneum, max NP , maximum neutrophil recruitment
to other tissue, max NT , and minimum circulating neutrophils, min NB. (B) Maximum
interleukin-1 in peritoneum, blood, and other tissue. Blood cytokine elimination rate was
fixed at dL = 1.4 /hr. The lethal threshold (dashed line) is the value of P0 above which the
simulation is lethal.
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fraction of baseline dL/dL0. Neutrophils recruited to the peritoneum increase, while recruit-
ment to other tissues decreases, as the blood cytokine elimination rate increases. Due to a
reduction in systemic neutrophil recruitment, the pool of circulating neutrophils maintains
a higher level with increasing elimination rate. The increase in neutrophil recruitment in
the peritoneum is a consequence of higher levels of circulating neutrophils. Panel B shows
maximum cytokine levels in the peritoneum, blood, and other tissues. In all cases, maximum
cytokine levels decrease with increasing blood cytokine elimination rate, with a large drop
in cytokine levels near the lethal threshold. Note that the pathogen dose is lethal when the
fractional elimination rate falls below 1.
These results show that an increase in blood cytokine elimination is a possible mecha-
nism for improved survival in septic animals treated with an HA device. Figure 5.5 shows
pathogen and peritoneal neutrophil trajectories for various blood cytokine elimination rates
with a fixed initial pathogen dose, P0 = 1638 a.u./ml. In panel A, the pathogen trajectory
tends towards zero for higher elimination rates, but tends to a lethal outcome for lower elim-
ination rates. Panel B shows that peritoneal neutrophil recruitment increases with higher
elimination rates, demonstrating the mechanism for improved pathogen elimination. Finally,
Figure 5.6. shows the minimum lethal pathogen dose as a function of the blood cytokine elim-
ination rate. The lethal pathogen dose is monotonic increasing for the range of elimination
rates simulated.
Together, these results demonstrate that the hypothesized HA mechanism is sufficient
to explain the improved survival of HA treated animals, increased neutrophil recruitment to
the peritoneum, and recruitment to other tissues. The model predicts that this mechanism
is predicated on a decrease in the level of circulating neutrophils.
5.4 FROM THE LABORATORY: ORGAN-SPECIFIC DATA
The simulation results presented above, along with other lines of evidence [177, 185], moti-
vated experimental collaborator Zhi-Yong Peng, et al., working in lab of Dr. John Kellum, to
measure white blood cell, chemokine, and cytokine levels in the blood, lung and peritoneum
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Figure 5.4: Neutrophils and IL-1 vs. Blood Cytokine Eliminate Rate. Neutrophil
recruitment to the peritoneum and levels of circulating neutrophils increase, while recruit-
ment to other tissues decreases, with an increase in the rate of blood cytokine elimination.
Improved recruitment to the lung is a consequence of higher levels of circulating neutrophils,
which is in turn a consequence of lower cytokine levels in other tissue. (A) Maximum
neutrophil recruitment to peritoneum, max NP , maximum neutrophil recruitment to other
tissue, max NT , and minimum circulating neutrophils, min NB. (B) Maximum interleukin-
1 in peritoneum, blood, and other tissue. Blood cytokine elimination rate is expressed as
a fraction of the baseline rate, dL0 = 1.4 /hr. All simulations performed with P0 = 1638
a.u./ml. The lethal threshold (dashed line) is the value of dL/dL0 above which the simulation
is lethal.
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BA
Figure 5.5: Increasing the blood cytokine elimination rate, dL, rescues an otherwise lethal
simulation. Improved pathogen elimination is a consequence of improved neutrophil re-
cruitment to the peritoneum with higher dL. (A) Pathogen trajectories and (B) peritoneal
neutrophils for various blood cytokine elimination rates. Blood cytokine elimination rate is
expressed as a fraction of the baseline rate, dL0 = 1.4 /hr. All simulations performed with
P0 = 1638 a.u./ml.
baseline
Figure 5.6: The minimum lethal pathogen dose increases with blood cytokine elimination
rate, dL.
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of rats subjected to CLP and treated with either HA or a sham device. I will briefly describe
their methods and results here. Male Sprague-Dawley rats (450-500g) were subjected to a
“less-lethal” CLP protocol [153]. At 18 hours post-CLP, animals received either HA or sham
treatment for 4 hours. The HA device was a 1 ml cartridge containing CytoSorb polymer
beads, with flow rate 0.8-1.0 ml/min. Blood was drawn at 18, 22 and 72 hours after CLP.
Animals were sacrificed at 72 hours and fluid was sampled from the lung by bronchoalveolar
lavage (BAL) with 15 ml of saline, and peritoneal fluid (PF) by aspiration of the peritoneal
cavity with 30 ml of saline. A panel of cytokines and chemokines was measured via multiplex
Luminex assays. White blood cells (WBC) were isolated in BAL and PF and the percent
polymorphonuclear leukocytes (PMN) and monocytes were assessed by flow cytometry. PMN
were also isolated and counted directly in PF and blood at 72 hours. Bacteria culture was
obtained from PF and blood samples at 72 hours. Further details of the experiments were
reported at Critical Care Congress [186] and a manuscript is in preparation.
All measurements were log transformed prior to computing mean and standard error.
Measurements below the detection limit of the assay were replaced with numbers drawn
from a uniform distribution over [LDL/2,LDL], where LDL is the lower detection limit.
Statistical significance was assessed by two-sample Student’s t-test with threshold p = 0.05.
5.4.1 Experimental results
IL-6, TNF-α, IL-10, and MCP1 were significantly lower in the blood at 72 hours in HA
versus sham treated animals (Figure 5.7). Surprisingly, none of the assayed cytokines and
chemokines were statistically different at the 22 hour time point that coincides with the
end of HA treatment. Cytokines and chemokines tended to be lower in HA at the 22 hour
time point, but the difference was not statistically significant. A similar result was obtained
in a second study [187]. As expected, there was no statistical difference in cytokines and
chemokines at the 18 hour time point coinciding with the start of HA.
IL-6, IL-10, CXCL1 (KC), MCP1, and MIP2 were significantly lower in BAL samples
at 72 hours in HA versus sham treated animals (Figure 5.7). Cytokines and chemokines in
PF tended to be higher in HA treated animals, but the difference was not significant. These
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results suggest that inflammation in the lung, but not the peritoneum, is reduced in the HA
treated animals.
The ratio of cytokines and chemokines in the PF and BAL to the blood was computed
and tested for differences between HA and sham treated animals. The ratio of IL-6, IL-10,
CXCL1, and MIP2 in PF to blood was significantly increased at 72 hours in HA treated versus
sham animals. The ratio of IL6 and MCP1 in BAL to blood was significantly decreased, while
the same ratio of TNF-α was significantly increased. Some evidence suggests the difference
in chemokine concentration between tissue and blood is an important factor in recruitment
of WBC to inflamed tissue [185].
Since measurements of cytokines and chemokines were very noisy, and since the trends
across them were similar, the data was standardized and lumped to determine the overall
trend in the data. Each cytokine and chemokine was standardized by its mean and stan-
dard deviation across all time points and organs. The standardized data for all cytokines
and chemokines was lumped. Mean and standard error of the lumped data was then com-
puted for each time point and tissue. Figure 5.7, lower right panel, shows the lumped
cytokine/chemokine data. Lumped cytokine/chemokine was significantly lower in BAL and
blood samples at 72 hours in HA versus sham treated animals. No statistical difference
was observed at the 22 hour time point, although the mean value was lower in HA treated
animals.
PMN counts in BAL were significantly lower in HA versus sham treated animals (Figure
5.8). PMN counts in the blood and PF were higher in HA treated animals, although the
difference was not statistically significant. Monocytes counts in PF were significantly higher
in HA treated animals, but not statistically different in blood or BAL. These results suggest
that WBC recruitment to the peritoneum is preserved or increased somewhat in HA treated
animals, while systemic recruitment is reduced. Since circulating WBC are not different
between sham and HA treated animals, it appears that depletion of circulating WBC is not
an important factor in HA device efficacy.
Bacterial culture in the PF and blood at 72 hours was not significantly different in HA
and sham treated animals (Figure 5.8), though average bacterial counts in the PF were
higher in sham versus HA. Bacterial counts in the blood were on the order of 102-103 /ml
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Figure 5.7: Experimental measurements: cytokine and chemokine measurements obtained
from a CLP rat model with HA or sham treatment. Blood was sampled at 18, 22 and 72
hours post CLP (B18,B22,B72). Measurements in the lung (BAL) and peritoneal fluid (PF)
were obtained at 72 hours post CLP. Data was log transformed prior to analysis. Mean and
standard error are shown. Asterisk indicates a significant p-value (0.05) under the Student’s
t-test. Data for each cytokine and chemokine was standardized and then averaged to show
the overall trend (lower right).
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Figure 5.8: Experimental measurements: neutrophil and bacteria cells counts obtained from
a CLP rat model with HA or sham treatment. Measurements were obtained 72 hours post
CLP in the lung (BAL), peritoneal fluid (PF) and blood (B72). Data was log transformed
prior to analysis. Mean and standard error are shown. Asterisk indicates a significant p-value
(0.05) under the student’s t-test.
compared to 106-107 /ml in PF.
Put together, the organ-level data shows that HA treatment decreases systemic inflamma-
tion as measured by cytokines, chemokines, and neutrophil recruitment. This is accompanied
by sustained or increased response at the site of infection, the peritoneum.
5.4.2 Comparison to sepsis model 1
Some of the model 1 predictions were validated by experiment, but others were not sup-
ported. The model predicted a decline in cytokines and neutrophils in tissues distant to the
site of infection in HA treated animals. This was confirmed by experiment, which found
significantly lower neutrophil counts, cytokines levels, and chemokine levels in BAL. The
model also predicted an increase in neutrophils and a drop in cytokines in PF for HA versus
sham. Experiments failed to find a significant difference in neutrophil counts, cytokines or
chemokines in PF, although the average counts were higher in HA. Since the model predicted
a small change in PF neutrophils, it is not surprising that the difference was not statistically
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significant. However, it is difficult to reconcile the model prediction of decreased PF cy-
tokines with experimental measurements that favor an increase. Therefore, I conclude that
the model failed to predict the PF cytokine response to HA treatment.
Model analysis suggested that improved pathogen clearance in HA was a consequence
of a partial reversal of circulating neutrophil depletion. Experimental data did not support
circulating neutrophil depletion or a difference in circulating levels between HA and sham
treated animals. Circulating neutrophils and monocytes in the blood were not significantly
different between HA and sham. Although baseline neutrophil counts were not measured,
levels of circulating neutrophils were in the range reported in healthy animals [182]. There-
fore, experiments did not support the proposed mechanism.
Surprisingly, experiments failed to detect a statistically significant difference in cytokines
or chemokines at the 22 hour time point. The 22 hour time point coincides with the ter-
mination of HA treatment. Since it is known that the HA device captures cytokines and
chemokines, it was expected that HA treated animals would have significantly lower levels
of cytokines and chemokines immediately following treatment. Since this was not the case,
it is unclear how HA treatment leads to reduced systemic inflammation and improved long
term survival. It is possible that cytokines and chemokines are moderately lower, but statis-
tical significance was not achieved due to a high signal to noise ratio in experimental assays.
Alternatively, an unmeasured inflammatory mediator may be responsible for the efficacy
of HA [187]. It is also possible that a mechanism other than capture of soluble signaling
molecules is responsible, e. g. the HA device changes the phenotype of WBCs by some
unknown mechanism.
In conclusion, sepsis model 1 predicted the response to HA treatment in the lung, but
failed to predict other features. Furthermore, a key component of the proposed mechanism—
reversal of circulating neutrophil depletion—was not supported by data. Therefore, model
1 must be rejected and modified.
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5.5 A CALIBRATED MODEL OF SEPSIS WITH HEMOADSORPTION
The mechanism of sepsis model 1 was based on a hypothesis that depends on depletion of
circulating neutrophils in sham treated animals that is partially reversed by HA treatment.
Since experiments did not support either the depletion of neutrophils or a significant dif-
ference between HA and sham, the model was deemed to be inadequate. Therefore, a new
model, based on a new hypothesis, was required.
The foundation of sepsis model 2 is the hypothesis that the ratio of local chemokine
levels to systemic levels (e.g. blood) is the key driver of neutrophil recruitment. Under this
hypothesis, reducing chemokine levels in the blood via HA treatment increases the ratio
of PF chemokines to blood chemokines. Consequently, neutrophil recruitment to the site
of infection is improved. The importance of the ratio of local to systemic chemokines was
reported by Call, et al. [185], while Dr. John Kellum proposed it as a potential mechanism
for the efficacy of the HA device. For brevity, we will refer to this as the chemokine ratio
hypothesis.
This chemokine ratio hypothesis is promising, on one hand, since it does not rely on
depletion of circulating neutrophils. It is less promising, on the other hand, since it depends
on the reduction of blood chemokines by the HA device. Experiments did not identify a
statistically significant difference in any of the measured blood chemokines at the time point
immediately following HA treatment (22 hours). Therefore it is questionable whether the HA
device is able to change the chemokine ratio as required. It is possible that the HA device
does reduce blood chemokines, but the difference is modest and thus difficult to achieve
statistical significance. Alternately, cytokines and chemokine levels might rebound quickly
after termination of treatment. If this is the case, then survival in the CLP must be sensitive
to a temporary decrease in the chemokine ratio. I hoped to determine if this explanation
was feasible by constructing a model that implements the ratio hypothesis.
Sepsis Model 2 was constructed to take advantage of the organ-level data obtained from
CLP experiments. The model was constructed with three compartments representing the
blood, PF, and lung. The compartments were populated by bacteria, macrophage, neu-
trophils, and a cytokine/chemokine. Since the data available is sparse (three time points in
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the blood, one in the lung, one in PF), I attempted to construct the simplest model suit-
able for testing the ratio hypothesis. As a consequence of this design choice, only a single
abstract molecule was chosen to represent the battery cytokines and chemokines measured.
This choice was thought to be reasonable since the sparsity of the data suggests that cal-
ibrating a more model complex model would inevitably lead to overfitting. Furthermore,
the experimental data reveals a similar quantitative trend for the cytokines and chemokines
measured (see Figure 5.7, lower right panel). Measured cytokines and chemokines were
standardized by mean and standard deviation and then lumped according to time point and
compartment to establish the quantitative values for the abstract cytokine/chemokine agent.
5.5.1 Model construction
An overview of Sepsis model 2 is shown in Figure 5.9. The model was constructed with the
principles described above. To summarize: (1) neutrophil recruitment is driven by the local
to systemic chemokine ratio, (2) circulating neutrophils are not depleted, (3) experimentally
measured species are the basis for the model, and (4) the model is kept as simple as possible.
The model was specified as a rule-based model in compartmental BioNetGen language [111].
The model consists of 3 compartments and 5 agents, whose dynamics are governed by 16
rules. The corresponding reaction network has 11 species and 20 reactions. The model
required 22 parameters, of which 7 are fixed prior to calibration (depending on the model
variant). The model is described in detail in the following sections. The complete BNGL
model is listed in Appendix H.2.
5.5.1.1 Compartments The model is composed of three compartments: peritoneum,
P; blood, B; and lung, L. The compartments are assumed to be well-mixed, as was the case in
Model 1. The endothelium is not explicitly represented in this model, instead traffic across
the endothelium is represented by phenomenological terms. It is assumed that pathogen are
isolated to the peritoneum. The model is based on a 500g rat with 15.6 ml of plasma [182].
The BNGL compartments block is below.
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Figure 5.9: Schematic of sepsis model 2. The model has three compartments: peritoneal
fluid (PF), blood (B), and lung (L). Compartments are populated with pathogen, Path (P);
macrophage, Mphage (M); neutrophils, Neutr (N); and a lumped chemokine/cytokine, Cyto
(C). Circles represent agents, boxes are constant inputs or forcing functions, arrows show
mass transfer or regulation.
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begin compartments
B 3 vB # blood
P 3 vP # peritoneum
L 3 vL # lung
end compartments
5.5.1.2 Agents Model compartments are populated by five types of agent: a pathogen
source, CLP; pathogen, Path; macrophage Mphage; neutrophils Neutro, and the abstract
cytokine/chemokine Cyto. The CLP agent has two states, s∼0 and s∼1. CLP is initialized
in state s∼0 (potential), progresses to s∼1 (active pathogen source), and is then eliminated
(CLP wound closes). Path is initialized at zero and is restricted to compartment P during
simulations. Mphage are present in compartments P and L, with their populations fixed
during simulation. Neutro are initially populated in compartment B, where the population
is held constant, but can migrate into P and L in response to Cyto. The BNGL “molecule
types” block, which defines the agents, is listed below:
begin molecule types
CLP(s∼0∼1) # pathogen source
Path() # pathogen
Cyto() # cytokine/chemokine
Mphage () # tissue macrophage
Neutro () # neutrophil
end molecule types
5.5.1.3 Rules CLP agents, which are a source of Path, are initialized in compartment P.
The CLP agent progresses through 2 stages and is then eliminated from the system. Elimi-
nation of CLP represents closure or “healing” of the wound. A two-stage process was chosen
to achieve a longer time course than the exponential decay of a single-stage process.
Path are introduced to the peritoneum by active CLP, i.e. state s∼1, and grow according
to a logistic rate law. Path are eliminated via phagocytosis by local Mphage and recruited
Neutr, where the rate is linear in Mphage and Neutr and saturable in Path. The model
assumes pathogen are contained in compartment P, i.e. the infection is local and does not
progress to bacteremia. BNGL rules governing CLP and Path dynamics are listed below.
Note that PathP, which appears in the logistic growth rate, is a BNGL observable that
counts Path@P, i.e. pathogen in the peritoneal compartment.
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# CLP and pathogen rules
CLP(s∼0) -> CLP(s∼1) dclp # CLP progression
CLP(s∼1) -> 0 dclp # CLP wound closure
CLP(s∼1) -> CLP(s∼1) + Path kpclp # pathogen source
Path -> Path + Path kp*(1-( PathP/vP)/pmax) # logistic growth
Mphage + Path -> Mphage pn/(xpn + Path/vP) # phagocyt. by Mphage
Neutro + Path -> Neutro kpn/(xpn + Path/vP) # phagocyt. by Neutro
Mphage populations are fixed during the simulation, so there are no rules describing their
population dynamics. Mphage produce Cyto according to a second-order Hill function that
depends on two terms: local Path and Neutr. Cyto production in response to Neutr is a
surrogate for the inflammatory response to tissue damage caused by neutrophil activity, such
as the release of radical oxygen species. The rationale for coarse-graining this process was
the lack of experimentally measured intermediates.
Cyto “leaks” between the tissue compartments and the blood according to a first order
rate law. The forward and reverse leak rates are constrained such that concentrations in
neighboring compartments are equalized at equilibrium. Cyto is eliminated in the blood and
tissue according to a first order rate law. Separate rate constants are specified for elimination
in the blood, where the liver and kidney actively remove cytokine and chemokines, and
tissue. Elimination rate in the blood can be enhanced by extracorporeal methods, e.g. HA
treatment. The rules governing cytokine dynamics are listed below (PathP, NeutroP, and
NeutrL are observables the count Path@P, Neutr@P, and Neutr@L, respectively).
# cytokine rules
Mphage@P -> Mphage@P + Cyto@P f1() # cytokine prod.
Mphage@L -> Mphage@L + Cyto@L f2()
Cyto@P <-> Cyto@B kcBT , kcBT*vP/vB # cytokine transport
Cyto@L <-> Cyto@B kcBT , kcBT*vL/vB
Cyto@P -> 0 dcT # cytokine elim.
Cyto@B -> 0 dcB
Cyto@L -> 0 dcT
# where:
f1() = kc/mT0 *(( PathP/vP/xcp )^2 + (NeutroP/vP/xcn )^2) \
/(1 + (PathP/vP/xcp)^2 + (NeutroP/vP/xcn )^2)
f2() = kc/mT0*( NeutroL/vL )^2/(( xcn^2 + NeutroL/vL)^2)
Neutr initially populate compartment B, where the population is fixed. Neutr migrate
to compartments P and L in response to local Cyto; however, migration is inhibited by the
presence of Cyto in compartment B. The rate function for recruitment is linear in tissue Cyto
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and inhibited in the denominator by Cyto in B. An additional constant term incB appears
in the denominator to prevent divergence to infinity at CytoB = 0. Neutr are eliminated
at a first-order rate that is independent of compartment. The BNGL rules for neutrophil
dynamics are listed below.
# neutrophil dynamics
Neutro@B -> Neutro@P f3p() # recruitment to Peritoneum
Neutro@B -> Neutro@L f4p() # recruitment to Lung
Neutro -> 0 dn # neutrophil death
# where:
f3() = (knc*incB/xnc )*( CytoP/vP)/( incB + (CytoB/vB))*vP/(nB0*vB)
f4() = (knc*incB/xnc )*( CytoL/vL)/( incB + (CytoB/vB))*vL/(nB0*vB)
An alternative model considered the possibility that the HA device captures blood neu-
trophils in addition to cytokines and chemokines. Ex vivo studies found that HA filters
neutrophils from blood [169], though this has not yet been observed in vivo. Since blood
neutrophil capture would have no effect if the population is fixed, a source of neutrophils in
the blood was added to the model and the population was permitted to vary dynamically.
The source is regulated by negative feedback which helps to stabilize circulating neutrophil
levels during inflammation. The variant of the model with blood neutrophil dynamics is
labeled sepsis model 2′.
# blood neutrophil source , sepsis model 2’
0 -> Neutro@B dn*nB0*(1 + nBfbk *(1 - (NeutroB/vB)/nB0))
5.5.2 Calibration and simulation
5.5.2.1 CLP protocol CLP was modeled by an abstract CLP agent placed in the peri-
toneal compartment of the sepsis model. The CLP agent was initialized at t = 0 to 1 a.u./ml
(a.u.=arbitrary unit) in state s∼0. The parameters dclp and kpclp, the CLP progression and
Path source rate constants, were treated as free parameters and calibrated. Since the sever-
ity of CLP in vivo depends on the number of punctures and the gauge of the needle [188],
the initial value of CLP was adjusted to produce more or less severe sepsis in silico.
5.5.2.2 HA protocol HA was modeled as a first order elimination of the lumped cy-
tokine/chemokine, Cyto, from the blood compartment. HA was initiated 18 hours post-CLP
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by increasing the blood Cyto elimination rate, dcB, and then terminated after 4 hours of
treatment by reseting dcB to baseline. HA supplemented the elimination rate by 1.69/hr,
which was computed under the assumption of a 0.8 ml/min flow rate, 0.45 hematocrit, 15.6
ml of plasma, and 100% capture rate.
5.5.2.3 Calibration The model was calibrated to experimental data presented in sec-
tion 5.4. Data was log-transformed prior to further analysis. Mean and standard error
were computed for bacteria and PMN for each time point and tissue. Each cytokine (IL-6,
TNF, IL-1β, IL-10) and chemokine (KC, MIP1, and MCP2) was standardized against its
mean and standard deviation across all time points and tissues. Standardized cytokines and
chemokines were then lumped together at each time point and location prior to calculation
of mean and standard error. Path, Neutr, and Cyto were respectively calibrated to bacteria,
PMN, and lumped cytokines/chemokines. In total, calibration data consisted of 2 species
(Neutr,Cyto) at 3 time points in B, 3 species (Path,Neutr,Cyto) at 1 time point in PF, and
2 species (Neutr,Cyto) at 1 time point in L.
Since the data was sparse (18 points) compared to the number of free parameters (15), a
Bayesian approach was chosen for calibration. Under the Bayesian approach, parameters are
sampled from the posterior distribution of parameters. Model predictions are then computed
as averages over the ensemble of model predictions generated from the parameters sets. The
key idea is that if many parameter sets explain that data well, then the predictions should
be based on the average across all those parameter sets. This approach has been successfully
applied to a variety of biological modeling problems [16,189,190].
Since model parameters are positive and range over orders of magnitude, all parameters
were log-transformed (base 10) prior to calibration. To reduce the likelihood of overfitting,
independent Laplace priors were defined for each free parameter. Laplace priors are the
Bayesian equivalent of L1-regularization (i.e. LASSO) [104]. Location parameters of the
Laplace distributions, µp, were based literature ranges, if available, and biological intuition
otherwise. A single scale parameter, b = 0.088, was selected for all parameters by running
trial calibrations with various scales and choosing the maximum scale that did not permit
large trajectory oscillations (evidence of overfitting). This corresponds to an L1 penalty
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of λ = 11.4. In addition to Laplace prior, some parameters were restricted to biologically
feasible ranges. Table 5.1 lists the model parameters, units, and prior distributions.
The log-prior probability for Laplace priors was computed by the formula:
logP
(
~θ
)
=
NP∑
p=1
−|θp − µp|
b
, (5.1)
where NP is the number of parameters.
Sham and HA trajectories were generated for each parameter set ~θ. Simulated tra-
jectories were log transformed prior to comparison with calibration data. Concentrations in
compartments P and L were “diluted” to achieve consistency with experimental methods (PF
was aspirated with 30 ml saline, BAL was performed with 15 ml saline). Log-likelihood was
computed as summation over time and location of the weighted square difference between
model trajectory and calibration data:
logL(~θ|X,Σ) =
∑
t
∑
i
−
(
log yt,i(~θ)− xt,i
)2
2σt,i2
, (5.2)
where yt,i(θ) is the model state of output i at time t, and xt,i and σt,i are the mean and
standard error of the log experimental data for output i at time t.
The unnormalized log-posterior probability was computed by the sum of the log-prior
and log-likelihood for sham and HA treatments:
logP (~θ|X,Σ) ∝ logL(~θ|X,Σ, sham) + logL(~θ|X,Σ,HA) + logP (~θ). (5.3)
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Table 5.1: Parameter values, ranges, and priors for sepsis model 2.
parameter units value/distribution/range notes
vP ml 15.6 interstitial volume of P
vB ml 15.6 plasma volume of B (500 g rat) [182,191])
vL ml 15.6 interstitial volume of L
mT0 103/ml 102 init. Mphage [192]
B0 103/ml 3.6× 103 init. Neutr@B [182]
CLP0 a.u./ml 1 init. CLP (arbitrary unit)
dclp /hr log-Laplace(.12, b) CLP progression rate
kpclp 103/hr log-Laplace(5× 103, b) Path arrival rate due to CLP
kp /hr log-Laplace(.12, b) Path growth rate [193]
pmax 103/ml 106 maximum Path
kpn /hr log-Laplace(3, b) phagocytosis, max [193]
xpn 103/ml log-Laplace(103, b) phagocyt., half-max Path [193]
kc /ml/hr log-Laplace(6, b) Cyto production, max
xcp 103/ml log-Laplace(103, b) Cyto production, half-max Path
xcn 103/ml log-Laplace(103, b) Cyto production, half-max Neutro
dcT /hr log-Laplace(.347, b) Cyto elim. in P, L [194]
.029 < θ < .116
dcB /hr log-Laplace(1.109, b) Cyto elim. in B [183]
.69 < θ < 2.77]
kcBT /hr log-Laplace(.347, b) Cyto transport rate [194]
.116 < θ < 1.39
dn /hr log-Laplace(.058, b) Neutro death rate [184]
.029 < θ < .116
knc 103/hr/ml log-Laplace(300, b) Neutro migration, max
xnc /ml log-Laplace(1, b) migration, half-max Cyto
incB /ml log-Laplace(1, b) migration, half-max Cyto@B inhibition
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5.5.2.4 Dynamic behavior constraints In addition to Laplace priors, parameters were
constrained to regions where certain dynamical behaviors are satisfied. These behaviors were
deemed to be biological necessities, and thus parameter sets that did not produce those
behaviors were excluded from the calibration.
The local tissue macrophage should be sufficient to clear a small dose pathogen insult
without recruiting neutrophils from the circulation. Mathematically, this behavior is guar-
anteed by showing that the Path-Mphage subsystem is stable at Path = 0, Mphage = mT0 .
Since the population of Mphage is fixed, I need only demonstrate that Path = 0 is a fixed
point and the derivative of Path is negative at 0. This is guaranteed if the inequality holds:
kp <
kpn ·mT0
xpn
,
where kp is the pathogen growth rate, kpn is the maximum rate of pathogen elimination per
macrophage, mT0 is the concentration of tissue macrophage, and xpn is the concentration
of Path for half-maximum elimination rate.
The local macrophage response should also be insufficient to restrain pathogen growth
(without aid of neutrophils) for sufficiently large source of of pathogen. If this were not the
case, then neutrophil recruitment would be unnecessary. Mathematically, this is guaranteed
by showing that there exists a pathogen source rate such that the derivative of Path is always
increasing if Neutro is held at zero. This holds if:
kpclp > kpn ·mT0 ,
where kpclp is the source of pathogen due to CLP. Note that for this calculation I have
assumed CLP is fixed at 1.
The positive feedback mechanism between Neutro and Cyto should have two stable
fixpoints when Path and Cyto@B are fixed at zero. The low fixed point corresponds to the
resting state of the inflammatory system. The high fixed point represents a self-reinforcing
inflammation that can persist in the absence of infection [20, 23, 195]. It is straightforward
to show that the Neutro-Cyto subsystem always has a stable fixed point at zero. Since the
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fixed point equation is cubic equation, it either has 1 or 3 real solutions. Existence of 3
solutions is guaranteed if the nullclines have a non-zero crossing, which is guaranteed if:
2xcn <
kc
dcT
knc
xnc · dn
Phase-plane analysis shows that if 3 fixpoints exist, then the upper fixed point is stable and
the middle fixed point is a saddle. Thus the inequality is sufficient to guarantee bistability.
Since HA improves survival in laboratory experiments, the calibrated model should also
“rescue” trajectories on an otherwise lethal course. This property was enforced heuristically
since an analytic condition for rescue is unknown. In HA simulations Path@P, Cyto@P and
Neutr@P must fall below ∼ 20% of peak experimental values by day 7 and ∼ 5% by day
10. This qualitative constraint is more questionable than the previous constraints since HA
survival in the laboratory was not complete.
5.5.2.5 Sampling the posterior parameter distribution Samples were generated
from the posterior parameter distribution using a variant of the Metropolis algorithm [105,
196]. The Metropolis algorithm, which belongs to the class of Markov chain Monte Carlo
(MCMC) methods, generates a chain of parameter samples whose distribution converges to
the correct posterior distribution [197, 198]. Briefly, at each step of the algorithm a new
sample is generated from a proposal distribution. The proposal sample is accepted based
on the ratio of its posterior probability to that of the previous sample. This ratio can be
computed from the unnormalized posterior probability, which is straightforward calculation.
If the ratio is greater than 1, the proposal is automatically accepted. Otherwise, the sample
is accepted with a probability given by the ratio. If the proposal is rejected, the original
sample is retained. The algorithm may be viewed as probabilistic hill-climbing: the chain
tends to climb towards regions of higher probability, but there is a chance of moving back
down to explore areas of low probability.
The parallel tempering method was used to generating parameter samples [108, 109].
Parallel tempering is a variant of the Metropolis that runs several MCMC chains in parallel
with different “temperatures”. Temperature is a parameter that determines strictness in
accepting less probable samples. In a high-temperature chain, relative probability is less
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important and the entropy, or “width”, of the parameter distribution dominates. At lower
temperatures, the relative probability becomes more important. Periodically the parallel
MCMC chains attempt to exchange samples. The exchange probability is based on the
product of the difference in log-probability and difference in inverse temperature. Since
the different chains are exploring the distribution at different resolutions and exchanging
information, the parallel tempering algorithm tends to converge more rapidly to the true
distribution.
Parallel tempering was performed with 4 chains and 25 Metropolis steps between at-
tempts at swapping chains. The proposal distribution was Gaussian with diagonal covariance
matrix. During a burn-in phase of 125,000 steps, the proposal step size and temperature
chains were adjusted periodically to improve step and swap acceptance rates. The target ac-
ceptance rate was 24%. After the burn-in phase, step size and temperature were fixed. The
auto-adjust procedure tended to produce good acceptance rate (data not shown). Following
burn-in, 5 million steps were performed. Samples were thinned to 1 in 25 steps, for a total of
200,000 samples. Parallel tempering with auto-adjust was implemented in MATLAB. Code
is available to the public at http://code.google.com/p/ptempest/.
5.5.2.6 Simulation The reaction network was generated in BioNetGen version 2.2.4.
The reaction network was subsequently translated to a system of ODEs via the BioNetGen
writeMexfile() action and integrated with SUNDIALS CVODE 2.6.0 [38] using the stiff
solver option. Absolute and relative tolerances for integration were 10−6 and 10−7, respec-
tively. Subsequent analysis was performed in MATLAB.
5.5.2.7 Trajectory classification Model trajectories were classified as septic lethal,
aseptic lethal, or sublethal based on the concentration of Path@P, Cyto@P, and Neutro@P at
day 21. To define the threshold, trajectories were generated from 500 parameter sets drawn
from the posterior distribution, with initial CLP ranging from .5–1.5 a.u./ml and either
sham or HA treatments at 0–1.6 ml/min. Histograms of Path@P, Cyto@P, and Neutro@P
at day 21 revealed two prominent modes: high and low Path@P. These were labeled sep-
tic lethal and non-septic. The non-septic group was composed of a major mode with
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low Cyto@P,Neutro@P; and a minor mode with moderate Cyto@P,Neutro@P. These modes
were labeled non-lethal and aseptic lethal. Thresholds discriminating between the modes
were selected by inspection: Path@P > 106 /ml for septic lethal; Neutro@P > 35 /ml and
Path@P < 106 /ml for aseptic lethal; and Neutro@P < 35 /ml and Path@P < 106 /ml for non-
lethal. For subsequent analysis, septic lethal and aseptic lethal trajectories were combined
into a single lethal category.
5.5.3 Model simulation results
Sepsis model 2 was calibrated to experimental data using Bayesian methods. Distributions
of model trajectories were visualized by sampling parameters for the posterior distribution,
simulating the trajectories, and then plotting the median trajectory along with the 16th and
84th percentiles. The distributions of sham and HA trajectories are shown in Figure 5.10a.
In HA simulations, pathogen trajectories returned to a low level by the end of the simulation,
as required during calibration. In contrast, sham distributions were a mixture of pathogen
trajectories that either return to a low level or grow out of control. Thus, the postulated
HA mechanism is plausible rationale for improved survival in the simulated cohorts.
While HA is able to rescue simulated animals from septic death, the quality of the model
fit is poor. CytoP and NeutrP were elevated in HA versus sham experiments at 72 hours,
but in model fits the HA trajectory is lower than sham. CytoL and NeutrL were elevated
in HA versus sham at 72 hours in both model and experiment, however the quantitative fit
between model and experiment is poor.
The poor fit was surprising since the number of experimental data points (18) is sparse
in comparison to the number of free parameters (15). This suggests that the model structure
may be an insufficient representation of the biological process. However, it is important to
note that measurements were very noisy, and differences between CytoP, NeutrP in HA and
sham did not reach the level of significance.
To assess whether poor fits were due to the strength of the Laplace prior, calibrations
were performed with prior distributions of varying width. The λ parameter controls the
prior strength; a smaller value tends yields better fits but also increases the likelihood of
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(a) sepsis model 2: base
(b) sepsis model 2′: blood neutrophil dynamics and capture
Figure 5.10: Trajectory distributions for sepsis model 2. Median trajectories and 16th and
84th percentiles are shown for HA (blue) and sham (red).
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overfitting. Trajectories from calibrations with λ=5.7, 7.1, and 9.5 showed oscillatory be-
havior, a symptom of overfitting. Thus, I concluded that λ = 11.4 was necessary to control
overfitting.
Distributions of parameter energy (unnormalized log-posterior), log-prior, and log-likeli-
hood are shown in Figure 5.11a. Energy is the negative sum of log-prior and log-likelihood.
The most probable log-likelihood was ∼ 58, while the most probable log-prior was ∼ 52.
Although log-likelihood is somewhat smaller than log-prior, the similarity in magnitude
shows that the prior plays a large role in the posterior distribution. Since reducing the prior
strength leads to oscillation, this suggests that more data points are desirable.
Marginal posterior parameter distributions (λ = 11.4) are shown in Figure 5.12a. The
Laplace prior is plotted along with the posterior histogram to reveal differences. Several pos-
terior distributions drifted away from the prior, demonstrating the importance of these pa-
rameters in achieve a good fit. Key parameters include xcp and xcn (pathogen and neutrophil
concentration corresponding to half-maximum cytokine production), dcB (blood cytokine
elimination rate), dn (neutrophil death rate), kp (pathogen growth rate), kpn (pathogen
elimination rate due to neutrophils), kc (max cytokine production rate), and knc (cytokine
concentration corresponding to half-maximum neutrophil recruitment). Parameters that
were less important for obtaining a good fit include kpclp (pathogen source due to CLP),
xpn (pathogen population corresponding to half-maximum elimination rate), dcT (tissue
cytokine elimination rate), kcBT (cytokine transport rate between blood and tissue), and
incB (blood cytokine concentration corresponding to half-maximum inhibition of neutrophil
recruitment).
The posterior distribution dclp is bimodal, revealing two distinct CLP progressions (fast
and slow) that fit the data with more-or-less equal quality. Figure 5.13 compares the trajec-
tory distributions of the slow and fast CLP progressions. The primary difference is observed
the PathP trajectory. PathP peaks at higher levels in fast versus slow CLP. A comparison
of marginal posterior parameter distributions for fast and slow progression CLP is shown in
Figure 5.14.
Efficacy of HA treatment was evaluated in silico by plotting percent lethality versus CLP
severity, CLP0, for sham treatment and HA treatment with varying degree of intensity. HA
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(a) sepsis model 2, original
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(b) sepsis model 2′, blood neutrophil dynamics and capture
Figure 5.11: Distribution of parameter fitness for sepsis model 2. Total energy (log-posterior)
and its log-likelihood and log-prior components are shown.
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(a) sepsis model 2: base
(b) sepsis model 2′: blood neutrophil dynamics and capture
Figure 5.12: Marginal posterior parameter distributions for sepsis model 2 and 2′. Line plots
show the Laplace prior. Parameters values are plotted on a log scale (base 10).
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(a) slow progression CLP
(b) fast progression CLP
Figure 5.13: Comparison of trajectory distributions for slow and fast CLP progression.
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Figure 5.14: Comparison of marginal posterior parameter distributions for slow and fast
CLP progression. Line plots show the Laplace prior. Parameters values are plotted on a log
scale (base 10).
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intensity was adjusted by increasing the flow rate through the device (0.4 - 2.0 ml/min).
Percent lethality was computed by drawing N = 500 parameter sets from the posterior
sample distribution and classifying the resultant trajectories as lethal or sublethal. The
results are shown in Figure 5.15a.
Percent lethality, as predicted by the model, is very sensitive to CLP severity near
CLP0 = 1 a.u/ml and insensitive otherwise. At baseline CLP severity, a 2% change in
severity increases lethality from under 10% to over 90%. This is illustrated in Figure 5.15
by a shaded red box. Experiments have demonstrated that CLP lethality is sensitive to
variables such as the needle gauge and the number of punctures. However, the experimen-
tal sensitivity appears to be much lower than model sensitivity. Ebong et al. [188] found
that 18-, 21-, and 25-gauge punctures induce 100%, 50%, and 5% lethality, respectively. A
21-gauge needle has a cross-sectional area 2.5-fold large than 25-gauge needle. Assuming
that CLP severity is linearly related to cross-sectional area of the puncture, this suggests
that a 2-fold increase in severity increases the lethality by about 50%. Hence, the extreme
sensitivity of lethality to to CLP (at baseline CLP0 = 1) is not supported by experiment.
HA treatment (0.8 ml/min) improves the 50% lethal dose (LD50) from 1 a.u./ml to
1.03 a.u./ml, an increase of 3% (Figure 5.15). Doubling the HA flow rate to 1.6 ml/min
further increases the LD50 to 1.06 a.u/ml, a 6% increase. Lethality is sensitive to HA only
in a narrow range of CLP severity from 0.97 to 1.1. Thus, efficacy of HA is not robust
in the model. In contrast, laboratory experiments suggest that improved survival with HA
treatment is robust in a rats subjected to CLP [153,186]. Thus, the model failed to replicate
the robust response to HA that has been observed in the laboratory.
5.5.3.1 Neutrophil dynamics and capture Since sepsis model 2 fits were not sat-
isfactory, an alternate model was considered. The alternative model, labeled sepsis model
2′, includes blood neutrophil dynamics. Additionally, the HA device captures circulating
neutrophils in addition to cytokine and chemokines. Model 2′ was calibrated using the same
methods described previously.
Trajectory distributions for model 2′ are shown in Figure 5.10b. Blood neutrophil levels
dropped during HA, but promptly rebounded to normal levels. Infection and inflammation
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(a) sepsis model 2: base
(b) sepsis model 2′: blood neutrophil dynamics and capture
Figure 5.15: Predicted lethality versus CLP severity with and without HA treatment. Per-
cent lethality is plotted against CLP severity, CLP0, for sham treatment (0 ml/min) and
HA treatment of variable intensity (0.4-2.0 ml/min). Shaded box shows values of CLP0
corresponding to 10% and 90% lethality with sham treatment.
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in the median sham treated animal resolved to a healthy state, in contrast to model 2 where
the median sham trajectory led to septic death. Otherwise, trajectory distributions are
qualitatively similar to model 2 and have the same shortcomings. Specifically, CytoP and
NeutroP levels are lower in HA versus sham, while experiments display the opposite trend.
CytoL and NeutroL are lower in HA versus sham, as shown in experiments, but do not fit
experimental data well.
Efficacy of HA treatment was evaluated, as before, by plotting percent lethality versus
CLP severity for sham and a range of HA intensities (0.4-2.0 ml/min). Results are shown in
Figure 5.15. Lethality is very sensitive to CLP severity in a narrow range near CLP0 = 1,
increasing from 10% to 90% lethality with only a 3% change in severity (shaded red box),
and insensitive otherwise. HA treatment at 0.8 ml/min improves survival in a narrow range
from CLP0 = 0.99 to 1.05 and is ineffective elsewhere. Thus, HA is not a robust treatment in
model 2′. As discussed above, laboratory experiments indicate that lethality is less sensitive
to changes in CLP severity and HA efficacy is more robust than predicted by model.
Distributions of parameter energy, log-prior, and log-likelihood are shown in Figure 5.11b.
Average energy and negative log-likelihood for model 2′ is higher than model 2. Therefore,
since model 2′ also has one more free parameter, model 2 is the preferred model in terms of
fitness and number of parameters.
5.6 DISCUSSION
I constructed models of sepsis with hemoadsorption treatment in order to understand the
causal mechanism for improved survival observed in experiments. The first model (Sec-
tion 5.3) implemented a mechanism wherein systemic cytokines activated endothelial cells,
leading to widespread neutrophil recruitment, depletion of circulating pools, and inadequate
neutrophil recruitment to the site of infection. By removing cytokines from the circulation,
HA reduced systemic recruitment, leading to improved circulating neutrophil levels, higher
recruitment to site of infection, and clearance of pathogen. In preliminary work, a set of
parameters were identified where HA treatment rescued the in silico animal from a lethal
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outcome. The model predicted higher peak neutrophils in the peritoneum, reduced neu-
trophil and cytokine levels in the lung, and higher circulating neutrophils in HA treated
animals.
Experimental collaborators collected organ-specific data from septic rats with HA or
sham treatment. As predicted, cytokines and neutrophil counts were significantly lower at
72 hours in the lung of HA versus sham animals. Cytokines in the blood at 72 hours were
also significantly lower in HA treated animals. However, there was no statistical differ-
ence between circulating neutrophils, peritoneal neutrophils, and peritoneal cytokines in HA
versus sham treated animals. Since experiments did not support a key component of the
mechanism, i.e. a substantial drop in circulating neutrophils in sham treated animals, the
first model was rejected.
A second model (Section 5.5) was constructed with an alternative hypothesis for HA
efficacy. In the second model, neutrophil recruitment was dependent on the ratio of local
to systemic chemokines. The HA device removes chemokines from the blood, increasing the
ratio, and improving neutrophil recruitment to the site of infection. The model was calibrated
to experimental data using Bayesian methods. Trajectory distributions were plotted and
demonstrated improved survival in HA treated animals. HA treatment led to a reduction
in inflammatory mediators in the blood and neutrophils in the lung and blood at 72 hours.
Nonetheless, the model fit was poor. Notably, inflammatory mediators and neutrophils in
the peritoneum were lower in HA than sham, despite experimental measurements suggesting
the opposite trend.
Sensitivity analysis found that the model lethality is very sensitive to CLP at a critical
threshold and otherwise insensitive. Similarly, HA treatment was effective over a small range
of CLP severity and otherwise ineffective. These results stand in contrast to laboratory
studies that show lethality increases gradually with the gauge of the puncture needle [188]
and that improved survival is a robust feature of HA.
Since the second model did not adequately reproduce experimental measurements, I
analyzed the regulatory structure of the model in search of an explanation. Figure 5.16
shows the regulatory interactions and feedback loops in sepsis model 2. HA treatment has a
negative influence on Cyto@B (step 1). Since Cyto@B negatively influences Neutro, the short-
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term effect of HA on neutrophil recruitment is positive (step 2a). At the same time, reduction
of Cyto@B reduces the positive influence on Cyto@P and Cyto@L (step 2b). Neutro and Cyto
participate in a positive feedback loop that acts as bistable switch. Increased Neutro pushes
the switch towards the elevated inflammation state, while reduced Cyto pushes the switch
toward rest. In lieu of quantitative analysis, the net effect of Cyto@B on the bistable switch
is indeterminate (step 3).
Suppose the net effect of reduced CytoB is an increase in Neutr and Cyto levels relative to
sham. If the increase is too large, the system becomes trapped in the elevated inflammation
state, a lethal outcome. Since HA improves survival, this cannot be the case. So the
system must stay in the basin that returns to rest in the absence of pathogen. An increase in
Neutro exerts a negative influence on Path (step 4), and Path levels decline relative to sham.
Reduced pathogen lowers the positive regulation of Cyto (step 5) and, assuming the boost in
Neutro was sufficient to put Path on downward trend, the Cyto-Neutr switch begins a return
to rest (step 6). This sequence of events leads to improved survival, as desired. Cyto and
Neutr are temporarily elevated during step 3, but improved pathogen clearance accelerates
the return to rest at steps 4-6. Therefore, the regulatory structure of the model does not
support a long term increase in peritoneal inflammation, unless the elevated inflammation
state is reached.
Alternatively, assume the net effect of reduced CytoB is a short-term decrease in Neutr
and Cyto levels relative to sham. If the system is approaching the elevated inflammation
state, this effect may push the system back into the rest basin. This would lead to improved
survival, but also to reduced Neutr and Cyto in PF. Again, the model does not permit a
long term increase in Neutr and Cyto due to HA treatment.
There is only one scenario where the model supports a long term increase of Neutr and
Cyto in HA relative to sham. This is case where the sham trajectory is tending towards
healthy resolution, but a short term increase in Neutr and Cyto due to HA pushes the
system into the elevated inflammation state. Since HA increases lethality in this case, it is
not compatible with reports of improved survival with HA.
In experiments, NeutrP and CytoP were elevated in HA compared to sham at 72 hours.
This is more than 2 days after HA treatment ends. Since the model regulatory structure
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Figure 5.16: Regulatory influences in sepsis model 2 and the mechanism of HA.
Positive influences are indicated by red arrows, negative influences by blue bars. Feedback
loops are shown with dotted arrows and bars. Numbered influences show the influence of
HA flowing through the system (see main text). HA negatively influences CytoB (1). Since
CytoB has a positive influence on Cyto, but a negative influence on Neutr, the net effect on
the Cyto-Neutr positive feedback loop is uncertain (3). If the net effect is positive, it cannot
be so strong as to push the system to the elevated inflammation state (since HA improves
survival). The resultant increase in Neutr negatively influences Path (4) and, in turn, the
positive regulation of Cyto by Path is reduced (5) and the system tends towards rest (6).
Alternatively, if the net effect of HA on Cyto-Neutr is negative, the system can be rescued
from an elevated inflammatory state and pushed into the basin of rest. In either case, the
Cyto and Neutr will be elevated for only a short period of time.
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does not support a long-term increase in Neutr and Cyto in HA, model 2 is an improbable
explanation for the data (improbable in the sense that the range of parameters where the
short-term effects last for 2+ days is likely to be be vanishingly small).
It is worth noting that experimental measurements differences between HA and sham in
PF did not reach the level of significance. So it is conceivable, but unlikely, that NeutrP
and CytoP levels are indeed somewhat lower in HA at the 72 hour time point. Confirmatory
experiments would determine if the first experimental results are reliable.
Nonetheless, discrepancies between experimental data and models suggest that further
work is needed to understand sepsis and HA. Alternative mechanisms should be considered.
For example, Alves-Filho, et al. found evidence that chemokine receptors are downregulated
on neutrophils in severe sepsis via a TLR2 dependent mechanism [199]. However, it is
unclear why HA treatment would impact TLR2 signaling. It may also prove useful to include
macrophage dynamics or independent pro- and anti-inflammatory cytokines, but calibrating
such a complex model to sparse and noisy data is questionable. Development of less-invasive
assays (permitting higher time resolution sampling) with lower noise should be a priority for
both modelers and experimentalists.
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APPENDIX A
BNGL SYNTAX
This appendix presents BNGL syntax, including comparments and energy patterns, in Ex-
tended Backus-Naur Form (EBNF). EBNF symbols are summarized in Table A1. The BNGL
specification listed here is a guideline, and not necessarily authoritative.
Comments are initiated by the # character and continue to the end of the line. Line
continuation is signified by \, which must be the last non-whitespace character on the line.
The following specification assumes that comments and line continuations have been handled
in preprocessing. Optional white space is also omitted from the syntax to improve clarity.
The following non-terminals are not defined below, but the standard definitions may be
assumed: Letter, Digit, Real, PositiveInteger, NaturalNumber (0, 1, . . .), and String.
Table A1: Summary of symbols in Extended Backus-Naur Form
description symbol
definition =
concatenation ,
termination ;
alternation (or) |
optional [ ... ]
one-or-more { ... }
terminal string " ... "
comment (* ... *)
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# BNGL syntax with compartments and energy patterns
# (Extended Backus -Naur Form)
WS = {" "|"\t"};
NewLine = {"\n"};
Name = Letter , [{ Letter|Digit|"_"}];
State = "∼",(Letter|Digit),[{ Letter|Digit|"_"}] | "∼?";
Bond = "!",{ Digit} | "!?" | "!+";
Tag = "%",( Letter|Digit),[{ Letter|Digit|"_"}];
Compartment = "@",Name;
LineLabel = {Digit},WS | Name ,":",[WS];
ComponentType = Name , [{"∼",State }];
Component = Name , [{"∼",State | "!",Bond | "%",Tag}];
MoleculeType = Name , ["(", [ComponentType , [{",", ComponentType }]], ")"];
Molecule =
Name , [{Tag|Compartment }], ["(" ,[ Component ,[{",", Component }]] ,")"]
| Name , ["(",[ Component ,[{",", Component }]],")"] , [{Tag|Compartment }];
SimpleMolecule = Name , [{Tag|Compartment }], ["()"]
| Name , ["()"] , [{Tag|Compartment }];
PatternMods = {"$" | "{ matchOnce }"};
PatternQuantifier = (" <"|" <="|"=="|" >="|" >") , NaturalNumber;
Pattern = "0"
| [{Tag|Compartment } ,(":"|"::")] , [PatternMods],
Molecule , [{".", Molecule}], [PatternQuantifier ];
Species = "0"
| [{Tag|Compartment } ,(":"|"::")] , [$], Molecule , [{"." , Molecule }];
SimpleSpecies = [{Tag|Compartment } ,(":"|"::")] , SimpleMolecule;
RuleModifier =
"DeleteMolecules" | "MoveConnected" | "TotalRate"
| "exclude_reactants ","(", PositiveInteger ,Pattern ,[{",", Pattern }] ,")"
| "include_reactants ","(", PositiveInteger ,Pattern ,[{",", Pattern }] ,")"
| "exclude_products ","(", PositiveInteger ,Pattern ,[{",", Pattern }] ,")"
| "include_products ","(", PositiveInteger ,Pattern ,[{",", Pattern }] ,")";
RateLaw =
MathExpression
| "Sat","(", MathExpression ,",",MathExpression ,")"
| "MM","(", MathExpression ,",",MathExpression ,")"
| "Hill","(", MathExpression ,",",MathExpression ,",",MathExpression ,")"
| "Arrhenius ","(", MathExpression ,",",MathExpression ,")";
186
(* optional whitespace is permitted in definitions below this point*)
UniRule = Pattern ,[{"+" , Pattern}], "->",Pattern ,[{"+" , Pattern}],
WS ,RateLaw ,[{WS ,RuleModifier }];
RevRule = Pattern ,[{"+" , Pattern}],"<->",Pattern ,[{"+" , Pattern}],
WS ,RateLaw ,",",RateLaw ,[{WS,RuleModifier }];
Rule = UniRule | RevRule;
PopulationMap =
Species , "->", SimpleSpecies , WS , RateLaw ,, [{WS ,RuleModifier }];
Reaction = NaturalNumber ,[{",", NaturalNumber }],
WS , NaturalNumber ,[{",", NaturalNumber }],
(Real|Real ,"*", Name);
Observable =
(" Molecules "|" Species"), WS , Name , WS , Pattern , [{",", Pattern }];
Group = Name , WS , [NaturalNumber ,"*"] , NaturalNumber ,
[{",", [NaturalNumber ,"*"], NaturalNumber }];
MathExpression = Real | Id | "(", MathExpression ,")"
| UnaryOperator ,MathExpression
| MathExpression ,BinaryOperator ,MathExpression
| Id ,"(" ,[ MathExpression , [{",", MathExpression }]] ,")";
ParameterDefn = Id, (WS|"=") , MathExpression;
FunctionDefn =
Id , ["(", [Name ,[{",", Name}]], ")"], (WS|"=") , MathExpression;
Args = Real | String | Args ,",",Args;
| "{", Name ,"=>",Args , [{",", Name ,"=>",Args}], "}"
| "[", (Real|String), [{",", (Real|String )}], "]";
Option = Name , "(",[ Args ] ,")" ,[";"];
Action = Name , "(",[ Args ] ,")" ,[";"];
(* block defintions *)
ParameterBlock = "begin parameters", NewLine ,
{[ LineLabel], ParameterDefn , NewLine},
"end molecule types", NewLine;
MoleculeTypeBlock = "begin molecule types", NewLine ,
{[ LineLabel], MoleculeType , NewLine},
"end molecule types", NewLine;
CompartmentBlock = "begin compartments", NewLine ,
{ [LineLabel], Compartment , WS, ("2"|"3") ,
WS, MathExpression , [WS, Name], NewLine },
"end comparments types", NewLine;
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SpeciesBlock = "begin seed species ", NewLine ,
{[ LineLabel], Species , WS , MathExpression , NewLine},
"end seed species ", NewLine
| "begin species ", NewLine ,
{[ LineLabel], Species , WS , MathExpression , NewLine},
"end seed species ", NewLine;
ObservableBlock = "begin observables", {NewLine},
{[ LineLabel], Observable , NewLine},
"end observables", NewLine;
GroupBlock = "begin groups", NewLine ,
{[ LineLabel], Group , NewLine},
"end groups", NewLine;
EnergyPatternBlock =
"begin energy patterns", NewLine ,
{[ LineLabel], Pattern , [WS], MathExpression , NewLine},
"end energy patterns", NewLine;
FunctionBlock = "begin functions ", NewLine ,
{[ LineLabel], FunctionDefn , NewLine},
"end functions ", NewLine;
ReactionRuleBlock = "begin reaction rules ", NewLine ,
{[ LineLabel], Rule , NewLine},
"end reaction rules ", NewLine;
ReactionBlock = "begin reactions", NewLine ,
{[ LineLabel], Reaction , NewLine},
"end reactions", NewLine;
PopulationMapBlock = "begin population maps", NewLine ,
{[ LineLabel], PopulationMap , NewLine},
"end parameters", NewLine;
ActionBlock = "begin actions", NewLine ,
{[ LineLabel], Action , NewLine},
"end actions", NewLine;
Block = ParameterBlock | MoleculesTypeBlock | CompartmentBlock
| SpeciesBlock | ObservableBlock | GroupBlock
| EnergyPatternBlock | FunctionBlock | ReactionRuleBlock
| ReactionBlock | PopulationMapBlock | ActionBlock;
Model = [{ Option}],
( {Block}
| "begin model", NewLine ,
{Block}
"end model", NewLine
),
[{ Action }];
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APPENDIX B
GRAPH-BASED FORMALISM FOR BIONETGEN
Here, I present the graph-theoretic formalism of rule-based modeling in BNGL. This material
is adapted from a previous graph-based description of BNGL by Blinov et al. [66] and also
draws inspiration from the κ-calculus graph formalism of Winskel and co-workers [200]. The
formalism of Blinov et al. is oriented towards a population-based approach. The terminology
of the present work diverges to some degree in order to support a particle-based perspective.
Although similar to κ, BNGL requires a distinct formalism since BNGL: (i) permits
multiple identical components in a molecule, and (ii) makes a formal distinction between
inter- and intra-molecular reactions via the + and . symbols.
B.1 PATTERN GRAPHS
Pattern graphs are objects that describe substructures, or “motifs,” within molecular com-
plexes. Similar to the concept of a functional group in organic chemistry, a pattern graph
specifies a molecular motif, or moiety, that participates in a characteristic class of reac-
tions. Any instance of a pattern graph within a complex will participate in its characteristic
reaction without regard to the composition and structure of the surrounding complex.
Definition 4 (Pattern Graph). Given a countable index set I, a set of type labels ΩT , and
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a set of state labels ΩS, a pattern graph is defined by the tuple:
P |= (M ⊂ I, C ⊂M × I, B ⊂ C × C±, type : M ∪ C → ΩT , state : C → ΩS ∪ {∅, ?})
where M is the set of molecules, C is the set of components, B is the set of component
bonds (edges), C± = C ∪{+,−} is the set of components augmented with the non-specific
bond wildcard ‘+’ and the null bond ‘−’, type is a function that assigns a type label to
each molecule and component, and state is a function that assigns a state label to each
component (‘∅’ is the null state and ‘?’ is the unspecified state wildcard). Furthermore,
P satisfies the following: (i) at most one bond per component; (ii) bonds are undirected; (iii)
no self bonds. The set of all pattern graphs is denoted by P.
Each component in C is contained by a unique molecule in M . If c = (m,n) ∈ C, then
component c is contained by molecule m. Components can be thought of as the nodes of
the pattern graph, bonds as edges between nodes, and molecules as groups of components.
Definition 5 (Connected Pattern Graph). A pattern graph P is connected if every pair
of molecules in the pattern graph is connected by a sequence of component bonds.
B.1.1 Example: representation of a BNGL pattern as a pattern graph
Consider the BNGL pattern
L(r!1).R(l!1,a∼P).
Let us represent this pattern formally as a pattern graph. We begin by assigning a unique
index to each molecule (from left to right) and a unique ordered pair of indices to each
component (also from left to right), where the first element of the pair is the index of the
molecule containing the component:
L1(r(1,1)!1).R2(l(2,1)!1,a(2,2)∼P).
Now we can write the corresponding pattern graph tuple P = (M,C,B, type, state), where
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M = { 1, 2 }
C = { (1,1), (2,1), (2,2) }
B =
{ (
(1, 1), (2, 1)
)
,
(
(2, 1), (1, 1)
)
,
(
(2, 2),−) }
type = { 1 7→ “L”, 2 7→ “R”, (1,1) 7→ “r”, (2,1) 7→ “l”, (2,2) 7→ “a” }
state = { (1,1) 7→ ∅, (2,1) 7→ ∅, (2,2) 7→ “P” }
Note that the bond from component r to component l appears in B twice, once for each
ordering of the components. This is simply a convention for indicating that the bond is
undirected. It is also clear that P is a connected pattern graph because molecules L and R
are connected through this bond.
B.2 COMPLEX GRAPHS AND ENSEMBLES OF COMPLEXES
A complex graph, or simply a complex , is a pattern graph that defines an assembly of
connected molecules with a precise configuration of bonds and states. While a general
pattern graph describes parts of a molecular complex, a complex graph describes a complete
instance of a molecular complex. In other words, there is no ambiguity, such as unspecified
state (‘?’) or non-specific bond (‘+’) wildcards.
Definition 6 (Complex Graph). A complex graph is a connected pattern graph where: (i)
every component state is defined (no state wildcards); (ii) every component has a null bond
or a proper bond (no bond wildcards).
The state of a model system is described by an ensemble of complexes.
Definition 7 (Ensemble of Complexes). An ensemble of complexes is a finite set of disjoint
complexes.
Intuitively, an ensemble of complexes is a “particle-based” representation of a system, where
each particle corresponds to a distinct molecule in one of the complexes.
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B.3 PATTERN GRAPH ISOMORPHISM AND SPECIES
It is useful to define the notion of equivalence of pattern graphs. We will say that two pattern
graphs are equivalent, or isomorphic, if they have the same composition and structure.
Definition 8 (Pattern Graph Isomorphism). Pattern graphs x and y are isomorphic, writ-
ten x ∼= y, if there exists a one-to-one and onto map φ of molecules and components in
x to those in y that preserves the following properties: (i) graph structure; (ii) component
containership; (iii) type; (iv) states. A mapping with these properties is called an isomor-
phism.
Since isomorphism is an equivalence relation on the set of complexes, we can partition any
ensemble into classes of isomorphic complexes, which we call species . This partition is useful
because all complexes within a class have the same composition and structure and, therefore,
each member has the same reaction motifs and propensities to participate in reaction rules.
Definition 9 (Species). Given a complex graph y, the species [y] is the set of all complexes
that are isomorphic to y. The set of all species is denoted by S.
Though [y] is properly a set, it can be represented by any complex y′ ∈ [y].
If X is an ensemble of complexes, then a similar but distinct concept is that of the
species [y] with respect to X, written [y|X]. This is the subset of complexes in X that are
isomorphic to y, i.e., {x ∈ X | x ∼= y}. The population of a species with respect to an
ensemble X is the number of complexes in [y|X], i.e., ρ([y|X]) = |{x ∈ X | x ∼= y}|. Thus,
a species with respect to an ensemble can be represented by a complex and a population
attribute: [y|X] ≡ (y, ρ([y|X])). The set of all species with a population attribute is denoted
S† = S×N≥0. Under this notation, an ensemble of complexes X can be represented by a set
of species with population counters,
S(X) = {(s, ρ([s|X])) : s ∈ X/∼=},
where X/ ∼= is the quotient set of X by ∼=.
We may choose to dispense with the reference to X entirely and directly represent a
system as a species ensemble.
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Definition 10 (Species Ensemble). A species ensemble S is a set of species with population
counters. More precisely,
S ⊂ {(s,Ns) | s ∈ S, Ns ∈ N≥0} .
If (s,Ns) ∈ S, then we will abuse notation slightly and write s ∈ S and define ρ(s) =
Ns. In contrast to an ensemble of complexes, a species ensemble is a “population-based”
representation of a system since complexes belonging to the same species are lumped together
into a single object.
B.4 EMBEDDINGS OF PATTERN GRAPHS
An embedding, or “pattern match,” is a map from a pattern to an instance of that pattern
within a complex or, more generally, another pattern.
Definition 11 (Embedding). Given patterns p and q, an embedding of p in q is a one-
to-one mapping φ from the molecules and components of p into those of q that preserves
the following properties: (i) graph structure compatibility; (ii) component containership;
(iii) type; (iv) state compatibility. The non-specific bond ‘+’ is compatible with any bond
except the null bond ‘-’. The unspecified state wildcard ‘?’ is compatible with any state.
An embedding of pattern p in pattern q is denoted by φp,q. If X is an ensemble of complexes,
then emb(p,X) is the set of all embeddings of pattern p into the complexes of X. Similarly,
the set of embeddings from pattern p into any other pattern graph is denoted by emb(p,P).
Embeddings of a pattern graph into a species, e.g., φ ∈ emb(p, s), where s ∈ S, should be
interpreted as embeddings into the pattern graph representing the species.
It is often useful to refer to the pattern graph or species that contains the specific instance
of an embedding. We call this the target of the embedding.
Definition 12 (Target). Given an embedding φ, the target of φ, written targ(φ), is the
pattern graph or species that contains the image of φ.
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B.5 REACTION RULES
A reaction rule represents a class of potential transformations on an ensemble of complexes.
Definition 13 (Reaction Rule). A reaction rule is defined by the tuple
r |= ( (Rv)Vv=1, (Pw)Ww=1, ψ, k ) ,
where V is the number of reactant patterns, W is the number of product patterns, (Rv)
are the reactant pattern graphs, (Pw) are the product pattern graphs, ψ is the component
correspondence map, and k is the propensity,1 which may be given by a non-negative
real number or function.
The reactant pattern graphs describe motifs in complexes where a reaction event may occur.
The product patterns describe the structure at the site of the motif subsequent to transfor-
mation under the action of the rule. The component correspondence map is a one-to-one,
partial mapping of molecules and components in (Rv) to those of (Pw) that satisfies several
properties (see below). The propensity k is defined such that k·dt is the probability for
each rule instance (described next) to undergo transformation in the next infinitesimal time
interval dt [25, 28]. In addition to a simple non-negative constant, the propensity may be a
function of the ensemble of complexes (a “global function”), the target of a reactant pattern
embedding (a “local function”), or both (a “composite function”) [56].
The component correspondence map, ψ, defines how molecules and components in the
reactant patterns correspond to those in the product patterns. The map is partial because a
subset of molecules and components may be deleted or synthesized by the action of the rule.
If a reactant molecule is not in the domain of ψ, dom(ψ), then the molecule and its components
are deleted. Similarly, if a product molecule is not in the image of ψ, im(ψ), then the molecule
and its components are synthesized. The differences in the bond and state configurations
1The traditional definition of the “propensity” is as the product of a constant, c, and a combinatorial
factor , h(X), which is a function of the system state X and represents the number of different ways in which
specific instances of the reactant species can react [25, 28]. Here, we are dispensing with the combinatorial
factor and using the term “propensity” to refer to a constant or function that is analogous to c in the
traditional definition. We sometimes refer to this quantity as an “instance rate.” Note that from a particle-
based perspective, each complex can be thought of as a unique species with a unit population, i.e., h(X)=1.
Thus, our definition of the propensity is simply a special case of the traditional definition.
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of corresponding components imply a set of pattern graph transformations. For example, if
two components in the reactant patterns do not share a bond edge but the corresponding
components in the product patterns do, then a “bond addition” transformation is implied
by the rule.
Definition 14 (Component Correspondence Map). Given reactant patterns (Rv)
V
v=1 and
product patterns (Pw)
W
w=1, a component correspondence map ψ is a one-to-one, partial
mapping from the molecules and components of (Rv) to those of (Pw),
ψ :
⋃
v
(MRv ∪ CRv) →
⋃
w
(MPw ∪ CPw) ,
that satisfies the following properties: (i) molecules map to molecules and components map
to components; (ii) types are preserved; (iii) molecule substructures are preserved; (iv) no
new wildcards appear in the product graphs.
It is useful to define the notion of the “reaction center” of a rule, which is the subset of
molecules and components in the reactant patterns that are modified by the action of the
rule.
Definition 15 (Reaction Center). The reaction center of a rule r, written RC(r), is the
subset of reactant molecules not in the domain of ψ (deleted molecules) plus the subset of
reactant components in the domain of ψ where the corresponding product component: (i) is
bound if the reactant component is unbound; (ii) is unbound if the reactant component is
bound; (iii) has a different state than the reactant component.
Conversely, molecules and components in the reactant patterns of a rule that are not within
the reaction center are called the “reaction context.” In BNGL, the reaction context repre-
sents additional conditions necessary for a transformation encoded in a rule to take place. By
convention, the reaction context does not contribute to the propensity of a rule, i.e., multiple
matches to the context does not increase the value of the propensity (multiple matches to
the center does). As such, it is necessary to equate embeddings where the images of the
reaction center are the same even if the context differs.
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Definition 16 (Embedding Equivalence). Given a rule r, with reaction center RC(r), the
embeddings φ, φ′ ∈ emb(Rv,P) are equivalent with respect to RC(r) if φ|RC(r ) = φ′|RC(r ), where
φ|RC(r ) is the restriction of the embedding map φ to the molecules and components in RC(r).
The equivalence class of embedding φ with respect to RC(r) is written [φ]. When the context
is clear, we will usually omit reference to RC(r). Furthermore, since the embedding class is
represented by any of its members, we will usually omit the square braces. Note that all
embeddings in an equivalence class have the same target. The set of all equivalence classes
of embeddings of pattern R is denoted by emb(R,P)/ RC(r).
In order to apply the transformation(s) encoded by a reaction rule, it is necessary to
have an embedding of each reactant pattern into a target. A rule instance is a collection of
embedding classes, one for each reactant pattern, whose targets can be transformed by the
action of a rule.
Definition 17 (Rule Instance). Given reactant patterns (Rv)
V
v=1, a rule instance is a tuple
of embedding classes ([φv]) ∈
∏V
v=1 emb(Rv,P)/ RC(r).
The targets of a rule instance are denoted by the tuple targ(([φv])) = {targ(φv)}Vv=1. Note
that the targets are not necessarily distinct.
The action of a rule is defined by an operator that maps rule instances to products.
The products are constructed by transforming the embedding targets according to the graph
operations implied by the differences between the reactant patterns and the product patterns
via the component correspondence map.
Definition 18 (Action of a Rule on a Rule Instance). Given a rule r with reactant patterns
(Rv)
V
v=1, the action of r is given by an operator that maps rule instances to tuples of products,
r[ ] :
V∏
v=1
emb(Rv,P)/ RC(r) → (P)<∞,
where (P)<∞ is the set of finite sequences of pattern graphs (although sometimes the pattern
graph is the representative of a species).
The details of this operator are beyond the scope of the present work (see Sec. 3.1 of Bli-
nov et al. [66] for a discussion within the context of network generation). It is sufficient for
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our purposes to simply state that we have a unique operator that maps rule instances to
products.
It may seem awkward that the action of a rule maps embeddings to products rather than
targets to products. However, this distinction is important because the same targets may be
transformed into different products depending on the specific embedding into those targets.
Thus, the action of a rule depends on both the targets and the embeddings, but since the
targets are implicit in the choice of embeddings it is unnecessary to explicitly mention them
in the definition. Also note that the number of products produced by the action of a rule is
not necessarily equal to the number of product patterns in the rule. This is generally rectified
by a post-action rejection step. For example, during network generation BioNetGen rejects
all reactions generated from a rule that violate the product-side molecularity of that rule [60]
(see below for further discussion).
If the targets of a rule instance belong to an ensemble of complexes, then we can naturally
define the action of the rule on the ensemble. The instance targets are removed from the
ensemble and replaced by the products generated by the action of the rule on the instance.
Definition 19 (Action of a Rule on an Ensemble of Complexes). Given an ensemble of
complexes X, a rule r, and a rule instance (φv) ∈
∏
v emb(Rv, X)/ RC(r), the action of r on
X through (φv), written r[(φv)](X), is
X 7→ (X \ targ((φv))) ∪ r[(φv)],
where r[(φv)] is the action of r on (φv).
The action of a rule on a species ensemble S is defined similarly except that targets and
products belonging to the species in S are handled by modification of the population counter
rather than set deletion and addition.
Definition 20 (Action of a Rule on a Species Ensemble). Given a species ensemble S, a
rule r, and a rule instance (φv) ∈
∏
v emb(Rv, S)/ RC(r), the action of r on S through (φv) is
S 7→{
(s,N ′s) | s ∈ S,N ′s = Ns −
∣∣{v ∈ {1 . . . Vr} |targ(φv) = s}∣∣+ ∣∣{w ∈ {1 . . .Wr} | pw = s}∣∣}
where (pw) are the products of the action r[(φv)].
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Given an ensemble of complexes X, the set of all rule instances for rule r in X is defined
to be
rinst
(
r,X
)
=
V∏
v=1
emb(Rv, X)/ RC(r).
This set, along with the rule action operator r[ ], encapsulates every possible transformation
on an ensemble of complexes by a reaction rule, and forms the basis for the NF simula-
tion approach [53, 55, 56]. The set of all rule instances for a species ensemble S is defined
analogously.
A few notes about rule instance propensities. The propensity of a rule instance is the
probability of the rule acting on the instance in the infinitesimal time interval dt. There are
several factors that determine this probability: (i) kr, the propensity of the rule; (ii) the
symmetry factor of the rule; (iii) the targets of the rule instance; (iv) the products of the
action. The symmetry factor of a rule is a positive constant associated with the intrinsic
symmetry of the reactant and product patterns of the rule. Its computation is the beyond
the scope of this document (see Blinov et al. [66] for a discussion). The targets of the rule
instance influence the propensity in two ways. First, the targets of the embeddings must be
distinct complexes, i.e., the set of targets must have the same molecularity as the rule. If
the targets are not distinct then the propensity is zero. Second, if the rule propensity is a
local function (see Sneddon et al. [53]), then the local structure of the target can influence
the propensity. The products can also influence the propensity, but only as a post-action
rejection. While it can be shown that the products, in an aggregate sense, always contain
embeddings of the product patterns, there is no guarantee that the products will have the
same molecularity as the product patterns. After the products are constructed by the action
of the rule, the molecularity of the products can be compared to that of the rule. If the
molecularity is different, then the products are rejected and the targets restored. Since
compliance with product molecularity is handled as a rejection step, the propensity of a rule
instance is actually an upper bound on the true propensity.
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Definition 21 (Propensity of a Rule Instance for an Ensemble of Complexes). Given a rule
r with propensity kr and symmetry constant sr, an ensemble of complexes X, and a rule
instance (φv), the propensity of the rule instance is
a
(
(φv)
)
=
kr
sr
V∏
v=1
max
{
0, 1−
∑
j<v
δ(φj, φv)
}
,
where δ(φj, φv) = 1 if targ(φj) = targ(φv) and 0 otherwise.
Similarly, for a species ensemble,
Definition 22 (Propensity of a Rule Instance for a Species Ensemble). Given a rule r with
propensity kr and symmetry constant sr, a species ensemble S, and a rule instance (φv), the
propensity of the rule instance is
a
(
(φv)
)
=
kr
sr
V∏
v=1
max
{
0, ρ(targ(φv))−
∑
j<v
δ(φj, φv)
}
.
Note that the propensity of a rule instance for an ensemble of complexes is just a special
case of this definition [i.e., ρ(targ(φv)) = 1 if targ(φv) is a complex x ∈ X].
B.6 BNGL MODELS
An observable defines a measurable output of a model system. Observables are composed
of a set of pattern graphs, each corresponding to a molecular motif that is detectable by an
experimental assay [60].
Definition 23 (Observable). An observable is defined by the tuple
O |= ( name, type ∈ {“Molecules”, “Species”}, (Pv)Vv=1 ) ,
where name is a label for the observable, type is a property that determines how the observable
is calculated, and (Pv) is a tuple of pattern graphs.
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The population of an observable is a measure of the number of embeddings of the pattern
graphs within the system. The type of the observable, “Molecule” or “Species”, determines
the method of computing the population (see Faeder et al. [60]). For an ensemble of com-
plexes X, the population of an observable is
ρ(O|X) =

∑V
v=1 |emb(Pv, X)| : type = “Molecules”
∑
x∈X H
(∑V
v=1 |emb(Pv, x)|
)
: type = “Species”
,
where H(z) = 1 if z ≥ 1 and 0 otherwise. Similarly, for a species ensemble S,
ρ(O|S) =

∑
s∈S ρ(s)
∑V
v=1 |emb(Pv, s)| : type = “Molecules”
∑
s∈S ρ(s)H
(∑V
v=1 |emb(Pv, s)|
)
: type = “Species”
.
A BNGL model completely specifies a dynamic system, including the initial system
configuration, the reaction rules that govern the dynamics, and a set of observables that
define the outputs of the system.
Definition 24 (Model). A BNGL model is defined by the tuple
M |= (seed species, observables, reaction rules) ,
where seed species is a subset of S† that specifies the initial state of the model system,
observables is a set of observables, and reaction rules is a set of reaction rules that
govern the dynamics of the system.
In practice, a BNGL model may also include parameters, molecule types (component-level
type graphs), and function definitions [60], but we will omit these here for simplicity. Note
that while seed species are always specified by a species ensemble in a model, the represen-
tation within a simulator may be as an ensemble of complexes (particle representation), a
species ensemble (population representation), or a hybrid ensemble (see below).
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APPENDIX C
RECEPTOR ACTIVATION MODEL
The complete receptor activation model, used as an illustration of energy modeling (Chap-
ter 2), is listed here. The model file is also included in the Models2 subfolder of BioNetGen
distribution 2.2.4.
# Receptor activation model for energy BNGL
begin model
# requires BioNetGen version >= 2.2.4
version ("2.2.4")
# Quantities have units in moles , so set this to Avogadro ’s Number
setOption (" NumberPerQuantityUnit " ,6.0221 e23)
begin parameters
# fundamental constants
RT 2.577 # kJ/mol
NA 6.022 e23 # /mol
PI 3.142 # Pi , no units
# Geometry parameters
rad_cell 1e-4 # radius of cell , dm
cell_dens 1e9 # density of cells , /L
width_PM 1e-7 # effectice width of membrane , dm
# Compartment volumes
volEC 1/ cell_dens # vol. extracellular space , L
volPM 4*PI*rad_cell ^2* width_PM # virtual vol. of plasma membrane , L
volCP 4/3*PI*rad_cell ^3 # vol. of cytoplasm , L
# initial concentrations
conc_L_0 20e-9 # mol/L
count_R_0 24000 # molecules/cell
conc_Ph_0 10e-9 # mol/L
conc_ATP_0 1.0e-3 # mol/L
conc_ADP_0 0.1e-3 # mol/L
# standard free energy of formation , kJ/mol
G_LR -47.5
G_RR -11.9
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G_RPh -41.5
G_RyP 51.1
G_ATP 51.1
G_RyP_Ph 5.9
G_LRR -5.9
G_LRRL -11.9
# baseline activation energy , kJ/mol
E0_LR -11.9
E0_RR -5.9
E0_RPh -17.8
E0_catRR -11.9
E0_catPh 5.9
# rate distribution parameter , no units
phi 0.5
end parameters
begin compartments
EC 3 volEC # extracellular space
PM 2 volPM EC # plasma membrane
CP 3 volCP PM # cytoplasm
end compartments
begin molecule types
L(r) # ligand
R(l,d,y∼0∼P) # trans -membrane receptor
Ph(y) # phosphotase
ATP() # ATP
ADP() # ADP
end molecule types
begin seed species
L@EC(r) conc_L_0*NA*volEC
R@PM(l,d,y∼0) count_R_0
Ph@CP(y) conc_Ph_0*NA*volCP
$ATP@CP () conc_ATP_0*NA*volCP # ATP quantity held constant
$ADP@CP () conc_ADP_0*NA*volCP # ADP quantity held constant
end seed species
begin observables
Molecules Lfree L(r)
Molecules Ltotal L()
Molecules Rbound L(r!1).R(l!1)
Molecules Rdimer R(d!1).R(d!1)
Molecules RyP R(y∼P!?)
Molecules Rtotal R()
Molecules RyP_Ph R(y!1).Ph(y!1)
Molecules PhTotal Ph()
end observables
begin energy patterns
# bond energy
L(r!1).R(l!1) G_LR/RT
R(d!1).R(d!1) G_RR/RT
R(y!1).Ph(y!1) G_RPh/RT
# state energy
R(y∼P!?) G_RyP/RT
# molecule energy
ATP() G_ATP/RT
# cooperativity
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R(y∼P!1).Ph(y!1) G_RyP_Ph/RT
L(r!1).R(l!1,d!2).R(d!2) G_LRR/RT
L(r!1).R(l!1,d!2).R(l!3,d!2).L(r!3) G_LRRL/RT
end energy patterns
begin reaction rules
# ligand binding
L(r) + R(l) <-> L(r!1).R(l!1) Arrhenius(phi ,E0_LR/RT)
# receptor dimerization
R(d) + R(d) <-> R(d!1).R(d!1) Arrhenius(phi ,E0_RR/RT)
# Ph binding
R(y) + Ph(y) <-> R(y!1).Ph(y!1) Arrhenius(phi ,E0_RPh/RT)
# trans -phosphorylation
R(d!1).R(d!1,y∼0) + ATP \
<-> R(d!1).R(d!1,y∼P) + ADP Arrhenius(phi ,E0_catRR/RT)
# dephosphorylation by phosphtase
R(y∼P!1).Ph(y!1) \
<-> R(y∼0!1).Ph(y!1) Arrhenius(phi ,E0_catPh/RT)
end reaction rules
end model
# generate reaction network ..
generate_network ({ overwrite =>1})
# simulate ODE system to steady state ..
simulate ({ method=>"ode",t_end=>12, n_steps =>120,atol=>1e-3,rtol=>1e-7})
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APPENDIX D
THE MONETARY COST OF SIMULATION MEMORY
We assume that each simulation is run on one virtual core (with possibly more than one
simulation running per core) and there is no memory sharing among simulations. Let I be
an Amazon EC2 instance type, mI the total instance memory, vI the number of virtual cores
in the instance, uvI the number of compute units per virtual core, CI the cost of the instance
per unit time, and N the number of simultaneous simulations running on an instance. For
each configuration pair (I, N), with N ∈{1, 2, . . .}, we will compute the cost (per unit time)
per “effective” compute unit (ECU). We will then obtain the minimum cost by finding that
(those) configuration(s) (multiple instances may have the same cost) with the lowest cost
under the constraint that the instance(s) has (have) sufficient memory to run N simulations.
Under our assumption that a simulation is run on one virtual core, the average number of
compute units available per simulation is the minimum of the number of compute units per
core and the total number of compute units divided by the number of running simulations,
us(I, N) = uvI ·min {1, vI/N} .
The number of ECUs is the number of running simulations multiplied by the average number
of compute units per simulation,
(I, N) = N · us(I, N) = uvI ·min {N, vI} .
Note that the number of ECUs is equal to the total number of compute units if N ≥ vI
and less if N <vI . The intuition here is that if the memory required per simulation limits
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the number of simulations that can be run simultaneously on an instance to fewer than the
number of virtual cores, then we must treat the instance as if it had fewer virtual cores since
some cannot be utilized.
The cost (per unit time) per ECU for a given configuration is then the cost of the instance
divided by the number of ECUs,
C(I, N) = CI
(I, N) =
CI
uvI ·min {N, vI}
.
For a given configuration, the memory available per simulation is
m(I, N) = mI/N.
Assuming that each simulation run requires ms units of memory, the minimum cost per
ECU is obtained by finding the lowest configuration cost under the constraint that the
configuration has sufficient memory available,
Cmin(ms) = min
all (I,N)
{C(I, N) : ms ≤ m(I, N)} .
We need only consider N ≤ vI when searching for the minimum cost because (I, N) is
constant (= uvIvI) for N ≥ vI . Cmin(ms) has been calculated considering all Amazon EC2
Standard , High-CPU , and High-Memory instance types [141] and plotted in Fig. 8 of the
main text. The configuration(s) associated with the minimum cost is (are) simply the set
χ(ms) = {(I, N) : C(I, N) = Cmin(ms) ∧ ms ≤ m(I, N)} .
Example: The Amazon EC2 High-Memory Double Extra Large instance has four virtual
cores with 3.25 compute units each, 34.2 GB of total memory, and a cost of $1.00/hr (January
2012 on-demand pricing, Linux operating system) [141]:
vI = 4,
uvI = 3.25,
mI = 34.2,
CI = 1.00.
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The number of compute units available per simulation is
us(I, N) = 3.25 ·min {1, 4/N} ,
and the number of ECUs is
(I, N) = 3.25 ·min {N, 4} .
This gives a cost per ECU of
C(I, N) = 1.00
3.25 ·min {N, 4} ,
with memory availability per simulation of
m(I, N) = 34.2/N.
For this instance type, we show in Fig. D1 the minimum effective cost, CImin(ms), versus
memory per simulation, ms. Up to ms = 8.6 GB it is possible to run four simultaneous
simulations at a cost of ∼$0.08/ECU-hr. We can run three simulations at ∼$0.10/ECU-
hr for 8.6 < ms ≤ 11.4 GB, two simulations at ∼$0.15/ECU-hr for 11.4 < ms ≤ 17.1 GB,
and one simulation at ∼$0.31/ECU-hr for 17.1<ms ≤ 34.2 GB. Above ms = 34.2 GB we
obviously cannot run any simulations because the memory requirement exceeds the total
memory available in the instance.
206
Figure D1: Minimum cost of effective compute unit vs. memory required. Results
are shown for the Amazon EC2 High-Memory Double Extra Large. Effective compute units
is the product of compute units per core and available CPU cores, less any idle cores due to
insufficient memory.
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APPENDIX E
FORMAL BASIS FOR HPP METHOD
E.1 FORMAL BASIS FOR THE PARTIAL NETWORK EXPANSION
(PNE) ALGORITHM
E.1.1 Hybrid ensembles
HPP simulation requires the notion of a hybrid ensemble. A hybrid ensemble is a parti-
cle/population representation of a system, since part of the system is represented as individ-
ual particles and the remainder as lumped populations.
Definition 25 (Hybrid Ensemble). A hybrid ensemble is the pair (X,S), where X is an
ensemble of complexes and S is a species ensemble.
For convenience, if (X,S) is a hybrid ensemble and x ∈ X, then we define ρ(x) = 1. The
action of a rule on a hybrid ensemble is defined by combining Defs. 19 and 20.
Definition 26 (Action of a Rule on a Hybrid Ensemble). Given a hybrid ensemble (X,S),
a rule r, and a rule instance (φv) ∈
∏
v emb(Rv, X ∪ S)/ RC(r), the action of r on (X,S)
through (φv) is
X 7→
(
X \ targ((φv))
)
∪
(
r[(φv)] \ S
)
,
S 7→
{
(s,N ′s) | s ∈ S,
N ′s = Ns −
∣∣{v ∈ {1 . . . Vr} : targ(φv) = s}∣∣+ ∣∣{w ∈ {1 . . .Wr} : pw = s}∣∣}
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where (pw) are the products of the action r[(φv)].
The set of all rule instances for a hybrid ensemble (X,S) is defined analogously to that for
an ensemble of complexes,
rinst
(
r,X ∪ S) = V∏
v=1
emb(Rv, X ∪ S)/ RC(r).
The propensity of a rule instance for a hybrid ensemble is the same as defined in Def. 22.
Finally, the population of an observable for a hybrid ensemble (X,S) is just the sum of the
observable counts for the complexes and the species, i.e.,
ρ(O|X,S) =

∑V
v=1 |emb(Pv, X)|+
∑
s∈S ρ(s)
∑V
v=1 |emb(Pv, s)|
: type = “Molecules”
∑
x∈X H
(∑V
v=1 |emb(Pv, x)|
)
+
∑
s∈S ρ(s)H
(∑V
v=1 |emb(Pv, s)|
)
: type = “Species”
.
E.1.2 Child rules and rule restriction
A reaction rule r′ is said to be a child of reaction rule r if the rule instances of r′ are
a subset of those of r and the action of r′ is equivalent to r on that subset. In formal
terms, there must be a rule instance (φv) ∈
∏
v emb(Rv, R
′
v) and a tuple of embeddings
(φw) ∈
∏
w emb(Pw, P
′
w). Furthermore, it must follow that the component correspondence
maps commute, i.e. φ′ ◦ ψ(x) = ψ′ ◦ φ(x) for all x ∈ dom(ψ), where φ and φ′ are the unions
of the respective embeddings. A child rule can be constructed from the pairing of a rule r
with a rule instance (φv). The child rule has reactant patterns given by the targets of (φv)
and product patterns constructed by the action of the rule on the instance.
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Definition 27 (Restriction of a Rule by a Rule Instance). The child rule induced by the
restriction of rule r by a rule instance (φv) is defined to be
r|(φv) =
(
targ((φv)) , r[(φv)], ψ
′, kr
)
,
where r[(φv)] are the products of the action of r on (φv) and ψ
′ is obtained from a single
pushout of φ and ψ (see Refs. [66, 201]). In general, the targets may be species or pattern
graphs.
Given a parent rule p, child rules r and r′ are equivalent if the reactant patterns are
isomorphic, the product patterns are isomorphic, and the component correspondence maps
commute with the isomorphisms.
Definition 28 (Child Rule Equivalence). Child rules r and r′ are equivalent, written r ∼= r′,
if the reactant patterns are isomorphic via mappings (φv), the product patterns are isomorphic
via mappings (φ′w), and the following hold:
• φ(dom(ψ)) = dom(ψ′) ,
• ∀z ∈ dom(ψ) : ψ′ ◦ φ(z) = φ′ ◦ ψ(z),
where φ and φ′ are the unions of the embedding maps.
The class of all child rules equivalent to r is denoted by [r]. The equivalence relation partitions
the set of child rules into classes. If R is a set of child rules, then the set of all equivalence
classes in R is denoted R/∼=. Child rules in the same class can be treated as a single entity
with a multiplicity factor that ensures that the propensity of the class is equal to the sum
of the individual propensities. A proof is beyond the scope of this document.
E.1.3 Population-mapping rules
A species is “unstructured” if it is represented by a complex consisting of a single molecule
that contains no components. Given a set of structured species S and a set of unstructured
species U , where the types in U do not overlap with those in S, an “unstructured representa-
tion” of the species in S is a one-to-one mapping λ : S → U . In the population-adapted NF
simulator, complexes belonging to an unstructured species can be treated as a population
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(a species ensemble) rather than as individual particles (an ensemble of complexes). Thus,
structured species can be treated as populations if an unstructured representation is pro-
vided and the reaction rules are partially expanded so that the dynamics of the unstructured
species are equivalent to those of the structured counterpart. This process is accomplished
by the PNE algorithm.
Prior to performing PNE, the modeler defines a set of population-mapping rules . Each
mapping in an unstructured representation implies a population-mapping rule, and con-
versely a set of population-mapping rules implies an unstructured representation. Formally,
a population-mapping rule is a reaction rule that matches complexes belonging to a single
species and transforms them into the unstructured representation.
Definition 29 (Population-mapping rule). Given an unstructured representation λ : S → U ,
a population-mapping rule for species s ∈ S is a reaction rule
ls |=
(
(s), (λ(s)), ∅, klump
)
,
where klump ≥ 0 is the “lumping rate constant.”
E.1.4 The PNE algorithm
Network expansion is the process of enumerating all of the specific reactions (at the res-
olution of species) implied by a set of reaction rules. The rule set produced by the PNE
algorithm is a partial network expansion in the sense that the reactions are enumerated only
with respect to the population species. Interactions among particles and between particles
and population species are encoded by a set of child rules derived from the original rule set.
Thus, there are three types of reaction rules among the set of children: (i) rules that govern
the interaction of particles; (ii) mixed particle-population rules that govern the interaction
of particles and population species; (iii) population reactions that govern the interactions
among population species. Rules of type (i) are just duplicates of the original reaction rules.
Rules of type (iii) are proper reactions since each reactant pattern matches exactly one
species. Rules of type (ii) and (iii) together encapsulate every possible interaction among
the population species and between population species and reactant motifs within particles.
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In this sense, PNE is a hybrid of network-based and network-free methods: particles inter-
act within an NF framework, populations interact within a network-based framework, and
particle-population interactions are handled in a hybrid manner. Pseudocode for the PNE
algorithm is presented as Algorithm 4. The method takes as input a BNGL model and a
set of population-mapping rules and returns a model with a partially expanded rule set (an
HPP model) that is dynamically equivalent to the original model for sufficiently large klump
(or for any klump if the “exact” option is selected; see Algorithm 4).
When the HPP model is loaded into the population-adapted NF simulator, all of the
unstructured species in U are represented as a species ensemble (i.e., as populations). The
structured species, however, are represented as an ensemble of complexes X (i.e., as parti-
cles). Therefore, the system representation is a hybrid ensemble (X,U †). The propensities
for rule instances are computed according to Def. 22. However, rule instances in which two or
more reactant patterns have the same target are given the same propensity as other instances
and then rejected in a post-sampling step. Furthermore, at simulation runtime, population-
mapping rules serve the practical purpose of matching unlumped particles belonging to a
population species, deleting the particle, and incrementing the population counter of the
corresponding unstructured representation. Runtime lumping is required since the PNE
algorithm is not guaranteed to identify every possible way that particle-particle or particle-
population events can yield a product belonging to the set of population species (e.g., through
complex dissociation). However, PNE does enumerate every way that a population species
can participate in a reaction as a reactant.
E.2 EQUIVALENCE OF THE PNE RULE SET AND THE ORIGINAL
RULE SET
We claim that PNE yields a system that is equivalent to the original model system in the
sense that for any ensemble of complexes the rule set generated by PNE encompasses the
same set of rule instances. We will outline a proof for the basic case where symmetry can
be ignored.
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Algorithm 4: Partial Network Expansion
input : model, a BNGL model (Def. 24); klump, a lumping rate constant
λ : S → U , unstructured representation of the species in S (Sec. E.1)
output: hpp model, the output model
// Transform seed species in S into the unstructured representation
foreach (s′, ns′) ∈ model.seed species do
if s′ ∈ S then
add (λ(s′), ns′) to hpp model.seed species
else
add (s′, ns′) to hpp model.seed species
foreach s ∈ S do
if @(s′, ns′) ∈ hpp model.seed species such that s′ ∼= s then
add (λ(s), 0) to hpp model.seed species
// Reformulate observables (Def. 23) in terms of unstructured representation
foreach (name, type, (Pv)) ∈ model.observables do
(P ′v) = (Pv) if type = “Molecules” then
foreach pair s ∈ S, Pv ∈ (Pv) do
add |emb(Pv, s)| copies of λ(s) to (P ′v)
else
foreach s ∈ S do
if ∪vemb(Pv, s) 6= ∅ then
add λ(s) to (P ′v)
add (name, type, (P ′v)) to hpp model.observables
// Expand reaction rules (Def. 13) around the species in S
foreach r :=
(
(Rv), (Pw), ψ, k
) ∈ model.reaction rules do
// 1: Gather reactant pattern embeddings foreach Rv ∈ (Rv) do
if @s ∈ S such that s ∼= Rv OR if “exact” method is desired then
add idRv,Rv to embeddings[v] // i.e., add the identity map of the reactant pattern
add emb(Rv, S)/ RC(r) to embeddings[v] // Def. 16
// 2: Construct a child rule for each rule instance in the Cartesian product of embeddings
foreach rule instance (φv) ∈
∏V
v=1 embeddings[v] do // Def. 17(
(R′v), (P
′
w), ψ
′, k
)
:= r | (φv) // Def. 27
// 3: Replace instances of structured population species with unstructured counterparts
foreach R′v ∈ (R′v) do
if ∃s ∈ S such that s = R′v then // equality is required!
substitute λ(s) for R′v
foreach P ′w ∈ (P ′w) do
if ∃s ∈ S such that s ∼= P ′w then // isomorphism is sufficient here
substitute λ(s) for P ′w
add
(
(R′v), (P
′
w), ψ
′, k
)
to child rules
// Compute equivalence classes of child rules (Def. 28) and add to hpp model
add (child rules/∼=) to hpp model.reaction rules
// Add population-mapping rules (Def. 29)
foreach s ∈ S do
add
(
(s), (λ(s)), ∅, klump
)
to hpp model.reaction rules
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Let X be an ensemble of complexes and r a rule with reactant patterns R1, R2, . . . , RN .
Furthermore, let s be a set of “structured” species, u be a set of “unstructured” species,
and m : s → u be a one-to-one correspondence of structured species in s and unstructured
species in u. Each unstructured species in u is complex consisting of a single molecule, whose
type is not in the original model, that has no components.
Suppose Xpo ⊆ {x ∈ X : ∃s ∈ s such that x ∼= s} ⊆ X, and let Xpa = X \ Xpo. let
H = (Xpo, Ss(Xpa) be the representation of X as a hybrid ensemble. In words, Xpo is a
subset of the complexes in X that will be represented by an ensemble of species, and Xpa is
the subset of complexes represented as an ensemble of complexes. Take note that we have
not assumed that all complexes belonging to species in s are in Xpo.
We begin by partitioning the set of rule instances of r in X into the various classes
of particle-particle interactions, particle-population interactions, and population-population
interactions. To be precise, let (Yn)
N
n=1 ∈
∏N
n=1{Xpa, Xpo} and define the subset of rule
instances where embedding n targets a complex in Yn
rinst(r; (Yn)) =
{(
(φn), kr∆
(
(φn)
))
: ∀n (φn ∈ emb(Rn, Yn))
}
.
Observe that the subsets rinst
(
r; (Yn)
)
partition the set of rule instances since:⋃
(Yn)∈
∏N
n=1{Xpa,Xpo}
rinst
(
r; (Yn)
)
= rinst
(
r,X
)
and
(Yn) 6= (Zn) =⇒ rinst
(
r; (Yn)
) ∩ rinst(r; (Zn)) = ∅.
Since the general notation is tedious, let us illustrate with a bimolecular reaction rule
(which is also the first interesting case):
rinst
(
r,X
)
= rinst
(
r; (Xpa, Xpa)
) ∪ rinst(r; (Xpa, Xpo))
∪ rinst(r; (Xpo, Xpa)) ∪ rinst(r; (Xpo, Xpo))
=
{(
φ1, φ2, k∆
(
(φ1, φ2)
))
: φ1 ∈ emb(R1, Xpa) , φ2 ∈ emb(R2, Xpa)
}⋃
{(
φ1, φ2, k∆
(
(φ1, φ2)
))
: φ1 ∈ emb(R1, Xpo) , φ2 ∈ emb(R2, Xpa)
}⋃
{(
φ1, φ2, k∆
(
(φ1, φ2)
))
: φ1 ∈ emb(R1, Xpa) , φ2 ∈ emb(R2, Xpo)
}⋃
{(
φ1, φ2, k∆
(
(φ1, φ2)
))
: φ1 ∈ emb(R1, Xpo) , φ2 ∈ emb(R2, Xpo)
}
.
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Notice that the the first term corresponds to rule instances among particles in Xpa, the second
and third terms correspond to mixed interactions among particles in Xpa and populations
of Xpo, and the the fourth term corresponds to interactions among populations in Xpo.
Next, let us group rule instances by the species of the target complexes in Xpo:
rinst
(
r,X
)
= . . . ={(
φ1, φ2, k∆
(
(φ1, φ2)
)) |φ1 ∈ emb(R1, Xpa) , φ2 ∈ emb(R2, Xpa)}⋃⋃
s∈s
{(φ1, φ2, k∆((φ1, φ2))) |φ1 ∈ emb(R1, [s|Xpo]) , φ2 ∈ emb(R2, Xpa)}⋃⋃
s∈s
{(φ1, φ2, k∆((φ1, φ2))) |φ1 ∈ emb(R1, Xpa) , φ2 ∈ emb(R2, [s|Xpo])}⋃⋃
s1∈s
⋃
s2∈s
{(φ1, φ2, k∆((φ1, φ2))) |φ1 ∈ emb(R1, [s1|Xpo]) , φ2 ∈ emb(R2, [s2|Xpo])},
recalling that emb(Rn, [s|Xpo]) is the set of embeddings from Rn into any complex x ∈ Xpo
such that x ∼= s.
And now we further partition the rule instances by the specific embeddings:
rinst
(
r,X
)
= . . . =
{(φ1, φ2, kδ) : φ1 ∈ emb(R1, Xpa) , φ2 ∈ emb(R2, Xpa)}
⋃
⋃
s∈s
⋃
φ1∈emb(R1,s)
⋃
x1∈Xpo
{(ids,x1 ◦ φ1, φ2, kδ) : φ2 ∈ emb(R2, Xpa)}
⋃
⋃
s∈s
⋃
φ2∈emb(R2,s)
⋃
x2∈Xpo
{(φ1, ids,x2 ◦ φ2, kδ) : φ1 ∈ emb(R1, Xpa)}
⋃
⋃
s1∈s
⋃
φ1∈emb(R1,s1)
⋃
x1∈Xpo
⋃
s2∈s
⋃
φ2∈emb(R1,s1)
⋃
x2∈Xpo
{(ids1,x1 ◦ φ1, ids2,x2 ◦ φ2, kδ)} ,
where ids,x is the map from the complex representing species s into complex x (which belongs
to s) induced by an isomorphism of s and x.
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Next, we can reformulate our rule instances in terms hybrid rule instances of r in the
hybrid ensemble representation, H = (Xpa, S(Xpo)):
rinst
(
r,X
)
= . . . ≡{(
φ1, φ2, kη
(
φ1, φ2
))
: φ1 ∈ emb(R1, Xpa) , φ2 ∈ emb(R2, Xpa)
}⋃
⋃
s∈S(Xpo)
⋃
φ1∈emb(R1,s)
{(φ1, φ2, kη(φ1, φ2)) : φ2 ∈ emb(R2, Xpa)}⋃
⋃
s∈S(Xpo)
⋃
φ2∈emb(R2,s)
{(φ1, φ2, kη(φ1, φ2)) : φ1 ∈ emb(R1, Xpa)}⋃
⋃
s1∈S(Xpo)
⋃
φ1∈emb(R1,s1)
⋃
s2∈S(Xpo)
⋃
φ2∈emb(R2,s2)
{(φ1, φ2, kη(φ1, φ2))}.
Recall that if s is a species, then emb(R2, s) is the set of embeddings into a representative
complex for species s, and not the set of embeddings into all complexes belonging to species
s. The population of complexes belonging to species s is factored into the η function.
The reader may have noticed that we have a set of hybrid rule instances, but we have
not specified the corresponding hybrid rules. Now we equate each of the above hybrid rule
instance with the equivalent hybrid rule that generates those instances.
rinst
(
r,X
)
= . . . ≡
rinst
(
r|(idR1 , idR2), H
)⋃
⋃
s∈s
⋃
φ1∈emb(R1,s)
rinst
(
r|(φ1, idR2), H
)⋃
⋃
s∈s
⋃
φ2∈emb(R2,s)
rinst
(
r|(idR1 , φ2), H
)⋃
⋃
s1∈s
⋃
φ1∈emb(R1,s1)
⋃
s2∈s
⋃
φ2∈emb(R2,s2)
rinst
(
r|(φ1, φ2), H
)
.
Regrouping terms, we find the the hybrid rules are generated from the restriction of rule r
by bundles in the cartesian product of two embedding sets
rinst
(
r,X
)
= . . . ≡
rinst(r|(φ1, φ2), H) :
φ1 ∈ {idR1}
⋃
s1∈s
emb(R1, s1) , φ2 ∈ {idR2}
⋃
s2∈s
emb(R2, s2)
}
.
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The embedding sets are precisely those used in the first step of PNE: the identity embedding
of the reactant pattern in itself along with every embedding of the reactant pattern in the
structured population species.
Therefore, the PNE rule set given by hybrid rules{
r|(φ1, φ2) : φ1 ∈ {idR1}
⋃
s1∈s
emb(R1, s1) , φ2 ∈ {idR2}
⋃
s2∈s
emb(R2, s2)
}
,
operating on the hybrid ensemble H, is equivalent to the orignal rule r operating on the
ensemble of complexes X.
The final step of PNE is substituting instances of structured population species in reac-
tion rules with the corresponding unstructured species. Since the map between structured
and unstructured representations is one-to-one and onto, there is no loss of fidelity due to
sustitution of one for the other.
E.2.1 The lumping rate constant and exactness of PNE
The above proof does not assume that all complexes with species in s belong to Xpo. Conse-
quently, the HPP simulation is equivalent to the network-free simulation even if the lumping
rate is finite. However, equivalence does depend upon inclusion of all particle-particle and
particle-population rules. As noted in the main text, PNE excludes such rules from the
final set if the reactant pattern is isomorphic to a population species. This is done for prag-
matic reasons, since those rules add extra overhead to the simulation. If the lumping rate
is sufficiently large, lumpable particles are rapidly converted to the population form and the
results are sufficiently accurate to appear statistically identical. This being the case, we felt
the overhead of extra rules was a greater burden than a slight loss in accuracy. If loss in
accuracy is a concern, the lumping rate may be set to an infinite value, i.e. instantaneous
lumping.
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APPENDIX F
GENERATING AND SIMULATING HPP MODELS WITH BNG/NFSIM
From a BioNetGen user’s perspective, once a set of species has been selected for lumping,
converting a standard BNGL model into an HPP model requires only two additional steps.
First, the population-mapping rules (see “Population species and population-mapping rules”
in the main text) must be specified within a population maps block of the BNGL model
file. Note that this is the only place where the population species should be specified, they
should not be included in the molecule types or seed species blocks (Sec. 1.4.8). The
lumping rate constant should be set to a large value (NFsim does not currently support
infinite rates) and can be specified either as a number or as a reference to a parameter in
the parameters block.
Next, the generate hybrid model() action must be invoked after the model specifica-
tion. Arguments are passed to generate hybrid model() in a comma-separated list enclosed
by curly braces and each argument/value pair has the form argument=>value. Allowed ar-
guments are:
• overwrite=>0/1: Disable/enable automatic overwriting of any existing hybrid model
(default: 0).
• execute=>0/1: Disable/enable execution of actions after generation of hybrid model
(default: 0).
• verbose=>0/1: Disable/enable verbose output during hybrid model generation (default:
0).
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• suffix=>"string": Set the HPP model suffix to value of “string” (default: “hpp”).
• actions=>["action1","action2",. . .]: Define a list of actions (as strings) to be in-
cluded at the end of the HPP model file.
• exact=>0/1: Disable/enable exact mode (default: 0); BioNetGen 2.2.3 or later.
A call to generate hybrid model() instructs BioNetGen to generate and write the HPP
model to the file [model] [suffix].bngl, where [model] is the original BNGL filename and
[suffix] is “hpp” by default and can be changed by the user using the suffix argument.
In generating the HPP model, BioNetGen automatically appends all of the population
species defined in the population maps block to the original molecule types block, each
followed by a population keyword to distinguish it as a population type. The seed species
block is modified by replacing any structured species selected for lumping with their pop-
ulation species counterparts. The model observables are also modified to account for the
introduction of the population species, which is straightforward. Observables are collections
of one or more patterns [60, 61]. Therefore, each structured species selected for lumping is
matched against each pattern in each observable and if a match is found then the associated
population species is added to the observable list. Finally, PNE is performed to obtain the
expanded rule set, to which the population-mapping rules are appended in the reaction
rules block. A before-and-after illustration of this process can be seen by comparing the
original (Text S2) and partially-expanded (Text S3) versions of the simple receptor activation
model considered in “Partial network expansion” and Figs. 2 and 3 of the main text.
If execute=>1 is passed to generate hybrid model(), BioNetGen will additionally per-
form any actions on the HPP model that are listed in the actions argument. For ex-
ample, a NFsim simulation can be run through BioNetGen by calling the simulate nf()
action [61,62], e.g.,
generate_hybrid_model({execute=>1, \
actions=>["simulate_nf({t_end=>10,n_steps=>100})"]}).
Alternatively, a XML encoding of the HPP model can be obtained by invoking the
writeXML() action:
generate hybrid model({execute=>1,actions=>["writeXML()"]}).
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This allows NFsim simulations to be run in standalone mode (see Refs. [53, 73]). Note that
NFsim version 1.11 or later is required to run HPP simulations.
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APPENDIX G
HPP ILLUSTRATIVE EXAMPLE, COMPLETE BNGL SOURCE
G.1 ORIGINAL MODEL
## recAct_example.bngl
##
## Simple model for illustration of HP/P method.
##
## This model is a simplified variant of the EGF receptor
## activation model published in:
## ML Blinov , JR Faeder , B Goldstein , WS Hlavacek.
## "A network model of early events in epidermal growth factor
## receptor signaling that accounts for combinatorial complexity ."
## BioSystems 83, 136 -151 (2006).
begin model
begin parameters
# fraction of cell , no units
f 0.10
# Avogadro ’s number , /mol
NA 6.0221 e23
# Volume , liters
V 1e-12*f
# initial species counts
L0 500e-9*NA*V
R0 100e-9*NA*V
A0 100e-9*NA*V
B0 100e-9*NA*V
C0 100e-9*NA*V
BC0 100e-9*NA*V
# rate constants , units /s
kp1 10e6/(NA*V)
km1 1.0
k2 1.0
k3 1.0
kp4 10e6/(NA*V)
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km4 1.0
kp5 10e6/(NA*V)
km5 1.0
kp6 10e6/(NA*V)
km6 1.0
k7 1.0
k8 1.0
kp9 10e6/(NA*V)
km9 1.0
# population lumping parameter
klump 10000
end parameters
begin molecule types
L(r) # ligand molecule
R(l,a∼0∼P,b∼0∼P) # transmembrane receptor
A(r,b∼0∼P) # cytosolic mediator A
B(r,c) # cytosolic mediator B
C(b) # cytosolic mediator C
end molecule types
begin seed species
L(r) L0
R(l,a∼0,b∼0) R0
A(r,b∼0) A0
B(r,c) B0
C(b) C0
B(r,c!1).C(b!1) BC0
end seed species
begin observables
Molecules LR L(r!1).R(l!1)
Molecules Rp R(a∼P!?) R(b∼P!?)
Molecules Ap A(b∼P!?)
Molecules RC R(b∼P!1).B(r!1,c!2).C(b!2),\
R(a∼P!1).A(r!1,b∼P!2).B(r!2,c!3).C(b!3)
# total counts (conserved)
Molecules Ltot L()
Molecules Rtot R()
Molecules Atot A()
Molecules Btot B()
Molecules Ctot C()
end observables
begin reaction rules
# ligand receptor binding
L(r) + R(l) <-> L(r!1).R(l!1) kp1 , km1
# ligand induced receptor phosphorylation
L(r!1).R(l!1,a∼0) -> L(r!1).R(l!1,a∼P) k2
L(r!1).R(l!1,b∼0) -> L(r!1).R(l!1,b∼P) k2
# receptor dephosphorylation
R(a∼P) -> R(a∼0) k3
R(b∼P) -> R(b∼0) k3
# phosphorylated receptor binding A
R(a∼P) + A(r) <-> R(a∼P!1).A(r!1) kp4 , km4
# phosphorylated receptor binding B
R(b∼P) + B(r) <-> R(b∼P!1).B(r!1) kp5 , km5
# B binding C
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B(c) + C(b) <-> B(c!1).C(b!1) kp6 , km6
# bound A phosphorylation
R(a∼P!1).A(r!1,b∼0) -> R(a∼P!1).A(r!1,b∼P) k7
# A dephosphorylation
A(b∼P) -> A(b∼0) k8
# phosphorylated A binding B
A(b∼P) + B(r) <-> A(b∼P!1).B(r!1) kp9 , km9
end reaction rules
begin population maps
L(r) -> P1() klump
A(r,b∼0) -> P2() klump
A(r,b∼P) -> P3() klump
A(r,b∼P!1).B(r!1,c) -> P4() klump
A(r,b∼P!1).B(r!1,c!2).C(b!2) -> P5() klump
B(r,c) -> P6() klump
B(r,c!1).C(b!1) -> P7() klump
C(b) -> P8() klump
end population maps
end model
## model actions ##
saveConcentrations ()
# simulate NF
setParameter ("f" ,0.01)
resetConcentrations ()
simulate_nf ({ suffix=>"nf",t_end=>40, n_steps =>120,gml = >1000000 , verbose =>1})
# generate hybrid particle/population model and simulate
setParameter ("f" ,0.01)
resetConcentrations ()
generate_hybrid_model ({ overwrite=>1,verbose=>1,execute=>1,\
actions =>[" simulate_nf ({ t_end=>40,n_steps =>120,\
gml = >1000000 , verbose = >1})"]})
# generate reaction network and simulate SSA
generate_network ({ overwrite =>1})
setParameter ("f" ,0.01)
resetConcentrations ()
simulate_ssa ({ suffix=>"ssa",t_end=>40, n_steps = >120})
G.2 HPP MODEL
# recAct_example_hpp.bngl
#
# Created by BioNetGen 2.2.3
substanceUnits (" Number ")
begin model
begin parameters
f 0.01
NA 6.0221 e23
V 1e-12*f
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L0 (500e-9*NA)*V
R0 (100e-9*NA)*V
A0 (100e-9*NA)*V
B0 (100e-9*NA)*V
C0 (100e-9*NA)*V
BC0 (100e-9*NA)*V
kp1 10e6/(NA*V)
km1 1.0
k2 1.0
k3 1.0
kp4 10e6/(NA*V)
km4 1.0
kp5 10e6/(NA*V)
km5 1.0
kp6 10e6/(NA*V)
km6 1.0
k7 1.0
k8 1.0
kp9 10e6/(NA*V)
km9 1.0
klump 10000
end parameters
begin molecule types
A(r,b∼0∼P)
P5() population
P7() population
P2() population
P1() population
B(r,c)
P6() population
C(b)
P3() population
R(l,a∼0∼P,b∼0∼P)
P8() population
P4() population
L(r)
end molecule types
begin observables
Molecules LR L(r!1).R(l!1)
Molecules Rp R(a∼P!?), R(b∼P!?)
Molecules Ap A(b∼P!?), P3(), P4(), P5()
Molecules RC R(b∼P!1).B(r!1,c!2).C(b!2), \
R(a∼P!1).A(r!1,b∼P!2).B(r!2,c!3).C(b!3)
Molecules Ltot L() P1()
Molecules Rtot R()
Molecules Atot A() P2() P3() P4() P5()
Molecules Btot B() P4() P5() P6() P7()
Molecules Ctot C() P5() P7() P8()
end observables
begin species
P1() L0
R(a∼0,b∼0,l) R0
P2() A0
P6() B0
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P8() C0
P7() BC0
P3() 0
P4() 0
P5() 0
end species
begin reaction rules
Rule1_v1: P1() + R(l) -> L(r!1).R(l!1) kp1
Rule1r_v1: L(r!1).R(l!1) -> P1() + R(l) km1 DeleteMolecules
Rule2_v1: L(r!1).R(a∼0,l!1) -> L(r!1).R(a∼P,l!1) k2
Rule3_v1: L(r!1).R(b∼0,l!1) -> L(r!1).R(b∼P,l!1) k2
Rule4_v1: R(a∼P) -> R(a∼0) k3
Rule5_v1: R(b∼P) -> R(b∼0) k3
Rule6_v1: R(a∼P) + A(r) -> A(r!1).R(a∼P!1) kp4
Rule6_v2: R(a∼P) + P2() -> A(b∼0,r!1).R(a∼P!1) kp4
Rule6_v3: R(a∼P) + P3() -> A(b∼P,r!1).R(a∼P!1) kp4
Rule6_v4: R(a∼P) + P4() -> A(b∼P!1,r!2).B(c,r!1).R(a∼P!2) kp4
Rule6_v5: R(a∼P) + P5() -> A(b∼P!1,r!2).B(c!3,r!1).C(b!3).R(a∼P!2) kp4
Rule6r_v1: A(r!1).R(a∼P!1) -> R(a∼P) + A(r) km4
Rule7_v1: R(b∼P) + B(r) -> B(r!1).R(b∼P!1) kp5
Rule7_v2: R(b∼P) + P6() -> B(c,r!1).R(b∼P!1) kp5
Rule7_v3: R(b∼P) + P7() -> B(c!1,r!2).C(b!1).R(b∼P!2) kp5
Rule7r_v1: B(r!1).R(b∼P!1) -> R(b∼P) + B(r) km5
Rule8_v1: B(c) + P8() -> B(c!1).C(b!1) kp6
Rule8_v2: P4() + P8() -> P5() kp6
Rule8_v3: P6() + P8() -> P7() kp6
Rule8r_v1: B(c!1).C(b!1) -> B(c) + P8() km6 DeleteMolecules
Rule8r_v2: P5() -> P4() + P8() km6
Rule8r_v3: P7() -> P6() + P8() km6
Rule9_v1: A(b∼0,r!1).R(a∼P!1) -> A(b∼P,r!1).R(a∼P!1) k7
Rule10_v1: A(b∼P) -> A(b∼0) k8
Rule10_v2: P3() -> P2() k8
Rule11_v1: A(b∼P) + B(r) -> A(b∼P!1).B(r!1) kp9
Rule11_v2: A(b∼P) + P6() -> A(b∼P!1).B(c,r!1) kp9
Rule11_v3: A(b∼P) + P7() -> A(b∼P!1).B(c!2,r!1).C(b!2) kp9
Rule11_v4: P3() + B(r) -> A(b∼P!1,r).B(r!1) kp9
Rule11_v5: P3() + P6() -> P4() kp9
Rule11_v6: P3() + P7() -> P5() kp9
Rule11r_v1: A(b∼P!1).B(r!1) -> A(b∼P) + B(r) km9
Rule11r_v2: P4() -> P3() + P6() km9
Rule11r_v3: P5() -> P3() + P7() km9
MapRule0: L(r) -> P1() klump
MapRule1: A(b∼0,r) -> P2() klump
MapRule2: A(b∼P,r) -> P3() klump
MapRule3: A(b∼P!1,r).B(c,r!1) -> P4() klump
MapRule4: A(b∼P!1,r).B(c!2,r!1).C(b!2) -> P5() klump
MapRule5: B(c,r) -> P6() klump
MapRule6: B(c!1,r).C(b!1) -> P7() klump
MapRule7: C(b) -> P8() klump
end reaction rules
end model
## model actions ##
simulate_nf ({t_end=>40, n_steps =>120,gml = >1000000 , verbose =>1})
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APPENDIX H
SEPSIS MODELS, COMPLETE BNGL SOURCE
H.1 SEPSIS MODEL 1
# Sepsis Model #1, BNGL format
version ("2.2.3")
begin model
begin parameters
# compartment volumes. See "the Laboratory Rat". Sharp , et al. 1998.
# 250 g rat , extracell. fluid: 74.2 ml (incl. plasma), plasma: 7.8 ml
volB 7.8 # ml
volP 7.8 # ml
volT 58.6 # ml
# initial conecentrations
P0 2000 # arbitrary units (a.u.)/ml
M0 50 # a.u./ml
E0 50 # a.u./ml
N0 500 # a.u./ml
# pathogen
sP_P 0.168 # pathogen growth rate , /hr
maxP 1e5 # max pathogen , a.u./ml
dP_P sP_P/maxP # pathogen competition , /(a.u./ml)/hr
# macrophage/pathogen
bMP 0.006 # path -macro binding rate , /(a.u./ml)/hr
sL_M 7.98 # IL1 production by macroph , pmol/hr/a.u.
dP_M 2.76 # path. elimination rate , after binding , /hr
# neutrophil/pathogen
bNP 0.006 # path -neutr binding rate , /(a.u./ml)/hr
dP_N 2.76 # path. elimination rate , after binding , /hr
sA_N 6.0 # IL1ra production by neutro., pmol/hr/a.u.
# neutrophil source/death
sN_B 30.0 # source of neutrophils in blood , a.u./hr
dN 0.06 # decay rate of neutr. /hr
# IL1 ,IL1ra receptor binding
bLE 0.0046 # IL1 -IL1R binding rate , /pM/hr (Kd = 150pM)
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uLE 0.70 # IL1 -IL1R unbinding rate , /hr
# endothelial cells
aE_L 600. # endo. activation rate , step 1, /hr (fast)
aE 0.348 # endo. activation rate , step 2, /hr (slow)
dE 0.174 # rate of endo. de-activation , /hr
# neutrophil recruitment
bEN 0.00498 # endo -neutr binding rate , /(a.u./ml)/hr
tN_E 4.14 # migration rate , /hr
# cytokine "leak" between tissues to blood
tL_PB 1.4 # transport rate IL1 ,IL1ra from P to B, /hr
tL_TB tL_PB # transport rate IL1 ,IL1ra from P to B, /hr
tL_BP volP/volB*tL_PB # transport rate IL1 ,IL1ra from B to P /hr
tL_BT volT/volB*tL_TB # transport rate IL1 ,IL1ra from B to T /hr
# cytokine elimination
dL 1.4 # elimination rate IL1 ,IL1ra , /hr
end parameters
begin compartments
B 3 volB # blood
eP 2 volP /10 B # peritoneal endothelium
P 3 volP eP # peritoneum
eT 2 volT /10 B # tissue endothelium
T 3 volT eT # tissue
end compartments
begin molecule types
Path(ph) # pathogen
Mphage(p) # macrophage
IL1(b) # ligand (IL1)
IL1ra(b) # receptor antagonist (IL1ra)
Neutro(p,e) # neutrophil
Endo(n,a∼0∼1∼2,r,r,r) # endothelial cell
end molecule types
begin seed species
@P: Path(ph) P0*volP
@P: Mphage(p) M0*volP
@T: Mphage(p) M0*volT
@eP: Endo(n,a∼0,r,r,r) E0*volP
@eT: Endo(n,a∼0,r,r,r) E0*volT
@B: Neutro(p,e) N0*volB
end seed species
begin observables
Molecules Path_P @P:Path()
Molecules Neutr_P @P:Neutro ()
Molecules Neutr_B @B:Neutro ()
Molecules Neutr_T @T:Neutro ()
Molecules IL1_P @P:IL1(b)
Molecules IL1_B @B:IL1(b)
Molecules IL1_T @T:IL1(b)
Molecules IL1ra_P @P:IL1ra(b)
Molecules IL1ra_B @B:IL1ra(b)
Molecules IL1ra_T @T:IL1ra(b)
Molecules Act_Endo_P @eP:Endo(a∼2)
Molecules Total_Endo_P @eP:Endo()
Molecules Act_Endo_T @eT:Endo(a∼2)
Molecules Total_Endo_T @eT:Endo()
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end observables
begin reaction rules
# logistic pathogen growth
Path(ph) -> Path(ph) + Path(ph) sP_P
Path(ph) + Path(ph) -> Path(ph) dP_P
# macrophage binding P, cytokine prod., and phagocytosis
Path(ph) + Mphage(p) -> Path(ph!1). Mphage(p!1) bMP
Mphage(p!1). Path(ph!1) -> Mphage(p!1). Path(ph!1) + IL1(b) sL_M
Path(ph!1). Mphage(p!1) -> Mphage(p) dP_M
# neutrophil binds P and phagocytoses
Path(ph) + Neutro(p,e) -> Path(ph!1). Neutro(p!1,e) NP
Path(ph!1). Neutro(p!1) -> Neutro(p) dP_N
# neutrophils secrete IL1ra after migration
Neutro@P -> Neutro@P + IL1ra(b)@P sA_N
Neutro@T -> Neutro@T + IL1ra(b)@T sA_N
# source and decay of neutrophils
0 -> Neutro(p,e)@B sN_B
Neutro -> 0 dN DeleteMolecules
# binding of IL1 ,IL1ra to endothelial cells
IL1(b)@P + Endo(r) <-> IL1(b!1)@P.Endo(r!1) bLE , uLE
IL1ra(b)@P + Endo(r) <-> IL1ra(b!1)@P.Endo(r!1) bLE , uLE
IL1(b)@T + Endo(r) <-> IL1(b!1)@T.Endo(r!1) bLE , uLE
IL1ra(b)@T + Endo(r) <-> IL1ra(b!1)@T.Endo(r!1) bLE , uLE
# activation/deactivation of endothelial cells
Endo(a∼0,r!1,r!2). IL1(b!1). IL1(b!2) \
-> Endo(a∼1,r!1,r!2). IL1(b!1). IL1(b!2) aE_L
Endo(a∼1) -> Endo(a∼2) aE
Endo(a∼2) -> Endo(a∼0) dE
# binding of neutrophils to activated endothelium
Endo(n,a∼2) + Neutro(e)@B -> Endo(n!1,a∼2). Neutro(e!1)@B bEN
# migration of neutrophils across enothelium
Endo(n!1) @eP.Neutro(e!1)@B -> Endo(n)@eP + Neutro(e)@P tN_E
Endo(n!1) @eT.Neutro(e!1)@B -> Endo(n)@eT + Neutro(e)@T tN_E
# leaking IL1 ,IL1ra to blood
IL1(b)@P <-> IL1(b)@B tL_PB , tL_BP
IL1(b)@T <-> IL1(b)@B tL_TB , tL_BT
IL1ra(b)@P <-> IL1ra(b)@B tL_PB , tL_BP
IL1ra(b)@T <-> IL1ra(b)@B tL_TB , tL_BT
# elimination of IL1 ,IL1ra from blood
IL1(b)@B -> 0 dL
IL1ra(b)@B -> 0 dL
end reaction rules
end model
H.2 SEPSIS MODEL 2
# Sepsis Model #2A, BNGL format
# Neutrophil recruitment is linear in tissue cytokine
# with inhibition by blood cytokine
version ("2.2.3")
begin model
begin parameters
228
# volume params
vP 15.6 # ml , interstitial volume , Peritoneal compartment
vB 15.6 # ml , plasma volume , Blood compartment
vL 15.6 # ml , interstitial volumne , Lung compartment
# init conditions
mT0 1e2 # 10^3/ml , resident macrophage in tissue
nB0 4.5e3 # 10^3/ml , baseline circulating neutrophils
CLP0 1 # a.u./ml , initial CLP condition
# CLP healrate
dclp 0.12 # /hr , CLP progression rate
# pathogen params
kpclp 4200 # 10^3/hr , source of pathogen from CLP
kp 0.174 # /hr , pathogen growth parameter
pmax 1e6 # 10^3/ml , maximum pathogen (logistic form)
kpn 3 # /hr , max elimination rate of pathogen (per neutrophil)
xpn 1e3 # 10^3/ml , conc. of pathogen resulting in half -max elim.
# cytokine params
kc 6 # /ml/hr , max production of cytokine
xcp 1e3 # 10^3/ml , conc. of pathogen for half -max cytokine prod.
xcn 1e3 # 10^3/ml , conc. of neutro. for half -max cytokine prod.
dcT 0.36 # /hr , cytokine elimination rate in tissue
dcB 1.0 # /hr , elimination rate in blood
kcBT 0.36 # /hr , cytokine transport rate between blood to tissue
# neutrophil params
dn 0.06 # /hr , death rate of neutrophils
knc 300 # 10^3/hr/ml , max neutrophil migration (/ml of tissue)
xnc 1 # /ml , conc. of tissue cytokine for half -max neutr. migr.
incB 1 # /ml , conc. of blood cytokine for
# half -max inhibition of neutrophil migr.
end parameters
begin molecule types
Path()
Cyto()
Mphage ()
Neutro ()
CLP(s∼0∼1)
end molecule types
begin compartments
B 3 vB # blood
P 3 vP # peritoneum
L 3 vL # lung
end compartments
begin seed species
Path@P 0
Cyto@P 0
Cyto@B 0
Cyto@L 0
Mphage@P mT0*vP
Mphage@L mT0*vL
Neutro@P 0
$Neutro@B nB0*vB
Neutro@L 0
CLP@P(s∼0) CLP0*vP
end seed species
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begin observables
Molecules PathP Path@P
Molecules CytoP Cyto@P
Molecules CytoB Cyto@B
Molecules CytoL Cyto@L
Molecules CLP CLP@P(s∼1)
Molecules NeutroP Neutro@P
Molecules NeutroB Neutro@B
Molecules NeutroL Neutro@L
end observables
begin reaction rules
# CLP "healing"
CLP(s∼0) -> CLP(s∼1) dclp
CLP(s∼1) -> 0 dclp
# source of pathgoen
CLP(s∼1) -> CLP(s∼1) + Path kpclp
# logistic growth
Path -> Path + Path kp*(1-( PathP/vP)/pmax)
# phagocytosis by resident phagocytes
Mphage + Path -> Mphage kpn/(xpn + PathP/vP)
# phagocytosis by recruited phagocytes
Neutro + Path -> Neutro kpn/(xpn + PathP/vP)
# cytokine production (due to Pathogen presence or Neutrophil activity)
Mphage@P -> Mphage@P + Cyto@P \
kc/mT0 *(( PathP/vP/xcp )^2 + (NeutroP/vP/xcn )^2) \
/(1 + (PathP/vP/xcp)^2 + (NeutroP/vP/xcn )^2)
Mphage@L -> Mphage@L + Cyto@L \
kc/mT0*( NeutroL/vL )^2/(( xcn^2 + NeutroL/vL)^2)
# cytokine "leak" into blood compartment
Cyto@P <-> Cyto@B kcBT , kcBT*vP/vB
Cyto@L <-> Cyto@B kcBT , kcBT*vL/vB
# cytokine elimination
Cyto@P -> 0 dcT
Cyto@B -> 0 dcB
Cyto@L -> 0 dcT
# neutrophil recruitment
Neutro@B -> Neutro@P \
(knc*incB/xnc)*( CytoP/vP)/( incB + (CytoB/vB))*vP/(nB0*vB)
Neutro@B -> Neutro@L \
(knc*incB/xnc)*( CytoL/vL)/( incB + (CytoB/vB))*vL/(nB0*vB)
# neutrophil elimination
Neutro -> 0 dn
end reaction rules
end model
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